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Abstract 
 
Anaesthesia is a reversible pharmacological state of the patient where hypnosis, analgesia 
and muscle relaxation are guaranteed and maintained throughout the surgery. Analgesics 
block the sensation of pain; hypnotics produce unconsciousness, while muscle relaxants 
prevent unwanted movement of muscle tone. 
Controlling the depth of anaesthesia is a very challenging task, as one has to deal with 
nonlinearity, inter- and intra-patient variability, multivariable characteristics, variable 
time delays, dynamics dependent on the hypnotic agent, model analysis variability, agent 
and stability issues. The modelling and automatic control of anaesthesia is believed to (i) 
benefit the safety of the patient undergoing surgery as side-effects may be reduced by 
optimizing the drug infusion rates, and (ii) support anaesthetists during critical situations 
by automating the drug delivery systems. 
In this work we have developed several advanced explicit/multi-parametric model 
predictive (mp-MPC) control strategies for the control of depth of anaesthesia. State 
estimation techniques are developed and used simultaneously with mp-MPC strategies to 
estimate the state of each individual patient, in an attempt to overcome the challenges of 
inter- and intra- patient variability, and deal with possible unmeasurable noisy outputs.  
Strategies to deal with the nonlinearity have been also developed including local 
linearization, exact linearization as well as a piece-wise linearization of the Hill curve 
leading to a hybrid formulation of the patient model and thereby the development of 
multiparametric hybrid model predictive control methodology. To deal with the inter- and 
intra- patient variability, as well as the noise on the process output, several robust 
techniques and a multiparametric moving horizon estimation technique have been design 
and implemented. 
All the studies described in the thesis are performed on clinical data for a set of 12 
patients who underwent general anaesthesia. 
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1. Chapter 1 
Introduction 
 
1.1 Anaesthesia Process 
 
Nowadays, general anaesthesia is an irreplaceable adjunct to modern surgery. Before the 
advent of anaesthesia, surgical procedures demanded extremely fast execution. The 
alteration of senses using drugs (opium, laudanum) and alcohol was well known since 
antiquity. The first recorded anaesthesia procedure was performed in 1842 using inhaled 
ether to deprive patient of their sense during surgery. The term “anaesthesia” (meaning 
no ability to sense, the word anaesthesia originates from the greek word "aisthesis" which 
means sensation and the prefix "an" is used for negation) was proposed to describe this 
new phenomenon.  
General anaesthesia ensures that patients are unconscious, feel no pain, have no memory 
of the surgery, remain still during the operation and have adequate autonomic nervous 
system, respiratory and cardiac responses to keep them alive. Achieving this is possible 
by using a variety of drugs (anaesthetics). 
The practice of modern clinical anaesthesia is based on the concepts of the anaesthesia 
triad and balanced anaesthesia shown in Figure 1.1. Anaesthesiologists administer a 
combination of drugs and adjust several infusion devices to achieve an adequate balance 
between hypnosis, analgesia and muscle relaxation of the patient. 
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Figure 1.1: Anaesthesia components 
 
Hypnosis describes a state of anaesthesia related to patient drug induced unconsciousness 
where the patient neither perceives nor recalls (amnesia) noxious stimuli i.e., stimuli 
associated with transmission of pain during events that occurred during surgery. The 
disability to recall is important because during surgery the patient might feel pain and be 
aware of the surgical procedures but cannot communicate this to the clinical staff. This 
awareness can be a traumatic experience, which is feared by the patients as well as the 
anaesthetists and should be avoided by maintaining sufficient hypnosis depth in the 
patient.  
Analgesia describes a special state of anaesthesia related to the disability of the patient to 
perceive pain. Surgical procedures are painful and can discomfort the patient. Although 
the patient is unconscious, may perceive the pain and this can alter the general 
anaesthesia state, if analgesics are not administered. A stable analgesia state is partially 
responsible for a stable hypnosis and vice versa. It is important to have a balance between 
hypnosis and analgesia.  
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Skeletal muscles relaxation or neuromuscular blockade is a standard practice during 
general anaesthesia to facilitate the access to internal organs and to depress movement 
responses to surgical stimulations. Many surgical procedures require skeletal muscle 
relaxation to improve surgical conditions or to reduce surgical risks caused by 
movements of the patients. 
There exists no single device, which accurately measures or estimates the anaesthetic 
state of the patient. However, the anaesthetic state is reflected in patient signs and 
biological signals. Patient signs reflecting the anaesthetic state involve response to 
speech, eyelash reflex, the constriction of the pupil of the eye, grimacing and other 
movement, breathing pattern, lachrimation and perspiration (Barash et al., 2009) and are 
relatively hard to measure online. Almost all mentioned patient signs indicate an 
excessively low anaesthetic depth. The heart rate, blood pressure, blood oxygen 
saturation and blood or end-tidal carbon dioxide concentrations are patient biological on-
line measurable quantities reflecting the anaesthetic state. These are monitored in every 
modern operating room. For example, noxious stimulation increases blood pressure and 
heart rate when the anaesthesia depth is inadequately low. Monitoring the blood carbon 
dioxide concentrations provide surrogate measures of the analgesia depth. 
Hypnosis and analgesia are the result of different pharmacological mechanisms within 
the central nervous system and it is not possible to be directly measured. Although there 
is no direct measure of unconsciousness or pain, there exist patient signs that can be 
sufficiently correlated with these anaesthesia states. Since consciousness is processed at 
the brain level, it is reasonable to assume that electroencephalogram signals (EEG), 
which reflect the brain activity, can be used to determine depth of drug induced 
unconsciousness. There are a number of signal processing tools and techniques available 
to quantify the EEG in order to derive an indirect measurement of hypnosis. To date there 
exist several anaesthesia monitors based on such indirect techniques, including the 
Bispectral Index (BIS) monitor (Johansen et al., 2000a), the State Entropy (SE) and 
Response Entropy (RE) monitors (Viertö-Oja et al.), the NeuroSENSE monitor (Bibian et 
al., 2011), the Cerebral State Index (CSI) monitor (Jensen et al., 2006) and the A-line 
monitor (Litvan et al., 2002). The BIS monitor is by far the clinically most wide-spread. 
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Bispectral analysis is a statistical technique that allows study of phenomena with 
nonlinear character such as surf beats and wave breaking (Rosenblatt et al., 1972). 
Bispectral analysis represents a different description of the EEG in that interfrequency 
phase relationships are measured, i.e., the bispectrum quantifies relationships among the 
underlying sinusoidal components of the EEG (Rampil, 1998, Sigl et al., 1994). Several 
variables from the EEG time domain (burst suppression) (Bruhn et al., 2000) and 
frequency domain (power spectrum, bispectrum, beta ratio, SynchFastSlow) are 
combined into a single index of hypnotic level. The weight factors of the various 
subparameters were assigned in a multivariate model based on a prospectively collected 
database of EEG recordings matched to corresponding states of hypnosis and to hypnotic 
drug levels. The BIS algorithm uses a complex formula (Johansen, 2006) with advanced 
artifact rejection techniques to define a dimensionless BIS value from 0 (isoelectric EEG) 
to 100 (alert and oriented) that is relatively independent of hypnotic agent. Awake, 
unpremedicated patients have BIS values at or above 93 (Figure 1.2). Loss of recall 
(<10%) occurs at BIS values of 75–80 (Iselin-Chaves et al., 1998). BIS correlates tightly 
with sedation scales such as the Observer’s Assessment of Awareness and Sedation 
(OAA/S) (Glass et al., 1997) during midazolam (Liu et al., 1996), propofol (Liu et al., 
1997, Irwin et al., 2002) or multiple hypnotic agents (Ibrahim et al., 2001, Mi et al., 
1999) administration. In these studies, loss of response to mild prodding (transition 
OAA/S 2–1) was defined as loss of consciousness and correlated to BIS values between 
68 and 75. BIS values of ≤60 have been associated with a low probability of recall and a 
high probability of unresponsiveness during surgery under general anaesthesia (Liu et al., 
1997). BIS values between 40 and 60 have been recommended for anaesthetic 
maintenance during general anaesthesia (Johansen et al., 2000b). Blinded observation of 
practitioners attempting a rapid emergence resulted in hypnotic maintenance at BIS 
values in the high 30s to low 40s corresponding to deep sedation and near burst 
suppression (Gan et al., 1997). As the BIS falls from the mid 30 s to zero, EEG burst 
suppression increases to cortical silence. BIS responds monotonically to increasing 
hypnotic drug dose (volatile or intravenous) across the entire spectrum of awareness, 
independent of agent, and is not significantly influenced by opioids (Johansen and Sebel, 
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2000a) . BIS does not monitor analgesia and does not predict spinal cord reflexes to 
painful stimuli such as movement or hemodynamic responses (Johansen and Sebel, 
2000a).  
 
Figure 1.2: Bispectral index (BIS) scale. Dimensionless scale from 0 (complete 
cortical EEG suppression) to 100 (awake) 
 
Significant EMG (electromyographic) activity may be present in sedated, spontaneously 
respiring patients, interfering with EEG signal acquisition and contaminating the BIS 
calculation. Conventionally, EEG signals are considered to exist in the 0.5–30 Hz band 
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and EMG signals in the 30–300 Hz band (although BIS uses EEG signals up to 47 Hz). 
This separation is not absolute, and low frequency EMG signals can occur in the 
conventional EEG band range. This EMG activity may be interpreted as high frequency, 
low amplitude waves, falsely elevating the BIS. Similarly, falsely elevated BIS values 
can also occur with high electrode impedances produced by inadequate electrode 
attachment or misplacement. Improvements in the BIS algorithm have focused on 
steadily decreasing the impact of EMG contamination in both anaesthetic and sedative 
ranges. An alert clinician needs to assess signal quality (SQI, Figure 1.3), EMG activity 
and BIS trend with relation to the clinical state of the patient prior to making any 
treatment decisions. 
 
Figure 1.3: Bispectral index XP monitor(Johansen, 2006) 
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The analgesia functional component of anaesthesia has not received yet enough attention. 
In recent years there are several studies with the aim of developing such devices based on 
indirect indicators but without sufficient demonstration of their scientific base. The 
widely accepted indirect measures are the hemodynamic variables like blood pressure 
and heart rate variability. The changes in respiratory rate and blood carbon dioxide 
concentrations can also provide an indirect measurement for the depth of analgesia. 
Monitoring the degree of muscle relaxation (neuromuscular blockade) can be performed 
by measuring the response to nerve stimulation using different techniques, by including 
mechanomyography (MMG), electromyography (EMG), acceleromyography (AMG). 
MMG is the measurement of evoked muscle tension, EMG is a method for evaluating the 
electrical activity produced by skeletal muscles and AMG is the measurement of 
acceleration of the contracting muscle. Small battery operated units are now available 
that are relatively inexpensive, easy to set up, and provide a measure the degree of 
neuromuscular blockade. 
In general anaesthesia the choice of anaesthetic drug assumes a fundamental role. Drugs 
given to induce and maintain anaesthesia can be either as gases or vapours (inhalational 
anaesthetics), or as injections (intravenous anaesthetics). Intravenous medications are 
given directly into a vein. Intravenous anaesthetic agents are used commonly to induce 
anaesthesia, as induction is usually smoother and more rapid than that associated with 
most of the inhalational agents. Intravenous anaesthetics administered as repeated bolus 
doses or by continuous infusion may also be used for maintenance of anaesthesia, either 
alone or in combination with inhalational agents. An advantage of inhaled anaesthetics is 
that measuring the difference between inhaled and exhaled concentrations allows an 
accurate estimation of plasma or brain drug uptake.  
Commonly used intravenous drugs are pure hypnotic drugs. Propofol is a relatively new 
intravenous drug, and has become widely accepted as the standard drug for intravenous 
anaesthesia. It has both fast redistribution and metabolism and does not accumulate in 
tissues as some of the other drugs. Unlike inhaled drugs, it is not possible to measure the 
effect site (brain) concentration of propofol in real-time. This disadvantage is outweighed 
by the possibility of precise titration by means of electronically controlled intravenous 
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infusion pumps. Besides, it is common practice to estimate the effect site drug 
concentration using mathematical patient models. The property of this drug to be purely 
hypnotic allows for decoupled control of the hypnotic and analgesic components of 
anaesthesia. Furthermore, the use of propofol is associated with low incidence of 
postoperative nausea and vomiting compared to other hypnotic drugs (Borgeat et al., 
1992). This decreases the duration of postoperative care and ultimately patient mortality. 
 
1.2 Control in anaesthesia 
 
From an input-output point of view the anaesthesia process includes manipulated 
variables that can be intravenous anaesthetics, volatile anaesthetics, muscle relaxants, 
ventilation parameters and vasodilators as well as disturbances, such as surgical stimulus 
and blood loss (Figure 1.4). The three non-measurable main components of anaesthesia 
are hypnosis, analgesia and muscle relaxation and they represent the controlled outputs. 
Since these outputs can not be measured directly a connection to the measurable outputs 
such as EEG parameters, hart rate, blood pressure, Bispectral index should be inferred. 
 
Figure 1.4: Input/Output representation of the anaesthesia 
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When inducing and maintaining anaesthesia, anaesthesiologists select initial doses based 
on a variety of considerations, they observe the results, and then make adjustments based 
on several factors, at irregularly varying intervals. In control engineering terminology, 
this constitutes a closed loop control system, due to the feedback present in the 
observations and interventions of the anaesthesiologist. This closed-loop control system 
has a special nature; (i) it has a human controller in the loop, and (ii) the control actions 
are intermittent and irregular in time due to the human controller. 
The purpose of computer-controlled closed-loop systems is to formalize the process of 
observation and intervention in order to provide better and more accurate control. Such 
systems use a near continuous signal of drug effect, calculate the error between the 
observed value and the setpoint value (selected by the user), and use this error in an 
algorithm to make frequent and regular adjustments to drug administration rates. 
Moreover, some computer-control systems try to predict the future drug effect so that 
better adjustments can be done in advance (Absalom et al., 2011). 
In order to have an accurate feedback control the process being controlled should be 
defined, and one or more real-time representative measures of the system state should be 
available. In engineering terms this means that the latter signals are designated as the 
process output/s, which have to be controlled according to certain agreed specifications. 
In an ideal case the control actuators or process input/s should, with minimal or known 
delay, cause predictable, linear changes in the process. 
The process of anaesthesia is rather complex and not well understood, resulting in a 
challenging control problem. Our current state of the art understanding of consciousness 
and the mechanisms of anaesthetic-induced loss of consciousness is rather limited. 
Consciousness is so ethereal that it is difficult to model. At present models are available, 
such as the mean field models of drug action, (Absalom et al., 2011) which describe 
phenomena in the electroencephalogram associated with different brain states. The 
anaesthetic literature is replete with references to “depth of anaesthesia,” implies that 
anaesthesia is a continuous function of effect-site concentration; however systems such as 
the brain are commonly nonlinear, bistable systems (Foster et al., 2008, ASA, 2006). 
The application of a closed-loop technology to drug delivery will assist physicians in 
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avoiding excessive over-dosages and under-dosages in their patients  (Westenskow, 
1997), optimizing the delivery of anaesthetics. Ideally, a robust controller would then 
tackle over-dosing and under-dosing by compensating for nonlinear drug responses, 
varying time delay, as well as inter and intra-patient variation. From a control 
engineering standpoint, Model Predictive Control (MPC) can play a crucial role in 
addressing some of the issues related to a closed loop technology, especially. (Torrico et 
al., 2007) Predictive control has advantages over other forms of automatic control in that 
it is robust against variable and unknown time-delay, over parameterization of system 
models, and has good disturbance rejection properties. It does, however, have a number 
of design parameters which must be adjusted carefully to suit the particular application 
and achieve the desired control performance. Model Based Predictive Control (MBPC) is 
a control methodology which uses on-line (=done while connected) a process model for 
calculating predictions of the future plant output and for optimizing future control 
actions. In fact MBPC is not a single specific control strategy but rather a family of 
control methods which have been developed with certain ideas in common (Keyser, 
2003). 
As shown in Figure 1.4, the control of anaesthesia poses a manifold of challenges: inter- 
and intra-patient variability, multivariable characteristics, variable time delays, dynamics 
dependent on the hypnotic agent, model analysis variability, agent and stability issues 
(Haddad et al., 2003), (Absalom et al., 2011), (Morley et al., 2000). In the open literature 
PID tuning techniques have been proposed. Since these classical controllers have no prior 
knowledge of the drug metabolism they cannot anticipate the response of the patient and 
their performance may be sub-optimal. Other authors developed model based strategies 
using fuzzy (Curatolo et al., 1996), predictive (Struys et al., 2003), (Ionescu et al., 2008), 
(Niño et al., 2009), (Hodrea et al., 2012), robust (Caiado Daniela et al., 2013), (Dumont 
et al., 2009) and adaptive (Haddad et al., 2003), (Nascu et al., 2012) control algorithms 
and applied them in clinical trials. 
As discussed earlier, drugs that are given for the induction and maintenance of general 
anaesthesia can be either inhalational or intravenous anaesthetics. An individualised 
physiological based, patient specific, compartmental model for volatile anaesthesia is 
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presented and developed in (Krieger et al., 2012) and a combined strategy of model 
predictive control (MPC) and estimation under uncertainty is presented in (Krieger et al., 
2014). For intravenous anaesthesia, robustness tests of MPC for depth of anaesthesia 
(DOA) control using the EPSAC (Extended Predictive Self Adaptive Controller) for a 
single input single output (SISO) model are presented in (Ionescu et al., 2011c), different 
protocols for the administration of Propofol and Remifentanil leading to a multiple input 
single output (MISO) model are evaluated in (Nascu et al., 2011) and in (Ionescu et al., 
2012) a second output variable is determined, that originates from the effect of 
Remifetanil and leads to the implementation of a multiple input multiple output (MIMO) 
algorithm. 
 
1.3 Project Objectives 
 
As discussed in the previous sections, a suitable control system for anaesthesia must be 
reliable and robust, transparent to the anaesthetist and must be applicable in clinical 
routine environment.  
 
Figure 1.5: Automated control of depth of anaesthesia 
 
The main objective of this research is to develop advanced control strategies for the 
control of intravenous anaesthesia. Specific aims include: 
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 The development of model based predictive control (MPC) strategies that account 
for the complex interactions in anaesthesia and the constraints imposed for patient 
safety 
 The development of explicit MPC strategies to increase the transparency and 
reliability of the control system solution and it’s acceptability to the anaesthetist 
 The employment of robust control strategies to address issues related to inter- and 
intra- patient variability. 
 The employment of estimation techniques to overcome issues related to 
unmeasurable data and process noise 
 The employment of hybrid MPC to deal with the nonlinearity and the inter- and 
intra- patient variability 
 
1.4 Thesis Outline 
 
In this thesis we have developed explicit MPC strategies for the control of depth of 
anaesthesia in the induction and maintenance phases. State estimation techniques are 
developed and implemented simultaneously with mp-MPC strategies to estimate the state 
of each individual patient. Furthermore, a hybrid formulation of the patient model is 
performed leading to a hybrid mp-MPC that is further implemented using several robust 
techniques. 
 
The thesis is organized as follows: 
 
Chapter 2: describes strategies toward model-based automation of intravenous 
anaesthesia employing advanced control techniques. In particular, based on a detailed 
compartmental mathematical model featuring pharmacokinetic and pharmacodynamics 
information, two alternative model predictive control strategies are presented: a model 
predictive control strategy, based on online optimization, the extended predictive self-
adaptive control and a multiparametric control strategy based on offline optimization, the 
multiparametric model predictive control.  
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Chapter 3: describes different design strategies for simultaneous muliparametric model 
predictive control and state estimation for intravenous anaesthesia. Three estimation 
techniques are implemented and compared: Kalman filter, offline and online moving 
horizon estimation. The state estimators are then implemented and tested simultaneously 
with multi-parametric model predictive controllers for real patient data. The estimators 
and the designed advanced control strategies are tested in both situations with and 
without noise influencing the measured output of the process. 
 
Chapter 4: reformulates the intravenous anaesthesia model as a hybrid model leading to 
a hybrid model predictive control problem thus overcoming the nonlinearity issue. The 
resulting problem is solved explicitly via the solution of a multi-parametric mixed integer 
quadratic programming problem. To deal with the inter- and intra- patient variability, an 
estimation strategy and different robust algorithms are designed and implemented with 
the hybrid multiparametric model predictive control. 
 
Chapter 5: describes PAROC, an integrated framework software platform for the 
development of explicit model predictive controllers. First, the main features of PAROC, 
including, high fidelity modelling, state-of-the-art multiparametric optimization 
techniques, explicit/multiparametric model predictive control strategies and a closed loop 
validation step are presented. The PAROC framework is applied on the anaesthesia 
process, in particular for the development of explicit/multiparametric model predictive 
controllers for the induction and maintenance phases of both intravenous and volatile 
anaesthesia. 
 
Chapter 6 presents concluding remarks together with the future potential extensions of 
the current work. 
 
Note that all theoretical aspects used throughout the thesis are presented in detail in the 
Appendix. 
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Appendix A presents the Sensitivity Analysis theory and current state of the art 
including: (i) Sobol’s Sensitivity Analysis, (ii) High Dimensional Model Representation 
(HDMR), (iii) Group Method of Data Handling (GMDH) and (iv) GMDH – HDMR 
Appendix B presents Model Reduction theory and current state of the art and presents 
both linear and nonlinear model order reduction 
Appendix C depicts the theory on multiparametric programming 
Appendix D presents theory on advanced model based control including the Extended 
Predictive Self Adaptive Control (EPSAC) and multiparametric Model Predictive Control 
(mp-MPC) 
Appendix E depicts estimation techniques starting with the Kalman filter, followed by 
moving horizon estimation and the formulation as a multiparametric moving horizon 
estimation 
Appendix D presents the application of the PAROC framework on a different case study 
– a distillation column  
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2. Chapter 2 
A Multiparametric Model Based Approach to 
Intravenous Anaesthesia 
 
2.1 Introduction 
 
Anaesthesia plays a very important role in surgery and in the intensive care unit (ICU). 
Moreover, the role of the anaesthetist has become more complex and indispensable to 
maintain the patients’ vital functions before, during, and after surgery. To estimate the 
drug effect in the patient’s body and calculate the corresponding drug infusion rates, 
average population models are used. These strategies may not always be safe for the 
patient since they do not take into account any measured variable in a feedback control 
scheme and even if they reach the desired level of sedation fast, it can result in unsafe 
minimal values (undershoot) (Bailey et al., 2005). In stress situations the anaesthetist has 
to deal with routine assessments and simultaneously solve complex problems quickly. 
The automation of some routine actions of the anaesthetist can reduce the workload and 
consequently increase the safety of the patient. 
Hitherto, many PID tuning techniques have been elaborated. Since these classical 
controllers have no prior knowledge of the drug metabolism they cannot anticipate the 
response of the patient and their performance may be sub-optimal. Therefore, model 
based strategies using fuzzy (Curatolo et al., 1996), predictive (Struys et al., 2003, 
Ionescu et al., 2008, Niño et al., 2009, Hodrea et al., 2012), robust (Caiado Daniela et al., 
2013, Dumont et al., 2009) and adaptive (Haddad et al., 2003, Nascu et al., 2012) control 
algorithms have been developed and applied in clinical trials. 
Model predictive control (MPC) is a model-based control technique that calculates the 
optimal control action considering constraints on the input, output, and state variables by 
solving an optimization problem. The downside of this control technique is that the 
optimization problem has to be solved online. One way to avoid this is to use 
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explicit/multiparametric model predictive control, which solves offline the optimization 
problem using multiparametric programming and derives the control inputs as a set of 
explicit functions of the system states. An important advantage of the multiparametric 
model predictive control (mp-MPC) is that the previously offline computed control laws 
can be easily implemented on embedded controllers. These types of devices use 
programming languages that cannot support powerful mathematical computations. The 
optimal control laws are retrievable immediately through simple function evaluations.  
The aim of this chapter is to design and compare four different types of model-based 
controllers for administration of Propofol during the intensive care unit (ICU) sedation. 
Based on a compartmental pharmacokinetic (PK) and pharmacodynamic (PD) patient 
model, global sensitivity analysis is first presented to determine the relative influence of 
the uncertain pharmacokinetic and pharmacodynamic parameters and variables. Then, a 
model predictive controller is designed using an Extended Predictive Self Adaptive 
Control (EPSAC) strategy and three explicit model predictive controllers are designed 
using an mp-MPC strategy. The difference between the three controllers based on the 
mp-MPC strategy is that one of them uses the local linearized patient model, whereas the 
other two use the compensation of the nonlinear part of the patient model. In one of the 
two controllers using the nonlinear compensation, the states are estimated using an online 
estimator, while for the other one, the states are computed using the nominal patient 
model. 
This chapter is organized as follows: The patient model including the pharmacokinetic 
and pharmacodynamic model as well as the patient data used throughout this work are 
presented in Section 2.2. Based on the presented mathematical model, global sensitivity 
analysis is presented in Section 2.3. Section 2.4 presents the multiparametric control 
strategy, the EPSAC strategy and the design of the controllers. The simulation results of 
the designed controllers in the induction and maintenance phase and discussions are 
presented in detail in Section 2.5. Finally, Section 2.6 summarizes the main outcome of 
this chapter. 
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2.2 Patient Model 
For intravenous administration, the controlling drug enters the circulatory system, where 
under the action of the heart it is mixed and evenly distributed. The drug must diffuse out 
of the circulatory system into extracellular volumes before it reaches the target organ or 
cells. Because it acts on the target, the controlling drug may also be subject to excretion 
by the kidneys and intestines, as well as biotransformation and inactivation by organs 
such as the liver, the renal epithelium, and the intestinal mucosa. In this study, Propofol is 
used as the administrated hypnotic drug.  
The model used for prediction should not be too complex, so as not to take too much 
computational time. On the other hand it should capture very well the dynamics of the 
patient in response to the applied Propofol infusion rate. The relationship between the 
infusion rate of Propofol and its effect can be described with pharmacokinetic (PK) and 
pharmacodynamic (PD) models. PK model describes the distribution of Propofol in the 
body and PD model describes the relationship between Propofol blood concentration and 
its clinical effect. 
 
Figure 2.1: Intravenous anaesthesia - Compartmental model of the patient 
37 
 
The PK-PD models most commonly used for Propofol are the 4
th
 order compartmental 
model introduced by Schnider (Schnider et al., 1999) and Minto (Minto et al., 1997) 
respectively and presented in Figure 2.1. 
 
2.2.1 Pharmacokinetic Model 
Pharmacokinetics, sometimes described as what the body responses to to a drug, refers to 
the movement of drug into, through, and out of the body - the time course of its 
absorption, bioavailability, distribution, metabolism, and excretion. Drug 
pharmacokinetics determines the onset, duration, and intensity of a drug’s effect. 
The pharmacokinetic model (PK) is expressed by linear relations as follows: 
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 (Equation 2.1) 
 
where C1 represents the drug concentration in the central compartment [mg/l]. The 
peripheral compartments 2 (muscle) and 3 (fat) model the drug exchange of the blood 
with well and poorly diffused body tissues. The concentrations of drug in the fast and 
slow equilibrating peripheral compartments are denoted by C2 and C3 respectively. The 
parameters kij for i=1:3, i≠j, denote the drug transfer frequency from the i
th
 to the j
th 
compartment, k10 the frequency of drug removal from the central compartment and u(t) 
[mg/min] is the infusion rate of the anaesthetic or analgesic drug into the central 
compartment. The parameters kij of the PK models depend on age, weight, height and 
gender and can be calculated for Propofol (Nascu et al., 2014c) as follows.  
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(Equation 2.2) 
where Cl1 is the rate at which the drug is cleared from the body, and Cl2 and Cl3 are the 
rates at which the drug is removed from the central compartment to the other two 
compartments by distribution.  
The lean body mass (lbm) for men (m) and women (f) are calculated as follows: 
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2.2.2 Pharmacodynamic Model 
The pharmacodynamics describe the link of concentration of the anaesthetic agent to the 
effect of the drug. The pharmacodynamic (PD) mathematical model is presented as 
follows: 
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An additional hypothetical effect compartment is added to represent the lag between 
plasma drug concentration and drug response. Its corresponding drug concentration is 
represented by the effect-site compartment concentration Ce. The effect compartment 
receives drug from the central compartment by a first-order process and is considered as a 
virtual additional compartment. Therefore, the drug transfer frequency for Propofol from 
the central compartment to the effect site-compartment is considered in clinical practice 
to be equal to the frequency of drug removal from the effect-site compartment 
ke0=k1e=0.456 [min
-1
].(Schnider et al., 1998, Schnider et al., 1999, Nunes et al., 2009)  
When considering the drug effect observed on the patient, the Bispectral Index (BIS) 
variable can be related to the effect drug concentration Ce by the empirical static 
nonlinear relationship (Equation 2.5), (Struys et al., 2003, Ionescu et al., 2008, Schnider 
et al., 1998, Schnider et al., 1999, Nunes et al., 2009) also called the Hill curve, which 
corresponds to the second part of the PD model. E0 denotes the baseline value (awake 
state - without drug), which by convention is typically assigned a value of 100, Emax 
denotes the maximum effect achieved by the drug infusion, EC50 is the drug 
concentration at 50% of the maximal effect and represents the patient sensitivity to the 
drug, and γ determines the steepness of the curve. 
As discussed in Chapter 1, the Bispectral Index (BIS) is a signal that is derived from the 
electro-encephalogram (EEG) used to assess the level of consciousness during 
anaesthesia.A BIS value of 0 equals EEG silence, while a BIS value of 100 is the value of 
a fully awake and conscious adult, 60 - 70 and 40 - 60 range represents light and 
moderate hypnotic condition, respectively. The target value during surgery is 50, giving 
us a range between 40 and 60 to guarantee adequate sedation. 
The inverse of the Hill curve can also be defined as follows: 
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(Equation 2.1) – (Equation 2.6) complete the PK-PD patient model for intravenous 
anaesthesia. 
 
2.2.3 Patient Data 
For intravenous anaesthesia a data set of 12 virtually realistic generated patients (Ionescu 
et al., 2011c) plus an extra patient representing the average values of all 12 patients (PaN 
– patient nominal) is presented in Table 2.1 and used for the simulation studies. To 
generate the virtual patient population, the patient simulator was fed with 10 different 
pharamcodynamic profiles. The pharmacodynamic profile for a virtual patient was 
defined as a certain drug effect site concentration-versus-effect relation i.e., an Emax 
model combined with a certain additional delay that could be imposed by certain monitor 
types. To obtain realistic values, the Emax models derived from clinical work as calculated 
at the end of the induction phase using data points measured during the induction phase 
were used (Struys et al., 2001).  
The parameter values of these patients are also used to calculate the parameters of the 
patient model. For a particular patient, E0 can be measured in awake state and Emax is 
considered to have the same value, Emax= E0. These parameters are considered known a 
priori in the studies. 
 
Table 2.1: Biometric values of the 12 patients for intravenous anaesthesia 
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1 40 163 54 M 6.33 98.8 2.24 
2 36 163 50 M 6.76 98.6 4.29 
3 28 164 52 M 8.44 91.2 4.1 
4 50 163 83 M 6.44 95.9 2.18 
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5 28 164 60 F 4.93 94.7 2.46 
6 43 163 59 M 12.0 90.2 2.42 
7 37 187 75 F 8.02 92.0 2.1 
8 38 174 80 M 6.56 95.5 4.12 
9 41 170 70 M 6.15 89.2 6.89 
10 37 167 58 M 13.7 83.1 1.65 
11 42 179 78 F 4.82 91.8 1.85 
12 34 172 58 M 4.95 96.2 1.84 
Mean  38 169 65 M 7.42 93.1 3 
 
2.3 Sensitivity Analysis 
Based on the mathematical model presented in the previous subchapter, global sensitivity 
analysis is first applied, in particular, Sobol’s method of sensitivity indices, the high 
dimensional model representation (HDMR) approach and GMDH-HDMR to determine 
the relative influence of the PK-PD parameters and variables. GMDH-HDMR, relies on 
the direct construction of the HDMR expansion through GMDH inductive modelling. 
The applied methodologies are presented in detail in Appendix A. By analysing the 
anaesthesia model, it can be observed that the dynamics of the linear part is influenced by 
the age, height, weight and gender parameters. The characteristic of the nonlinear part is 
influenced by EC50, E0 and γ parameters. The relative influence of the uncertain PK and 
PD parameters and the variables on the measurable outputs is investigated. The 
sensitivity index (SI) represents the relative influence of the parameter or variable on the 
output at a given time. To perform the analysis, using the mathematical models presented 
in Section 2.2, an anaesthesia experiment was simulated. A step of 50 [mg/min] was 
applied on the anaesthetic drug infusion rate that represents the input of the model. The 
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evolution of the output was investigated for an interval of 100 minutes, until steady state 
regime is reached. During simulations all parameters and variables were varied between 
their bounds. S1-S7 represents the sensitivity index for age, height, weight, EC50, E0, γ 
and gender respectively. 
Figure 2.2 presents the evolution of the first order Sobol’ sensitivity indices at different 
sample points starting from t=2 minutes to t=100 minutes. At the beginning of 
anaesthesia E0, the baseline value (the awake state, without drug) has the highest 
sensitivity index with respect to the BIS but it converges asymptotically to 0 with time as 
the patient enters the deep anaesthesia state. Analysing the sensitivities indices from 
Figure 2.2, it is observed that the most important parameter is EC50 (sensitivity index 
S4), the drug concentration at 50% of the maximal effect, representing the patient 
sensitivity to the drug. Note that EC50 (S4) increases exponentially and stabilizes when 
the BIS reaches its steady state regime. Also note that because the nonlinearity is 
represented by a sigmoid, the parameter γ (S6), which determines the steepness of the 
curve, has more influence in the beginning of anaesthesia due to the high nonlinearity of 
this zone. Note also that the sensitivity indices of the parameters of the linear part (PK) 
(Equation 2.1), increase with the nonlinearity slope but the corresponding values are less 
important than the ones for the parameters of the nonlinear part (Equation 2.5). 
 
Figure 2.2: Evolution of the first order sensitivity indices 
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Figure 2.3: Comparison GMDH HDMR for small data samples (N=40) t=14 
 
Table 2.2 further depicts a comparison of the results obtained with the various techniques 
(i) Sobol’s Sensitivity Analysis, (i) GMDH-HDMR and (iii) HDMR reported for four of 
the parameters. These parameters are weight (S3), EC50 (S4), E0 (S5), γ (S6) and were 
chosen as they have the highest sensitivity index at t=14 minutes when using Sobol’s 
sensitivity analysis as presented in Figure 2.2. The GMDH-HDMR approach only 
computes the indices for the parameter it selects as important, therefore S1 (age), S2 
(height) and S7 (gender) are not calculated. 
Table 2.2: Sensitivity Analysis. Comparison of GMDH and HDMR at t=14 
  Sobol' 
GMDH-
HDMR(40) HDMR(40) 
S4 – EC50 0.,37122289 0.44268 0.47 
S5 – E0 0.11501718 0.111865 0.8305 
S3 - weight 0.07972202 0.08903 0 
S6 - γ 0.07690754 0.0715 0.99 
0
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S4 S5 S3 S6
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GMDH-HDMR(40)
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Sensitivity Analysis using GMDH-HDMR can be performed on a limited number of 
sample points and as a result, the most important individual contributions are detected. 
HDMR is able to do this with 256 Sobol’ sample points but it will fail to operate properly 
for only 40 data points. For example, as depicted in Figure 2.3, the individual 
contribution of the third parameter (S3) is completely ignored and the interaction is not 
detected either. The advantage of GMDH-HDMR is that most of the time it gives more 
accurate results than HDMR with small number of data samples. HDMR becomes 
unreliable with limited sets of samples as it can miss important first order contributions. 
Moreover, the strength of GMDH-HDMR is the ability to be economical in the number 
of simulations required. This can be useful in the case of computationally expensive high 
fidelity models. GMDH inductively selects the most important parameters performing as 
a sparse method for calculating sensitivity indices, with scarce recourse to model 
simulations. HDMR on the contrary relies on the calculation of the sensitivity indices for 
all parameters and potential interactions. It captures non-linear system outputs as a 
summation of variable correlations in a hierarchical order. In a full model expansion, it 
considers all possible variable interactions and their contribution to the original function. 
The first term describes the average value of the fitness landscape near a reference point 
called cut-center. Second order terms express the independent effects of each variable if 
decision variables are deviated from the cutcenter. Higher order terms denote the residual 
group effect of variables. Therefore, the terms are independent or orthogonal to each 
other to form a mean convergent series. From Table 2.2 it can be observed that γ (S6) has 
the highest sensitivity index with respect to the BIS. Since this method exhibits better 
results for this type of model, γ (S6) shows which patient is most sensitive to the drug. 
2.4 Advanced Model Based Control Strategies 
Model Predictive Control (MPC) is a control methodology based on two main principles: 
explicit online use of a process model to predict the process output at future time instants, 
and the computation of an optimal control action by minimizing a cost function, 
including constraints on the process variables. 
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The main differences between the different types of MPC algorithms are: (i) the type of 
model used to represent the process and its disturbances, (ii) the cost function(s) to be 
minimized, with or without constraints, and (iii) the type of optimization performed. 
Details of the method formulation are presented in Appendix D. 
2.4.1 EPSAC Strategy 
Extended Predictive Self Adaptive Control (EPSAC) is one of the various NMPC 
design methods reported in literature (Su et al., 2016) and it adopts the approach of 
iterative optimization based on a predefined input trajectory (Keyser, 2003, De Keyser et 
al., 1985). A potential drawback of previous EPSAC methods is the incorporation of a 
convolution model in the formulation of the control algorithms. Since model parameters 
are obtained by introducing a step change to the current input value specified by the base 
input trajectory, the predicted outputs at sampling instants further away from the current 
sampling instant become less accurate due to process nonlinearity, leading to inevitable 
modelling error that degrades the achievable closed-loop performance. Another potential 
downside of this method is that the optimization problem has to be solved online. This 
issue is addressed in the following subchapters. 
For the EPSAC approach (see Appendix D and (Keyser, 2003)), the controller output is 
obtained by minimizing the cost function: 
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2 2
0
1
1
2
   (Equation 2.7) 
 
The design parameters are: N1= the minimum costing horizon N2= the maximum costing 
horizon, N2-N1 = the prediction horizon Nu=control horizon,  =weight parameter. The 
signal r represents the reference trajectory.  
In our case the process input is represented by the Propofol infusion rate applied to the 
patient. The process output is the BIS index and is predicted at time instant t over the 
prediction horizon N2-N1, based on the measurements available at that moment and the 
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future outputs of the control signal. The cost function is an extended EPSAC cost 
function that penalizes the control movements using the weight parameter λ. 
 
2.4.2 Multiparametric Strategy 
For the mp-MPC (see Appendix D), the generic optimization problem solved is: 
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(Equation 2.8) 
 
where x denote the states, y the outputs and u the controls, all being (discrete) time 
dependent vectors, with the tracked output variables having time-dependent set points y
R
. 
Finally, Δu correspond to changes in control variables, Δu(k) = u(k) – u(k-1). The 
prediction horizon is denoted by N and control horizon by Nu. X, U are the sets of the 
state and input constraints that contain the origin in their interior. The weight matrix for 
manipulated variables R is a positive definite diagonal matrix ( 0R ), QR is the weight 
for tracked outputs and R1 is a weight matrix for the control action changes (Δu). The 
control problem is posed as a quadratic convex optimization problem for which an 
explicit solution can be obtained. The key idea is to derive the optimal control inputs as a 
set of explicit affine functions of the current state of the system: 
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where s is the number of critical regions. 
 
2.5 Control Design 
The presence of the Hill nonlinearity (Equation 2.5) complicates the use of linear 
controller synthesis. Two methods to overcome this problem are proposed in this chapter: 
(i) exact and (ii) local linearization (note: Chapter 4 presents a hybrid formulation).  
The local linearization is based on the linearized patient model (Equation 2.1), 
(Equation 2.4) and (Equation 2.5) using the parameter values of the nominal patient, a 
priori known, for a BIS value of 50 obtained using gPROMS ((PSE), 2010). The 
controller is designed using the linearized patient model as presented in Figure 2.4. 
Figure 2.5 depicts the control design scheme where the designed controller minimizes the 
error between the BIS target value and the measured BIS giving the patient the optimal 
Propofol Drug infusion rate that will derive the patient to the desired setpoint value.  
 
Figure 2.4: Controller design using local linearization  
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Figure 2.5: Control scheme using local linearization 
 
Exact linearization is based on the compensation of the nonlinearity introduced by the 
Hill curve (Equation 2.5), in the PD model ((Equation 2.4) and (Equation 2.5)). Since the 
Hill nonlinearity is a monotonic function of the normalized effect site concentration, it 
has an inverse presented in (Equation 2.6). Using a parameter scheduling technique the 
inverse Hill function could be implemented in the control design scheme as illustrated by 
the block diagram in Figure 2.7. In the Patient Model, the Hill curve uses the nonlinear 
parameters of the real patient (E0 , Emax, EC50 , γ), while the inverse Hill function is using 
the nonlinear parameter corresponding to the nominal patient a priori known  (E0
mean
, 
Emax
 mean
, EC50
 mean
 , γ mean).  
 
Figure 2.6: Controller design using exact linearization 
49 
 
 
Figure 2.7: Control scheme using exact linearization 
 
For this method the controller is designed using the Linear Part ((Equation 2.1) and 
(Equation 2.4)) of the patient model ((Equation 2.1), (Equation 2.4) and (Equation 2.5)) 
with the linear parameters of the nominal patient (age, height, weight, gender) as 
presented in Figure 2.6. Note that the BIS target here is transformed in Ce target using the 
inverse Hill function since the controlled variable is the estimated drug concentration 
eCˆ .  
 
Figure 2.8: The nonlinear characteristic of the Hill curve for all patients 
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Figure 2.9: The nonlinearity compensation of the Hill curve for all patients 
 
 
Figure 2.10: The static gain of the Hill curve for all patients 
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Figure 2.8 depicts the static characteristic of the Hill curve (Equation 2.5) from the 
Patient model for all patients in Table 2.1 where the nominal patient is represented with 
black and the black stars depict the BIS target value (=50). The nonlinearity 
compensation using the inverse of the Hill curve (Equation 2.6), based on the parameter 
values of the nominal patient from Table 2.1 is depicted in Figure 2.9 for all patients. At a 
first glance it can be observed that even after the nonlinearity compensation, some 
patients (especially patient 9 – represented with blue) still exhibit a nonlinear behaviour. 
Fortunately the nonlinear behaviour only appears at large values of the drug infusion rate 
(control action) which in clinical practice are not common. In this work the drug infusion 
is limited to 50 (mg/min) which ensures that the nonlinear behaviour of the patients is 
avoided. Moreover it can be observed that until the values of the control action 
corresponding to a BIS value of 50 are reached, denoted with a red star in Figure 2.9, all 
12 patients have a linear behaviour. At the BIS target set at the value of 50, Figure 2.10 
presents the static gain of the Hill function for different patients (represented by black 
stars), where it can be observed that we have variations between 3 and 10 for the static 
gain. The nonlinearity compensation should assure a static gain equal to 1 between Ce 
and 
eCˆ , this is shown in Figure 2.10 (represented by red stars) where values between 0.98 
and 1.1 can be observed. 
An exact linearization takes place only for the case where the patient model is identical to 
the nominal model (red line in Figure 2.9); in this case the nonlinearity is cancelled out 
i.e., 
ee CC 
ˆ . 
An important challenge of depth of anaesthesia (DOA) control is the high inter- and intra-
patient variability. This results in different dynamics in the PK model, and changes in the 
parameters of the Hill function for each patient model. Four control strategies, a model 
predictive controller, EPSAC, and three different mp-MPC are designed and evaluated. 
The framework for the different ways of designing the controllers is presented in Figure 
2.11. 
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Figure 2.11: Control scheme development flowchart 
 
The patient response is simulated using Patient Model block, composed of the PK–PD 
linear part ((Equation 2.1) and the effect site concentration (Equation 2.4)) and the 
nonlinear PD part composed of the Hill nonlinearity, (Equation 2.5). BIS can be 
measured; however, the states cannot and have to be estimated: either using the drug rate 
input and the nominal state-space patient model or by using the drug rate input and 
measured output (BIS) of the process, the state-space nominal model and a correction 
estimator based on the output changes. 
To analyse the influence of the changes in the dynamics of the PK model on the control 
performances, two types of control schemes are implemented, one uses the states given 
by the nominal model (A) and the other uses an estimator to adjust the states based on the 
dynamics of each patient (B). 
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The influence on the changes of parameters of the Hill curve on the control performances 
is analysed by two types of control schemes, one using the local linearization of the 
complete PK–PD patient model (C) and the second is based on the exact linearization 
(D). The following design parameters are used: the weight matrix for tracked outputs (y), 
QR=1000, weight matrix for manipulated variables (u), R=1, the control horizon Nu=1 
and the prediction horizon N=20 in both mp-MPC and EPSAC. The EPSAC has an extra 
weighting factor λ from (Equation 2.7) for which its default value λ=0 was used. The 
states used in the design of the controllers are C1, C2, C3, Ce as described in (Equation 
2.1). The clinically recommended sampling time is of 5 seconds (Ionescu et al., 2008). 
N1, N2, and Nu are chosen based on the characteristics of the process and the desired 
performances. Based on (Clarke et al., 1987, Mohtadi et al., 1987), N should be large, at 
least 2n−1 but not larger than the rise time of the process. For anaesthesia, due to medical 
procedures, we are constrained to use a small sampling time leads to a choice of a greater 
value for N. Also, the dead time is not considered since it is very small and does not 
affect the process, therefore N1 = 1. In choosing Nu for processes with no 
unstable/underdamped poles, like anaesthesia, Nu = 1 is generally satisfactory. A choice 
of the Q, R, and QR is given by Bryson’s rule (Franklin et al., 2001a). Usually the pump 
for the Propofol drug infusion is limited to 200 mg/min (3.3 mg/sec) but it can be 
observed from simulations as well as literature that the controller gives maximum values 
of 70 mg/min for the drug infusion. To test the ability of the controller in dealing with 
severe constraints as well as avoiding giving the patient unnecessary amounts of drug 
infusion (leading to longer recovery time) in this work the drug infusion is limited to 50 
mg/min. 
2.5.1 Case 1: Extended Prediction Self-Adaptive Control 
(EPSAC) 
In this section, we apply a particular case of online MPC, the EPSAC strategy 
described in detail in Appendix D. The structure of the control system proposed in this 
section is shown in Figure 2.12.  
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Figure 2.12: EPSAC control scheme 
 
The Patient Model block is composed of the PK Model (Equation 2.1), the Effect Site 
Compartment (Equation 2.4) and the Hill function (Equation 2.5). The control strategy is 
based on the exact linearization (see Figure 2.6) and the I/O linear nominal part of the 
patient model (see Figure 2.6). The controller output is obtained by minimizing the cost 
function (Equation 2.7) with the design parameters in Section 2.5. The control algorithm 
uses for prediction a transfer function derived from the Linear Part ((Equation 2.1) and 
(Equation 2.4)) of the Patient Model. The inverse of the Hill curve (Equation 2.6) is used 
to compensate the nonlinearity as presented in Figure 2.7. The Patient Model uses the 
parameter values of the real patient while the inverse of the Hill curve and the linear 
model used for the controller use the parameter values of the nominal patient from Table 
2.1. 
2.5.2 Case 2:  mp-MPC Without Nonlinearity Compensation 
The structure of the control scheme is presented in Figure 2.13. This approach uses the 
explicit/multiparametric Model Predictive Control strategy based on local linearization of 
the Patient Model for the parameter values of the nominal patient from Table 2.1 as 
presented in Figure 2.4. The controller uses the error between the measured BIS and the 
BIS target value as well as the state space model of the nominal patient to give the patient 
the optimal Propofol Drug Infusion Rate. 
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Figure 2.13 Case 2: mp-MPC without nonlinearity compensation - control scheme  
 
To obtain the linearized patient model, the PK and PD model for the nominal patient is 
implemented in gPROMS ((PSE), 2010) and the state space of the linearized nominal 
patient model at BIS = 50 is determined. Using these matrices, the mp-QP optimization 
problem (Equation 2.8) is solved to obtain the control laws using a MATLAB 
implementation of multiparametric quadratic programming algorithm (ParOs, 2004, 
Pistikopoulos et al., 1999) and determine the mp-MPC control laws that will be used to 
calculate the optimal control action. 
 
2.5.3 Case 3:  mp-MPC With Nonlinearity Compensation 
This approach uses explicit/multiparametric MPC based on exact linearization as 
presented in Figure 2.6. The controller is designed on the Linear Part of the Patient 
Model using the values of the nominal patient from Table 2.1 The optimization problem 
(Equation 2.8) is solved offline using POP(ParOs, 2004) to obtain the explicit control 
laws. Since the controller is now designed only on the linear part it will use the error 
between the Ce target and the eCˆ  given by the inverse Hill function as well as the state 
space of the nominal patient values to give the optimal opofol Drug Infusion Rate as 
depicted in Figure 2.14. Note that here the inverse Hill function uses the values of the 
nominal patient while the Patient Model uses the real values of the real simulated patient. 
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Figure 2.14: Case 3:mp-MPC with nonlinearity compensation - control scheme 
 
2.5.4 Case 4:  mp-MPC With Nonlinearity Compensation and 
Estimation 
This approach, as the one presented in the previous subsection uses the 
explicit/multiparametric MPC strategy and has a similar control scheme Figure 2.15. the 
design of the controller is based on exact linearization (Figure 2.6).  
The difference is the use of a state estimator that will give the controller the states of the 
real patient. The real patient states are estimated using a Kalman filter (Welch et al., 
2001) based on the state space model of the nominal patient, the online BIS measurement, 
and the drug rate. 
 
Figure 2.15: Case 4: mp-MPC with nonlinearity compensation and estimator - 
control scheme 
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2.6 Results 
In this section, the results of a simulation study to evaluate the four control strategies for 
the administration of Propofol are presented. DOA is monitored using the BIS during the 
induction and maintenance phase of general anaesthesia. The closed-loop control tests are 
performed on a set of 12 patients (Ionescu et al., 2011a) plus an extra patient representing 
the nominal values of all 12 patients (PaN - patient nominal). The parameters values of 
these patients are given in Table 2.1 and are also used to calculate the parameters of the 
patient model. All designed controllers are simulated first for the set of data presented in 
Table I in order to have a better understanding of their behaviour on the different types of 
patients, and analyse the inter- and intra-patient variability. Next, the four controllers will 
be tested against each other and simulated for different patients so as to be able to 
compare their performances by means of the BIS index and the corresponding Propofol 
infusion rates.  
In common practice the operation procedure does not start until the patient reaches an 
adequate DOA, usually taking up to 15 minutes. Thus, a rise time between 5 min and 7 
min gives good performances. The target value during surgery is 50, giving us a range 
between 40 and 60 to guarantee adequate sedation, resulting in an overshoot/undershoot 
lower than 10%. 
2.6.1 Induction Phase 
Ideally, the induction phase of the patient in an operational DOA is performed as fast as 
possible, such that little time is lost before the surgeon can start operating. It is, therefore, 
desirable that the patient reaches the BIS = 50 target and remains within the target value 
without much undershoot or overshoot, i.e., values below BIS = 40 and above BIS = 60 
should be avoided. In Figure 2.16, Figure 2.18, Figure 2.20 and Figure 2.21, we have the 
simulations of the four controllers for all 12 patients and the nominal one in the induction 
phase. Figure 2.17 presents the map of the critical regions (CR – the region in the space 
of the parameters where the objective and optimization variable obtained as a function of  
the varying parameters are valid) for the controller using local linearization (Case 2); and 
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in Figure 2.19, we have the map of the CR for the controllers designed using exact 
linearization, by using the inverse of the Hill curve (Cases 3 and 4).  
 
Figure 2.16: BIS output for all 13 patients for Case 1 – induction phase 
 
 
Figure 2.17: Map of critical regions Case 2 
0 1 2 3 4 5 6 7
40
50
60
70
80
90
100
time (min)
B
IS
 
 
patient 9 - most sensitive
patient 10 - least sensitive
patient 13 - nominal patient
-6 -4 -2 0 2 4 6 8 10
-20
0
20
40
60
80
100
Propofol (mg/s)
B
IS
17 Feasible Region Fragments
 
 
59 
 
 
Figure 2.18: BIS output for all 13 patients for Case 2 – induction phase 
 
 
Figure 2.19: Map of critical regions Case 3 and Case 4 
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Figure 2.20: BIS output for all 13 patients for Case 3 – induction phase 
 
Figure 2.21: BIS output for all 13 patients for Case 4 – induction phase 
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Simulations of some patients show very small oscillations around the steady-state values. 
The average settling time for EPSAC is approximately 7 min, and for the mp-MPC 
controllers is approximately 5 min. In common practice, the operation procedure does not 
start until the patient reaches an adequate DOA, usually taking up to 15 min. Thus, a 
settling time between 5 and 7 min gives good performances. The best performances are 
obtained for Case 2. It seems that the local linearization is able to deal with inter- and 
intra-patient variability. Also, the process was linearized at BIS = 50, which is the value 
of the controller set point. The EPSAC controller is more influenced by interpatient 
variability and for some patients the settling time has greater values. For the nominal 
patient PaN, the four controllers: EPSAC and the mp-MPC controllers, are simulated, the 
results are compared and presented in Figure 2.22. For patient 9, the most sensitive 
patient, this simulation is presented in Figure 2.24. In Figure 2.23 and Figure 2.25, we 
have the corresponding Propofol infusion rates for the two patients. We can observe that 
due to the less aggressive behavior of the EPSAC controller, the output evolution will be 
smoother. In all the cases, the Propofol infusion rates are limited to 50 (mg/min). The 
same conclusions as for Figure 2.16 - Figure 2.21 valid here. For both simulated patients, 
the EPSAC controller has a slower response 
 
Figure 2.22: BIS response for the four controllers for PaN 
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Figure 2.23: Output for the four controllers for the PaN 
 
Figure 2.24: BIS response for the four controllers for patient 9 
0 1 2 3 4 5 6 7
40
50
60
70
80
90
time (min)
B
IS
 
 
Case 1
Case 2
Case 3
Case 4
63 
 
 
Figure 2.25: Output for the four controllers for patient 9 
 
The optimal control action of the multiparametric controller from Case 3 is presented in 
Table 2.3, along with the corresponding closed loop simulation control action for the 
nominal patient and patient 9 (Figure 2.26). Although both patients are in the induction 
phase, due to the inter- patient variability, different critical regions of the multiparametric 
controller i.e., control laws provide the optimal control action at each time step for the 
two patients (for example at T=3, 4, 5). This results in different control policies as 
observed in Figure 2.26. T=1 corresponds to the control action at time 160 seconds. Since 
the sampling time is of 5 seconds the control action given at every T corresponds to the 
sampling time starting from 32 to 38. 
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Table 2.3: Optimal control action for Patient 9 and the nominal Patient 
Step 
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Figure 2.26: Optimal control action for Patient 9 and the nominal patient  
 
2.6.2 Maintenance Phase 
During the maintenance phase, it is important that the controller rejects the disturbances 
occurred during surgery as fast as possible and bring the patient to the BIS target value. 
In this phase, typical disturbances can be applied additively to the output of the process to 
check the controller’s ability to reject them (West et al., 2013). A standard stimulus 
profile is defined and is presented in Figure 2.27. Each interval denotes a specific event 
in the operation theatre. Stimulus A represents response to intubation; B a surgical 
incision that is followed by a period of no surgical stimulation i.e., waiting for pathology 
result; C mimics an abrupt stimulus after a period of low level stimulation; D the onset of 
a continuous normal surgical stimulation; E, F, and G simulate short-lasting, larger 
stimulation within the surgical period; and H represents the withdrawal of stimulation 
during the closing period (Yelneedi et al., 2009). 
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Figure 2.27:  The artificially generated disturbance signal 
 
In Figure 2.28 and Figure 2.30, the performance of the disturbance rejection of the four 
controllers for PaN and a more sensitive patient (patient 9) are shown. The figures 
present the most challenging part of the disturbance rejection test, namely B-C-D-E. In 
Figure 2.29 and Figure 2.31, we have the corresponding Propofol infusion rate for PaN 
and patient 9, limited between 0 and 50 mg/min. The simulations are performed for the 
maintenance phase using the disturbance signal (see Figure 2.27) between 60 and 140 
min. The simulations show only small differences between the controllers and, thus, 
comparable performances of all four controllers. For the first control scheme, the 
behaviour of the controller is less aggressive; the response is slower but it also has the 
smallest values of the undershoot. 
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Figure 2.28: BIS response for the four controllers for PaN with disturbance 
 
Figure 2.29: Output for the four controllers for PaN with disturbance 
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Figure 2.30: BIS response for the four controllers for patient 9 with disturbance 
 
Figure 2.31: Output for the four controllers for patient 9 with disturbance 
 
80 82 84 86 88 90 92 94 96 98 100
20
30
40
50
60
70
80
90
time (min)
B
IS
 
 
disturbance signal
Case 1
Case 2
Case 3
Case 4
69 
 
2.6.3 Discussion 
The aim of this chapter is to evaluate the performance of a model-based predictive 
control algorithm and model predictive multiparametric control for automatic induction 
and control of DOA during the induction and the maintenance phases.  
Some of the most important aspects of this application are the high inter- and intra-patient 
variability, variable time delays, dynamics dependent on the hypnotic agent, and model 
analysis variability. These are just some of the issues that are dealt with when trying to 
control the DOA. 
The hypnotic agent Propofol is given as the input and the output is described by the BIS, 
resulting in a SISO system. SISO patient models for control of most anaesthetic drugs 
already exist in the literature and their parameters are estimated based on age, weight, 
gender, and height.  
Four different types of controllers are designed and tested. The first controller is based on 
the online optimization EPSAC MPC technique. The other three controllers are based on 
the offline optimization mp-MPC: one uses the linearized patient model and the other two 
uses the compensation of the nonlinear part of the patient model. The difference between 
the two control strategies using nonlinearity compensation is that for one of them the 
states are computed using the nominal patient model, whereas the other one uses an 
online estimator. 
In order to address the issue of inter- and intra-patient variability, each of the four 
controllers are first tested for the whole set of patients presented in Table 2.1 for the 
induction and the maintenance phase. The maps of the CR for the mp-MPC are presented 
in Figure 2.17 and Figure 2.19. One can observe that for the controllers using the 
nonlinearity compensation (exact linearization), there are less CR than for the controller 
using local linearization. This will make the controllers from Cases 3 and 4 easier to 
implement on embedded devices. 
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The undershoot of the most sensitive patient is of 4.6%. As it can be observed from 
Figure 2.18, Figure 2.20 and Figure 2.21, representing the BIS response of the mp-MPC 
controllers, the three cases have very similar settling time, lower than for the EPSAC 
strategy, an average of 270 seconds. For the undershoot evaluation we will consider the 
worst case scenario, meaning the most sensitive patient. We obtain for the first controller 
(Case 2) an undershoot of 3.7%, for Case 3 an undershoot of 5.8% and for Case 4, an 
undershot of 5.78%. All undershoots are below 10% which represents the maximum 
limit. For the induction phase it can be said that all four controllers perform well each of 
them having their own advantages: i.e., lower settling time, smaller undershoot. 
The controllers are tested in the maintenance phase in order to see how well they can deal 
with the disturbance rejection. In Figure 2.28 and Figure 2.30, we can observe the four 
controllers response to a disturbance signal that mimics the events that occur in an 
operation theatre for PaN and for patient 9. 
All four controllers are tested against each other for the induction and maintenance phase 
for two different patients. The first patient is PaN, and the second patient used for 
comparison, patient 9, represents the most sensitive patient. It is worth mentioning that 
the controllers are designed using the values of the nominal patient which means that for 
this patient, we will have the best behaviour of the controllers. As it can be observed from 
Figure 2.22, Figure 2.23, Figure 2.28 and Figure 2.29, the BIS response and the output 
for PaN in the induction phase and the maintenance phase, respectively, the three offline 
controllers have a very similar behavior. All the controllers present no undershoot and a 
fast settling time. The EPSAC controller has a less aggressive behaviour; hence, a longer 
settling time compared to the mp-MPC controllers, but as can be observed in the 
maintenance phase, it will have less undershoot. In Figure 2.24, Figure 2.25, Figure 2.30 
and Figure 2.31, we have the BIS response and the output for patient 9 in the induction 
phase and the maintenance phase. This patient represents the worst-case scenario since it 
is the most sensitive patient. We can observe from the figures that all four controllers 
have good performances and their responses are very close to each other. However, the 
controller from Case 2 gives the best performances for this patient in the induction phase 
particularly lower undershoot, 3.7%, and faster settling time, 300 sec. This shows that the 
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combination between the linearization method based on gPROMS and optimization 
methods based on mp-MPC gives good results even without the nonlinearity 
compensation. 
It is important to state that the design of the mp-MPC controller using the linearized 
patient model is the simplest design version of the four controllers since it does not use an 
estimator and it avoids using the nonlinearity compensation, which introduces additional 
complexity in the DOA control. Moreover, it obtains the best performances which can be 
explained through the fact that the nonlinearity of the Hill curve is more intense at 
extreme values of the BIS index and weaker around the BIS value of 50 where the model 
was linearized and where the BIS target is set. If the induction phase and the maintenance 
phase are kept around the value of 50%, Case 2 will give very good performances. But if 
the disturbances take the process out of the 50% area, we can observe that the 
performances are not as good as in the case of nonlinearity compensation. Case 2 does 
not provide good performances if the disturbances are substantial. Due to the Hill 
nonlinearity, the real-patient model has smaller gain at the extreme values of the control 
variable. In the case of substantial disturbances, the control variable goes to the extreme 
values and the controller has a slower response but also a lower undershoot/overshoot. 
Using nonlinearity compensation is a good alternative in this case. Moreover, the 
computations required for the nonlinearity compensation are rather straightforward (the 
inverse of the Hill curve), and there are no recursive computations that might lead to 
accumulation of errors. 
The estimator used for the mp-MPC with nonlinearity compensation can also be applied 
for the mp-MPC using local linearization. It was not used for this study because as it can 
be observed from the simulations, the case with nonlinearity compensation is more 
meaningful in the presence of disturbance. 
The aim of the studies on control of anaesthesia is to be able to implement the controllers 
on embedded devices (see MOBILE project – MOBILE ERC Advanced Grant, No: 
226462). These types of devices do not have the same computational power as the 
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computers where simulations are performed in real time. This would make classical MPC 
more difficult to implement since matrix operations are harder to program on embedded 
devices. The mp programming algorithms derive the explicit mapping of the optimal 
control actions as a function of the current states resulting in the implementation of a 
simple lookup table and simple function evaluations. This makes the mp-MPC controllers 
much easier to implement for the control of DOA. 
For each patient, there will be a variable dose-response relationship. For the same 
reference value, the controller sends different drug rate and the blood and effect-site 
concentrations levels are different for each patient. The safety limit for Propofol blood 
concentration and effect-site concentration is fulfilled by maintaining the drug infusion 
below 50 mg/min. It can be observed from Figure 2.23, Figure 2.25, Figure 2.29 and 
Figure 2.31 that the drug infusion rates are maintained below this limit. 
Note that the robustness of the performance is analyzed by having the controllers 
designed on a nominal model (Ionescu et al., 2008) and then tested on a wide set of 
patient models parameters where the impact of parameter uncertainties were analysed. 
Formal robust criteria can also be included as discussed in Chapter 4. 
2.7 Conclusions 
In this chapter, we have designed and evaluated four different controllers for the 
regulation of DOA during induction and maintenance phase. For the maintenance phase, 
a realistic disturbance signal was considered and applied. A simulation study was 
performed on a set of 12 virtually generated patients plus the mean patient. The 
performance of the four controllers was compared with each other for a sensitive patient 
and the nominal patient. 
Some important aspects of this application are the high inter- patient variability and the 
presence of important disturbances during the maintenance phase. The results show a 
high efficiency, optimal dosage, and robustness of the MPC algorithm to induce and 
maintain the desired BIS reference while rejecting typical disturbances from surgery. The 
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mp-MPC approach, which is an offline optimization method, has similar performances 
with the online method and promising results. 
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3. Chapter 3 
Simultaneous Estimation and Advanced Control for 
the Anaesthesia Process 
 
3.1 Introduction 
 
In the previous chapter we have designed and studied different controllers for the 
regulation of depth of anaesthesia during induction and maintenance phase. More 
specifically we presented: (i) a model predictive control strategy that is based on online 
optimization (EPSAC) and (ii) a multi-parametric model predictive control strategy based 
on offline optimization (mp-MPC). The implementation of these controllers, as discussed 
in Chapter 2 is based on the assumption that the state values are readily available from 
the system measurements and that we have a clear measurable output with not much 
noise influence. However, in reality, the measured output may be noisy (as discussed in 
Chapter1.1) and the system measurements may not produce this information directly - 
instead the state information needs to be inferred from the available output 
measurements. This can be done developing state estimators which is the subject of this 
chapter. 
The use of estimation techniques will enable to: (i) estimate the state of each individual 
patient and adjust them based on his/her corresponding dynamics; (ii) overcome the noisy 
output measurements and (iii) deal with the system constraints (in conjunction with an 
MPC structure).  
While in Chapter 2 for the Case 4 (Section 2.5.4), Kalman filter was implemented 
simultaneously with mp-MPC, it was observed that the performances of the controller 
was not significantly improved due to its limitations such as handling system constraints 
and noise. As a result, in this chapter, online and offline moving horizon estimator 
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(MHE) will be investigated and implemented simultaneous with mp-MPC. For 
comparison purposes, Kalman filter will be also tested. All resulting controllers with the 
corresponding estimation techniques are tested for both induction and maintenance phase 
for a set of 12 patient data. 
This chapter is organized as follows: the design of three different estimation strategies as 
well as their performances on different patients are presented in Section 3.2. Section 3.3 
presents the formulation and design of the simultaneous mp-MPC and estimation. The 
simulation results of the designed control strategies for the induction and maintenance 
phase are presented in Section 3.4 while discussions are presented in Section 3.5. Finally 
Section 3.6 summarizes the main outcome of this chapter. 
 
3.2 Multiparametric Moving Horizon Estimation (mp-
MHE) 
 
The idea of moving horizon estimation is to estimate the state using a moving and fixed-
size window of data. Once a new measurement becomes available, the oldest 
measurement is discarded and the new measurement is added. The concept is to penalize 
deviations between measurement data and predicted outputs. In addition – for theoretical 
reasons - a regularization term on the initial state estimate is added to the objective 
function. There are two main characteristics that distinguish MHE from other estimation 
strategies, such as Kalman filter: (i) prior information in the form of constraints on the 
states, disturbances and parameters can be included; (ii) since MHE is optimization based 
it is able to handle explicitly nonlinear system dynamics through the use of approximate 
nonlinear optimization algorithms. Here MHE is first formulated as a multiparametric 
problem and then combined with an explicit  mp-MPC strategy. These concepts are 
discussed next. 
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3.2.1 Multiparametric Moving Horizon Estimation (mp-MHE) 
Formulation 
Based on the moving horizon estimation theory presented in Appendix E the resulting 
multiparametric moving horizon estimation formulation can be obtained. 
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Where N is the length of the horizon, T is the current point in time, Q and R are positive 
definite diagonal weighting matrices on the noises, PSS is the steady state solution for the 
Kalman filter. NT NTw

 1}ˆ{  and 
T
NTv 1}{   are sequences of independent, normally distributed 
random numbers with mean values w  for {w} and zero-mean for {v}. NTNTx  /1  is the 
arrival cost which captures the previous measurements that are not considered any more. 
NTNTx  /ˆ  is the solution of the MHE at the previous time step. 
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3.2.2 Estimation Design 
The schematic of the estimator used for the different estimation techniques is presented in 
Figure 3.1. The Estimator block uses the input of the system, the Drug Infusion Rate (u) 
and the output measurements (from the sensor) of the system to estimate the states of the 
simulated patient. The process disturbances w   R
p
 and measurement disturbance v   Rp 
are considered unknown variables. The goal of the estimation is to construct an estimate 
of the trajectory of x for the simulated patient using only the process input values, the 
output measurements and the state space model of the nominal patient. Note that for 
control purposes we are usually interested in the estimate of the state at the current time, 
T, rather than the entire trajectory over the interval [0,T]. We have two sources of error: 
(i) the state transition is affected by an unknown process disturbance (or noise), w, and 
(ii) the measurement process is affected by another disturbance, v. In the MHE approach, 
we formulate the optimization objective to minimize the size of these errors thus finding 
a trajectory of the state that comes close to satisfying the (error-free) model while still 
fitting the measurements. 
 
 
Figure 3.1 Intravenous anaesthesia - Schematic of the Estimator– General Case 
 
State estimation is important as the controller requires the state space of the patient. Since 
there are no available measurements of the states nor do we have a model for each 
individual patient available ‘a priori’, usually the controller uses the state space model of 
the nominal patient. Estimation of the real states of individual patients is expected to 
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improve the overall performances of the controller while significantly increasing the 
safety of the patient. 
Here three types of estimators, Kalman filter, online MHE and offline mp-MHE are used 
to estimate the current states of the patients using the nominal patient model, the patient 
measurements and the drug rate. Two approaches for the design of the estimators are 
employed: (i) the first case uses the output of the PD model (the nonlinear part) more 
precisely the measurement of the BIS index (ii) the second case considers the output 
eCˆ  
of the inverse Hill curve (Equation 2.6) (applied to the BIS index)– see Figure 3.2 and 
Figure 3.7. 
The simulations were performed in open loop for a step on the input of 12 mg/min 
(Propofol drug infusion rate). The value was chosen such that steady state values of the 
states to reach the recommended range for the maintenance phase. For the design of the 
MHE, the following tuning parameters are used: a horizon of N=3, Q=1 and R=0.01; the 
parameters vector includes the N past measurements and values for the manipulated 
variable. 
3.2.2.1 Estimation Design – Case 1 
As shown in Figure 3.2, the first estimation design strategy uses the Drug Infusion Rate 
(u) and the output of the PD Model, the Measured BIS in order to obtain the estimated 
states. This introduces nonlinearities in the estimation since the PD Model contains the 
nonlinear Hill curve –see (Equation 2.5). Three types of state estimators are 
implemented: the Kalman filter, online MHE and offline mp-MHE and tested against 
each other for the different patients of Table 2.1. 
The results of the estimation are shown in Figure 3.3, Figure 3.4, Figure 3.5 and Figure 
3.6. Note that the estimation using online MHE and mp-MHE show identical behaviour 
as expected with the difference between the two being that the mp-MHE can be 
implemented offline. The advantages of the mp-MHE is that by using a multiparametric 
approach it by passes the real time approach, thus overcoming the computational 
efficiency issues. Instead of solving the optimization problem at every sampling time, the 
mp-MHE uses the input and the output data to consult an off-line constructed look-up 
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table that indicates what closed-form expression from a finite collection must be used to 
estimate the values of state variables. Both the look-up table and the finite collection of 
closed-form expressions for state estimation are constructed once via off-line 
optimization (Darby et al., 2007). Hence, in the figures, online MHE is not shown. 
 
 
Figure 3.2: Intravenous anaesthesia - Schematic of the Estimation – Case 1 
 
Note also that in all figures presented we have simulated the states of: (i) the nominal 
patient for which a state space model is a priori available; (ii) the actual patient; (iii) the 
actual patient estimated using mp-MHE; (iv) the actual patient estimated using Kalman 
filter.  
The simulation of the estimators are performed first under the assumption that the 
measured output (BIS index) is noise free and the results are presented in Figure 3.3 - 
Figure 3.5 for patient 2 and 7, respectively. Figure 3.4 and Figure 3.5 present the results 
for patients 2 and 7 for two of the four states. The two states are chosen such as to best 
highlight the differences between the state estimators and they represent the 
concentration of drug in the muscles and the concentration of the effect site compartment 
respectively. 
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Figure 3.3: Intravenous anaesthesia - State estimation for patient 2 – all states– no 
noise 
 
 
Figure 3.4: Intravenous anaesthesia - State estimation for patient 2 – 2 states – no 
noise 
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Figure 3.5: Intravenous anaesthesia - State estimation for patient 7 – 2 states – no 
noise 
 
It can be observed that in the presence of no noise we obtain the weakest results for the 
estimator using the nominal state space model, followed by Kalman filter and the MHE 
has slightly better performances since it is able to deal with system constraints. 
As discussed in Chapter 1.1 the Bispectral index (BIS) is highly influenced by noise 
and disturbances. Hence, noise has been added to the measured BIS index, and included 
for the moving horizon estimation; a Gaussian distribution with a 3% standard deviation 
is assumed. Figure 3.6 depicts the states in the presence of noise on the output. In this 
case estimation obtained with the mp-MHE estimation were improved, the estimated 
states being very close to the real patients despite the fact that the estimators were 
developed using the nominal patient state space model.  
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Figure 3.6: Intravenous anaesthesia - State estimation for patient 2 – 2 states – with 
noise 
 
3.2.2.2 Estimation Design – Case 2 
 
Figure 3.7: Intravenous anaesthesia - Schematic of the Estimation – Case 2 
 
In the first case the output of the Hill function (BIS index) is used as an input for the 
estimators. In this case, to compensate for the nonlinearity, the inverse of the Hill curve is 
used on the measured output (Figure 3.7). This will make 
eCˆ  as input for the estimators 
and will overcome the issues introduced by the nonlinearity.  
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Three types of state estimators are implemented, similar to Case 1: the Kalman filter, 
online MHE and offline mp-MHE and tested against each other for the different patients 
(Table 2.1). All three estimators are designed using the state space model of the nominal 
patient, the 
eCˆ  concentration (obtained by using the inverse of the Hill curve on the 
measured output) and the Drug Infusion Rate.  
In the case of the mp-MHE, the parameters of the multiparametric programming problem 
in (Equation 3.1) are the past and current measurements and inputs and the initial guess 
for the estimated states. Figure 3.8 presents the solution of the multiparametric 
programming problem in the form of 2-dimensional projection of the critical regions. The 
projections are based on the states of the parameter vectors while the values of the rest of 
the parameters are set to certain values within their feasible bunds so as to generate the 
graph. In this case θ1 and θ2 are the second state representing the drug concentration in 
the muscle compartment and the concentration in the effect site compartment. 
 
Figure 3.8: Intravenous Anaesthesia mp-MHE - critical regions 
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The simulations are performed following the structure in Figure 3.7. The results of the 
performances for the designed estimators using the output without being influenced by 
noise are presented in Figure 3.9 and Figure 3.10. It can be observed that without having 
the output corrupted by noise the estimators exhibit closer performances much better than 
the ones obtained by computing the states using the state space nominal model. 
In Figure 3.11 an ideal case is presented where the nominal patient is the same as the 
one simulated and the process is not affected by noise. In this case all three estimators 
exhibit similar behaviour and estimate perfectly the real states. 
 
Figure 3.9: Intravenous anaesthesia - State estimation for patient 7 – no noise 
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Figure 3.10: Intravenous anaesthesia - State estimation for patient 8 – 2 states –no 
noise 
 
 
Figure 3.11: Intravenous anaesthesia - State estimation for the mean patient 
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In  
Figure 3.12 and Figure 3.13 we show the results of the performance for the designed 
estimators using the output that is strongly corrupted by noise.  
Figure 3.12 and Figure 3.13 show simulation results for the state estimation for patients 7 
and 8 for two out of the 4 estimated states. The two states are chosen such as to best 
highlight the differences between the state estimators and they represent the 
concentration of drug in the muscles and the concentration of the effect site compartment.  
For both patients as in the previous case the mp-MHE estimator exhibits better 
performance due to its capability of dealing with constraints and the non-gaussian noise 
in the process. As it can be observed from  
Figure 3.12 and Figure 3.13, in this case the estimated states are very close to the real 
patients states. 
 
 
Figure 3.12: Intravenous anaesthesia - State estimation for patient 7- 2 states – with 
noise 
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Figure 3.13: Intravenous anaesthesia - State estimation for patient 8 – 2 states – with 
noise 
 
3.3 Simultaneous Estimation & MP-MPC Strategy 
 
In this section developed estimation strategies are implemented simultaneously with mp-
MPC for the control of intravenous anaesthesia. The proposed control design scheme for 
simultaneous estimation and mp-MPC is presented in Figure 3.14.  
 
Figure 3.14: Schematic of simultaneous mp-MHE and mp-MPC for intravenous 
anaesthesia 
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The Patient is simulated using the mathematical model of the patient composed of the 
pharmacokinetic part (linear) and the pharamacodynamic part, including the Hill curve 
(nonlinear) as described in Chapter 2.1. The inverse Hill function block, designed based 
on the nominal patient model, is used to compensate for the nonlinearity introduced by 
the Hill curve in the Pharacodynamic model. This block uses the Measured BIS and 
provides the corresponding Ĉe  to the mp-MPC block. The BIS Target can be set by the 
user but for general anaesthesia it is set to the value of 50. Since the mp-MPC block uses 
the corresponding Ĉe of the Measured BIS, the BIS Target will be transformed in Ce 
Target by using the inverse of the Hill curve block. The Estimator block is used to 
estimate the state of each individual patient. The commonly used technique to generate 
the states for the controller in the absence of the real state measurements is to compute 
them using the control action for the simulated patient and the nominal state space model. 
By estimating the states of every simulated patient, the controller instead of using the 
states computed using the nominal patient model will use the estimated values of states 
corresponding to each individual patient. Finally, the mp-MPC block, using the individual 
patient states given by the Estimator block, calculates the error between the Ĉe 
corresponding to the Measured BIS from the Patient and the Target Ce and provides the 
optimal Drug rate u to the Patient block in order to drive it to the desired target value. 
The Hill curve (Equation 2.5) introduces nonlinearities in the system which complicate 
for the use of linear MPC controllers synthesis. To compensate for the nonlinearity, a 
parameter scheduling technique, as presented in Chapter 2.5, the inverse of the Hill curve 
(Equation 2.6), is implemented in the controller with the nominal patient model 
parameters as shown in Figure 3.14; f is using the nonlinearity parameter of the real 
patient (E0 , Emax, EC50 , γ), while f 
-1
 is using the parameter assumed by the controller 
(the nominal patient nonlinear parameters a priori known  E0
mean
, Emax
 mean
, EC50
 mean
 , γ 
mean
). The controller then aims at controlling the estimated drug concentration
eCˆ  using a 
linear controller. 
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3.3.1  Simultaneous mp-MHE and mp-MPC formulation 
Using the explicit/multiparametric MPC formulation described Appendix D, the 
control strategy is based on the nonlinearity compensation and the state space model of 
the PK-PD linear part for the nominal patient model. The following mp-QP optimization 
problem is solved to obtain the control laws using the POP toolbox (Pistikopoulos et al., 
1999) and determine the controller.  
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(Equation 3.2) 
where ?̂? are the estimated states given by the state estimator, y outputs and u controls, w 
are the process disturbances and v the measurement noise all (discrete) time dependent 
vectors. The subsets of output variables that get tracked have time-dependent set points 
y
R. Finally, Δu are changes in control variables, Δu(k) = u(k) – u(k-1). The prediction 
horizon is denoted by N and control horizon by Nu. X, U are the sets of the state and input 
constraints that contain the origin in their interior. Both 0Q , the objective coefficient 
for the states and 0P , the terminal weight matrix for the states, are positive definite 
diagonal matrices. The weight matrix for manipulated variables 0R  is a positive 
definite diagonal matrix, QR is the weight matrix for tracked outputs and R1 is a weight 
matrix for the control action changes (Δu).  
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Figure 3.15: Map of critical regions - mp-MPC 
 
For the design of the controller, the following tunning parameters are used: the 
objective coefficients for states (x), Q=0 when we have no state estimation and Q=1 in 
the case with state estimation, the weight matrix for tracked outputs (y), QR=1000, 
weight matrix for manipulated variables (u), R=1, the control horizon Nu=1 and the 
prediction horizon N=20. The states used in the design of the controllers are C1, C2, C3, 
Ce as described in (Equation 2.1) and (Equation 2.4). The clinically recommended 
sampling time is of 5 seconds (Ionescu et al., 2008).  N and Nu are chosen based on the 
characteristics of the process and the desired performances. Based on (Clarke et al., 1987, 
Mohtadi et al., 1987) N should be large, at least 2n-1 but no larger than the rise-time of 
the process. For anaesthesia due to medical procedures we are constrained to use a small 
sampling time that will lead to a choice of a greater value for N. In choosing Nu, for 
processes with no unstable/underdamped poles, like anaesthesia, Nu=1 is generally 
satisfactory. A choice of the Q, R and QR is given by Bryson’s rule (Franklin et al., 
2001c). 
Figure 3.15 presents a typical solution of the multiparametric programming problem in 
the form of 2-dimensional projection of the critical space. The parametric vector θ 
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consists of: the estimated states, the current time output and the output reference 
(BIS=50). Here θ1 and θ2 represent the concentration of the effect site compartment, Ce 
and the BIS index.  
 
3.4 Results 
 
In this section, the results of a simulation study to evaluate the three controllers for the 
administration of Propofol are presented. The three controller are: (i) the nominal 
controller that uses no state estimation, (ii) the simultaneous mp-MPC and Kalman filter 
and (iii) the simultaneous mp-MPC and mp-MHE. DOA is monitored using the BIS 
index during the induction and maintenance phase of general anaesthesia. The closed 
loop control sets are performed on a set of 12 patients plus an extra patient (Table 2.1) 
representing the nominal values of all 12 patients. The designed controllers are tested 
both under the assumption that the output of the system is not influenced by noise and 
with the output corrupted by noise and disturbances. 
The simulations are performed first for the set of data presented in Table 1 so as to have a 
better understanding of their behaviour on different types of patients, and analyse the 
inter- and intra- patient variability. Next, the three controllers are tested against each 
other and simulated for different patients to be able to compare their performances by 
means of BIS and the corresponding Propofol infusion rates. 
3.4.1 Induction Phase 
Ideally the induction phase of the patient in an operational DOA is performed as fast as 
possible, so that little time is lost before the surgeon can start operating. It is therefore 
desirable that the patient reaches the BIS=50 target fast and remains within the target 
value without much undershoot or overshoot, i.e., values below BIS=40 and above 
BIS=60 should be avoided.  
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Figure 3.16 - Figure 3.21 present the simulations of the nominal controller and the two 
simultaneous mp-MPC and estimaton in the induction phase. Simulations of some 
patients show very small oscillations around the steady-state values. The average settling 
time for the designed controller is: (i) 280 seconds for nominal controller, (ii) 240 
seconds for the simultaneous mp-MPC and Kalman filter and 225 seconds for the 
simultaneous mp-MPC and mp-MHE. The best performance is obtained for the 
simultaneous mp-MPC and mp-MHE. The mp-MHE is able to deal better with the inter- 
and intra- patient variability. 
 
Figure 3.16: BIS response for all 13 patients in the induction phase – nominal mp-
MPC 
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Figure 3.17: Propofol infusion rate for all 13 patients in the induction phase – 
nominal mp-MPC 
 
Figure 3.18: BIS response for all 13 patients in the induction phase – simultaneous 
mp-MPC and Kalman filter 
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Figure 3.19: Propofol infusion rate for all 13 patients in the induction phase – 
simultaneous mp-MPC and Kalman filter 
 
 
Figure 3.20: BIS response for all 13 patients in the induction phase – simultaneous 
mp-MPC and mp-MHE 
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Figure 3.21: Propofol infusion rate for all 13 patients in the induction phase – 
simultaneous mp-MHE and mp-MPC 
 
The designed controllers are tested for two different patients, patient 4 and patient 9 
(patient 9 represents the most sensitive patient). Figure 3.22, Figure 3.23, Figure 3.25 and 
Figure 3.26 represent the BIS response of the 2 patients while Figure 3.24 and Figure 
3.27 show the corresponding control action (drug infusion). It can be observed that all 
three controllers exhibit similar performances with a settling time of 200 seconds. Note 
that for all simulations we have: (i) with blue the mp-MPC without state estimation, (ii) 
with black the simultaneous mp-MPC and Kalman filter, (iii) with magenta the 
simultaneous mp-MPC and mp-MHE and (iv) with red the setpoint for the BIS index. 
From Figure 3.23 and Figure 3.26 where we have a zoom in on the BIS response of the 
three controllers we can observe that the undershoot of the most sensitive patient is of 
2.2%. For the undershoot the worst case is considered meaning the most sensitive patient 
(patient 9). Also the simultaneous Kalman filter and mp-MPC as well as mp-MHE and 
mp-MPC have similar performances for this case where we have no noise corrupting the 
output. However, the simultaneous mp-MHE and mp-MPC has slightly better 
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performance for both patients since it is able to give better estimates of the states of the 
patients (see Section 3.2.2). 
 
Figure 3.22: BIS response of the three controllers for patient 4 in the induction 
phase without noise 
 
Figure 3.23: BIS response of the three controllers for patient 4 in the induction 
phase without noise – zoom in 
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Figure 3.24: Propofol infusion rate of the three controllers for patient 4 in the 
induction phase without noise 
 
Figure 3.25: BIS response of the three controllers for patient 9 in the induction 
phase without noise 
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Figure 3.26: BIS response of the three controllers for patient 9 in the induction 
phase without noise – zoom in 
 
Figure 3.27: Propofol infusion rate of the three controllers for patient 9 in the 
induction phase without noise 
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The optimal control action of the simultaneous mp-MPC and mp-MHE is presented in 
Table 3.1, along with the corresponding closed loop simulation control action for the 
nominal patient and patient 9 (Figure 3.28). Although both patients are in the induction 
phase, due to the inter- patient variability, different critical regions of the multiparametric 
controller i.e., control laws provide the optimal control action at each time step for the 
two patients. 
 
Table 3.1: Simultaneous mp-MHE and mp-MPC optimal control action for 
Patient 9 and the nominal Patient 
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Figure 3.28:Optimal control action for Patient 9 and the nominal patient 
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set of patients from Table 2.1. The results are presented for two of the patients, patient 4 
and the most sensitive patient, patient 9. Figure 3.29, Figure 3.30, Figure 3.32 and Figure 
3.33 present the BIS output for the simulated patients while Figure 3.31 and Figure 3.34 
depict the corresponding control action. It can be observed that the simulations exhibit a 
similar settling time as the case where there is no noise, around 200 seconds. In this case, 
due to the noise on the output we observe that the simultaneous mp-MHE and mp-MPC 
has significantly better performances then the controller that uses no estimation and the 
simultaneous Kalman filter and mp-MPC. For patient 4 the undershoot for the mp-MPC 
using no estimation is of 5.4%, the simultaneous Kalman filter and mp-MPC is of 3.6% 
and the simultaneous mp-MHE and mp-MPC has an undershoot of under 0.7% which can 
be considered as insignificant. For patient 9, representing the worst case scenario by 
being the most sensitive patient we have an undershoot of 5.9% for the mp-MPC without 
estimation, 4% for the simultaneous Kalman filter and mp-MPC and only 2.2% for the 
simultaneous mp-MHE and mp-MPC. Moreover, the better performances of the 
simultaneous mp-MHE and mp-MPC are justified due to the fact that the MHE is able to 
deal with noise and system constraints. The performances of the three controllers can be 
better observed in Figure 3.30 and Figure 3.33 where we have a zoom in on the most 
significant part of the simulation. 
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Figure 3.29: BIS response of the three controllers for patient 4 in the induction 
phase with noise 
 
 
Figure 3.30: BIS response of the three controllers for patient 4 in the induction 
phase with noise – zoom in 
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Figure 3.31: Propofol infusion rate of the three controllers for patient 4 in the 
induction phase with noise 
 
Figure 3.32: BIS response of the three controllers for patient 9 in the induction 
phase with noise 
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Figure 3.33: BIS response of the three controllers for patient 9 in the induction 
phase with noise – zoom in 
 
Figure 3.34: Propofol infusion rate of the three controllers for patient 9 in the 
induction phase with noise 
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For an in depth understanding of the need of using state estimation simultaneous with 
mp-MPC the controllers have been tested comparatively (also with a mp-MPC using no 
estimation) both under the assumption that the output is noise free and corrupted by 
noise. It can be observed that (i) the controllers provides maximum amount of drug 
infusion in order to drive the output to the desired setpoint value; (ii) as soon as the 
setpoint value is reached, the controller focuses on ensuring that over- and under- shoot 
of the system is avoided until reaching steady state; (iii) for the case where the output is 
strongly influenced by noise, the controllers exhibit satisfactory performances, especially 
fast settling time and avoids any significant undershoot/overshoot; (iv) the controller 
using mp-MHE estimation exhibits better overall performance, especially in the case 
where the output is noisy, with no significant undershoot and a settling time of 200 
seconds.  
3.4.2 Maintenance Phase 
During the maintenance phase, it is important that the controller rejects the disturbances 
occurred during surgery as fast as possible and bring the patient to the BIS target value. 
In this phase, typical disturbances can be applied additively to the output of the process to 
check the controller’s ability to reject them (West et al., 2013). A standard stimulus 
profile is defined and is presented in Figure 3.35. Each interval denotes a specific event 
in the operation theatre. Stimulus A represents response to intubation; B a surgical 
incision that is followed by a period of no surgical stimulation i.e., waiting for pathology 
result; C mimics an abrupt stimulus after a period of low level stimulation; D the onset of 
a continuous normal surgical stimulation; E, F, and G simulate short-lasting, larger 
stimulation within the surgical period; and H represents the withdrawal of stimulation 
during the closing period (Yelneedi et al., 2009). 
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Figure 3.35: The artificially generated disturbance signal 
 
In Figure 3.36 - Figure 3.41 we have the simulations of the three controllers and the 
nominal one in the maintenance phase. The controllers are tested for the whole set of 
patients in order to address the issue of inter- and intra- patient variability for each 
controller. 
 
Figure 3.36: BIS response for all 13 patients in the maintenance phase – nominal 
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Figure 3.37: Propofol infusion rate for all 13 patients in the maintenance phase – 
nominal mp-MPC 
 
Figure 3.38: BIS response for all 13 patients in the maintenance phase – 
simultaneous mp-MPC and Kalman filter 
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Figure 3.39: Propofol infusion rate for all 13 patients in the maintenance phase – 
simultaneous mp-MPC and Kalman filter 
 
Figure 3.40: BIS response for all 13 patients in the maintenance phase – 
simultaneous mp-MPC and mp-MHE 
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Figure 3.41: Propofol infusion rate for all 13 patients in the maintenance phase – 
simultaneous mp-MPC and mp-MHE 
 
In Figure 3.42, Figure 3.43, Figure 3.46 and Figure 3.47, the performance of the 
disturbance rejection for patient 4 and the most sensitive patient (patient 9) are shown. 
Figure 3.44 and Figure 3.48 present the BIS response for the most challenging part of the 
disturbance rejection test, namely B-C-D-E while in Figure 3.45 and Figure 3.49 we have 
the corresponding Propofol infusion rate for patient 4 and patient 9. The simulations are 
performed for the maintenance phase using the disturbance signal (see Figure 3.35). The 
simulations show only small differences between the controllers. The controller using 
mp-MHE has a less aggressive behaviour, thus a smaller value for the undershoot.  
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Figure 3.42: BIS response of the three controllers for patient 4 in the maintenance 
phase without noise 
 
Figure 3.43: Propofol infusion rate of the three controllers for patient 4 in the 
maintenance phase without noise 
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Figure 3.44: BIS response of the three controllers for patient 4 in the maintenance 
phase - B-C-D-E interval - without noise  
 
Figure 3.45: Propofol infusion rate of the three controllers for patient 4 in the 
maintenance phase - B-C-D-E interval - without noise 
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Figure 3.46: BIS response of the three controllers for patient 9 in the maintenance 
phase without noise 
 
Figure 3.47: Propofol infusion rate of the three controllers for patient 9 in the 
maintenance phase without noise 
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Figure 3.48: BIS response of the three controllers for patient 9 in the maintenance 
phase - B-C-D-E interval - without noise 
 
Figure 3.49: Propofol infusion rate of the three controllers for patient 9 in the 
maintenance phase - B-C-D-E interval - without noise 
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In Figure 3.50 - Figure 3.57 the three controllers are tested for the maintenance phase 
under the influence of noise (see Chapter1.1) for patient 4 and the most sensitive patient 
(patient 9). Figure 3.50 and Figure 3.54 depict the BIS output for the simulated patients 
for the whole disturbance signal while Figure 3.52 and Figure 3.56 depict the BIS output 
for the most challenging part of the disturbance signal (B-C-D-E). In Figure 3.51, Figure 
3.53, Figure 3.55, and Figure 3.57 we have the corresponding Propofol infusion rates. It 
can be observed that under the influence of noise the best results are obtained for the 
controller using mp-MHE followed by the controller using the Kalman filter. 
 
Figure 3.50: BIS response of the three controllers for patient 4 in the maintenance 
phase with noise 
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Figure 3.51: Propofol infusion rate of the three controllers for patient 4 in the 
maintenance phase with noise 
 
Figure 3.52: BIS response of the three controllers for patient 4 in the maintenance 
phase - B-C-D-E interval - without noise 
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Figure 3.53: Propofol infusion rate of the three controllers for patient 4 in the 
maintenance phase - B-C-D-E interval - with noise 
 
Figure 3.54: BIS response of the three controllers for patient 9 in the maintenance 
phase with noise 
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Figure 3.55: Propofol infusion rate of the three controllers for patient 9 in the 
maintenance phase with noise 
 
Figure 3.56: BIS response of the three controllers for patient 9 in the maintenance 
phase - B-C-D-E interval - without noise 
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Figure 3.57: Propofol infusion rate of the three controllers for patient 9 in the 
maintenance phase - B-C-D-E interval - with noise 
 
3.5 Discussion 
 
The aim of this chapter is to design and evaluate different estimation techniques that can 
be implemented simultaneously with mp-MPC for the automatic induction and control of 
DOA during induction and maintenance phase. The performance of the controllers are 
analysed both with and without noise influencing the output (BIS index).  
Three different types of estimation techniques are designed and tested: (i) Kalman filter, 
(ii) online moving horizon estimation and (iii) offline moving horizon. Two different 
design schemes are presented for the implementation of the estimators that use as input: 
(i) the output of the Hill curve (BIS index) and (ii) the Ĉe by applying the inverse of the 
Hill curve to compensate for the nonlinearity introduced by the Hill function. Since the 
second scheme avoids the use of the nonlinearity in the design of the estimators it will 
show better overall performances. The MHE estimators show better performances than 
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the Kalman filter especially under the influence of noise. The online and offline MHE 
exhibit similar performances, the mp-MPC has the advantage that by using 
multiparametric programming, it manages to avoid the computation expenses of online 
MHE by solving the optimization problem once and offline. This will further facilitate 
the implementation of such techniques on embedded devices. Due to these advantages of 
the mp-MHE the online MHE is not considered in further studies. 
The Kalman filter and mp-MHE are simultaneously implemented with mp-MPC and 
along with the nominal controller tested in the induction and maintenance phase for the 
set of patients in Table 2.1. To address the inter- and intra- patient variability each of the 
three controllers are tested for the whole set of patients.  
In the induction phase, for the nominal controller we have an average settling time 280 
seconds, for the simultaneous Kalman filter and mp-MPC, an average of 240 seconds and 
an average of 225 seconds for the simultaneous mp-MHE and mp-MPC. For the 
undershoot evaluation, the worst case scenario is considered, meaning the most sensitive 
patient. Without the presence of noise, we obtain a maximum undershoot of: (i) 5.9% for 
the nominal mp-MPC without state estimation, (ii) 4% for the simultaneous Kalman filter 
and mp-MPC and (iii) 2% for the simultaneous mp-MHE and mp-MPC. All undershoots 
are below 10% which represents the maximum limit. We can say that as an overall 
performance the simultaneous mp-MHE and mp-MPC shows better results especially 
under the influence of noise.  
The controllers are tested in the maintenance phase in order to see how well they can deal 
with disturbance rejection. In Figure 3.42 - Figure 3.57 we can observe the four 
controllers response to a disturbance signal that mimics the events that occur in an 
operation theatre for patient 4 and for patient 9 with and without the influence of noise.  
For each patient there will be a variable dose-response relationship. For the same 
reference value, the controller sends different drug rate and the blood and effect-site 
concentrations levels are different for each patient.  
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3.6 Conclusions 
 
In this chapter we have designed and evaluated three different state estimation techniques 
(Kalman filter, offline moving horizon estimation and online moving horizon) for the 
intravenous anaesthesia process. For intravenous anaesthesia the performances were 
analysed and tested comparatively on a set of 12 patients. The state estimators are 
implemented simultaneously with mp-MPC and simulated for the same set of patients in 
the induction and maintenance phase both with and without noise influencing the output.  
It is therefore desirable that the patient reaches the BIS=50 target and remains within the 
target value without much undershoot or overshoot, i.e., values below BIS=40 and above 
BIS=60 should be avoided. In common practice the operation procedure does not start 
until the patient reaches an adequate DOA, usually taking up to 15 minutes. Thus, a rise 
time between 5 min and 7 min gives good performances. 
The designed methodologies show good performances: fast settling time and no 
significant overshoot or undershoot. Good performances for the control of DOA are 
defined by maintaining the BIS between the values of 40 and 60 as well as having a 
settling time lower than 15 minutes (in common practice it usually takes up to 15 minutes 
to reach DOA). The moving horizon estimator exhibits better performance compared to 
the other estimation techniques especially under the influence of noise and constraints. 
Moreover since the BIS output is influenced by strong noise, the use of the mp-MHE 
brings improvements to the control strategies. The estimators provide sufficiently 
accurate information to the parametric controllers to induce and maintain the desired 
Bispectral Index reference based only on the measured information.  
Furthermore the proposed strategies were able to deal with two of the main challenges 
in controlling the depth of anaesthesia: (i) nonlinearity by using the inverse of the Hill 
function and (ii) inter- and intra- patient variability by using estimation techniques to 
estimate the state of each individual patient. Alternative strategies that are able to deal 
with these challenges are further investigated in the following chapter. 
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4. Chapter 4 
 Hybrid and Robust Explicit Model Predictive 
Control Strategies 
 
4.1 Introduction 
 
In most drug delivery systems such as controlling the depth of anaesthesia, the 
nonlinearities are typically present in the pharmacodynamic model of the system and are 
described by the Hill curve representing the relation between the concentration of the 
drug and the effect observed on the patient. For the case of infusion of anaesthetic agents, 
the nonlinear Hill curve approximation has been used in both volatile (Krieger et al., 
2014) and intravenous (Nascu et al., 2012, Nascu et al., 2014a) anaesthesia 
In this chapter we further focus on different ways in dealing with the most important two 
challenges in controlling the depth of anaesthesia (DOA): nonlinearity and inter- and 
intra- patient variability. Advanced control strategies using either hybrid and robust 
multiparametric model predictive control or simultaneous hybrid multiparametric model 
predictive control and state estimation techniques are developed and tested. Here we first 
generate a piece-wise linearization of the Hill curve. The main advantage of this 
procedure is that the parameter space is linearized and that the uncertainty in some key 
parameters of the Hill curve is compensated for. As a result of the linearization, the 
anaesthesia model is described by a piece-wise affine system. This will lead to a hybrid 
model predictive control (hMPC) problem formulation (Bemporad et al., 1999a) and thus 
a mixed-integer quadratic programming (MIQP) problem formulation. However, the 
online implementation of hMPC involves the online solution of the MIQP problem, 
which introduces a high computational burden. To overcome this, the hMPC problem is 
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solved explicitly offline via the solution of state-of-the-art multi-parametric mixed integer 
quadratic programming problem (mp-MIQP) (Dua et al., 2002i, Oberdieck et al., 2015). 
Another important challenge in the control of DOA that is addressed in this chapter is the 
high inter- and intra- patient variability, which introduces a high degree of uncertainty in 
the system. A number of robust control strategies and a state estimation technique are 
developed and presented simultaneously with the hybrid multiparametric model 
predictive control (mp-hMPC). State estimation is used for the unavailable states as well 
as in order to overcome issues that arise from noisy outputs. In particular, moving 
horizon estimators (MHE), implemented in a multi-parametric fashion (Nascu et al., 
2014j, Darby and Nikolaou, 2007, Voelker et al., 2013) is used simultaneously with the 
hMPC control. The control strategies are tested on a set of 12 patients for the induction 
and maintenance phase of general anaesthesia. 
The chapter is organized as follows: the pharmacokinetic and pharmacodynamic patient 
model as well as the formulation of the hybrid patient model is presented in Section 4.2. 
Section 4.3 presents the design of the hybrid multiparametric model predictive controller 
along with the robust control strategies and the moving horizon estimation strategy. The 
simulation results of the designed controllers using the presented robust and estimation 
strategies for the induction and maintenance phase are presented in Section 4.4. In section 
4.5 we present the discussions following the results section while in Section 4.6 we 
summarize the main outcome of this chapter. 
 
4.2 Patient Model formulation 
 
4.2.1 Patient Model 
The patient model for the administration of intravenous anaesthesia is composed of the 
pharmacokinetic (PK) and pharmacodynamic (PD) models. PK model describes the 
distribution of Propofol in the body and PD model describes the relationship between 
Propofol blood concentration and its clinical effect. The PK-PD models most commonly 
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used for Propofol are the 4
th
 order compartmental model introduced by Schnider 
(Schnider et al., 1999) and Minto (Minto et al., 1997) 
The PK model is expressed by linear relations as follows: 
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where x1 represents the drug concentration in the central compartment [mg/l]. The 
peripheral compartments 2 (muscle) and 3 (fat) model the drug exchange of the blood 
with well and poorly diffused body tissues. The concentrations of drug in the fast and 
slow equilibrating peripheral compartments are denoted by x2 and x3 respectively. The 
parameters kij for i=1:3, i≠j, denote the drug transfer frequency from the i
th
 to the j
th 
compartment, , k10 the frequency of drug removal from the central compartment. u(t) 
[mg/min] is the infusion rate of the anaesthetic or analgesic drug into the central 
compartment. The parameters kij of the PK models depend on age, weight, height and 
gender and can be calculated for Propofol as presented in Table 2.1. A more detailed 
description of the patient model can be found in Chapter 1.1. 
The PD mathematical model is presented as follows: 
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 (Equation 4.2) 
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(Equation 4.3) 
 
The additional hypothetical effect compartment is added to represent the lag between 
plasma drug concentration and drug response. Its corresponding drug concentration is 
represented by the effect-site compartment concentration Ce. The drug transfer frequency 
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for Propofol from the central compartment to the effect site-compartment is considered in 
clinical practice to be equal to the frequency of drug removal from the effect-site 
compartment ke0=k1e=0.456 [min
-1
].(Schnider et al., 1998, Schnider et al., 1999, Nunes et 
al., 2009)  
The Hill curve (Equation 4.3), corresponds to the second part of the PD model. E0 
denotes the baseline value (awake state - without drug), which by convention is typically 
assigned a value of 100, Emax denotes the maximum effect achieved by the drug infusion, 
EC50 is the drug concentration at 50% of the maximal effect and represents the patient 
sensitivity to the drug, and γ determines the steepness of the curve. 
 
4.2.2 Hybrid Patient Model 
A feature of the PD model for DOA control is the presence of nonlinearities 
corresponding to the Hill curve. Due to its S shape profile, a piecewise linearization of 
the Hill curve which divides the BIS into three partitions, where each partition 𝑖 is 
associated with a different linear function 𝐵𝐼𝑆 = 𝐶𝑖𝐶𝑒 + 𝑒𝑖. The resulting piece-wise 
affine formulation is shown in Table 4.1 where the parameters describing the PK model 
can be found in Table 2.1. 
125 
 
 
Figure 4.1: The original Hill curve and a piece-wise linearized version. The red 
dotes denote the points around which the linearization was performed while the 
purple arrows show the switching points 𝝀𝟏 and 𝝀𝟐, respectively 
 
The binary variables δ thereby denote whether a certain partition is active. As a result, 
this system belongs to the class of hybrid systems, i.e., systems which are described by 
continuous as well as discrete dynamics and/or logical constraints. 
Table 4.1: Hybrid model for intravenous anaesthesia 
Intravenous Anaesthesia 
PK model 
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PD model (Hill curve) 
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Where 𝛿 ∈ [0,1]3; 𝐶𝑖 , 𝑒𝑖, 𝑖 ∈ {1,2,3} are found using the first order Taylor expansions at 
the points for the linearization; ∑ 𝛿𝑖𝑖 = 1. 
Note that ∑ 𝛿𝑖𝑖 = 1 holds, as only one linearization is active for every drug concentration 
𝐶𝑒, and the choice of which linearization is active is described via the switching points 𝜆1 
and 𝜆2 (see Figure 4.1)  
Systems which can be described via the equations presented in Table 4.1 are part of the 
mixed-logical dynamical (MLD) systems, which are a well-studied class of systems 
(Bemporad et al., 1999b, Heemels et al., 2001). The basic principle is thereby that 
additionally to the commonly encountered continuous parts, discrete elements are present 
in the problem formulation, either as inputs, states, variables or outputs. Additional 
information can be found in Appendix C. 
 
4.3 Control Design 
 
4.3.1 Hybrid formulation of the control problem –intravenous 
anaesthesia 
Based on the piece-wise affine formulation presented in Table 4.1, the following hybrid 
explicit MPC can be obtained (Bemporad and Morari, 1999a): 
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(Equation 4.4) 
 
where x are states, y outputs and u controls, all (discrete) time dependent vectors. The 
prediction horizon is denoted by N and control horizon by Nu. X, U are the sets of the 
state and input constraints that contain the origin in their interior. The weight matrix for 
manipulated variables 0R  is a positive definite diagonal matrix and QR is the weight 
matrix for tracked outputs. Thus, if a certain combination of integer variables is fixed, 
(Equation 4.4) results in a convex QP. For the design of the controller the following 
design parameters were used: the objective coefficients for states (x), the weight matrix 
for tracked outputs (y), QR=10
2
, weight matrix for manipulated variables (u), R=1. 
(Equation 4.4) can be recast as an mp-MIQP problem for which we have recently 
proposed the first exact solution reported in the literature (Oberdieck and Pistikopoulos, 
2015) (see also Figure 4.2). Once the algorithm is initialized, a candidate solution is 
found, which is fixed in the original problem thus transforming it into a mp-QP problem. 
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The mp-QP problem is solved using available solvers. Next, the objective values of the 
mp-QP problem and the upper bound in the critical region considered are compared 
against each other to form a new, tighter upper bound. The algorithm terminates if a 
termination criterion is reached. More details on the exact solution can be found in 
Appendix C. 
 
Figure 4.2: The general framework for the solution of mp-MIQP problems 
 
Figure 4.3 presents a typical solution of the multiparametric programming problem in 
the form of 2-dimensional projection of the critical space. The parametric vector θ 
consists of: the estimated states, the current time output and the output reference 
(BIS=50). Here θ1 and θ2 represent the concentration of the effect site compartment, Ce 
and the first state x1.  
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Figure 4.3: Map of critical regions - mp-hMPC 
 
4.3.2 Robust & estimation of the hybrid mp-MPC control 
strategy 
 
Another challenge for the DOA control is the high inter- and intra- patient variability, 
which introduces a high degree of uncertainty in the system. Thus, robust control 
strategies or estimation techniques are required. Robust techniques and a multiparametric 
moving horizon estimation technique which are able to deal with these types of problems 
have been developed. 
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4.3.2.1 Strategy 1 – Moving Horizon Estimation (MHE)  
Moving horizon estimation (MHE) is an estimation method that considers a limited 
amount of past data. It provides information about the states of the system when 
measurements are unavailable, noisy or unreliable (Voelker et al., 2013, Nascu et al., 
2014j). Moreover, it has the advantage of incorporating system knowledge as constraints 
in the estimation problem. In MHE the system states and disturbances are derived by 
solving (Equation 4.5)   
 Using simultaneous mp-MHE and mp-hMPC the state of each individual patient will be 
estimated and used by the controller (Nascu et al., 2014e) by formulating and solving a 
constrained moving horizon estimator with multiparametric programming (Nascu et al., 
2014e) as follows: the mp-MHE is obtained by substituting the state space formulation of 
the estimated system ?̂?𝑡+1 = 𝐴?̂?𝑡 + 𝐵𝑢𝑘 + 𝐺?̂?𝑡, 𝑣𝑡 = 𝑦𝑡 − 𝐶?̂?𝑡 into: 
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(Equation 4.5) 
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Where N is the length of the horizon, T is the current point in time, Q and R are positive 
definite diagonal weighting matrices on the noises, PSS is the steady state solution for the 
Kalman filter. 
NT
NTw

 1}ˆ{  and 
T
NTv 1}{   are sequences of independent, normally distributed 
random numbers with mean values w  for {w} and zero-mean for {v}. NTNTx  /1  is the 
arrival costwhich captures the previous measurements that are not considered any more. 
 
4.3.2.2 Strategy 2 – Offset Free  
One key problem of inter- patient variability is the presence of an offset in the output of 
the process. Hence, the first (intuitive) approach is to introduce a new parameter Δy, 
which captures this offset. In a mathematical form, it can be understood as expanding the 
definition of the output yk: 
 Nkyyxx
error
k
R
kqkq ,...,1  ,)(,1,    (Equation 4.6) 
 
and added penalties in the objective function of problem: 
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Note that the offset Δy is assumed to be the same for the entire horizon. At each step, this 
offset is calculated, and fed as a parameter to the system, thus resulting in an offset-free 
approach. The advantage of this approach is its simplicity (in fact, (Sakizlis et al., 2004a) 
proposed a similar strategy), however it only provides a symptomatic approach, rather 
than tackling the underlying issue. 
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4.3.2.3 Strategy 3 –State Output Correction 
This approach is inspired by the work of (Chang et al., 2013, Chang et al., 2014a, Chang 
et al., 2014c), who proposed an "error compensator", i.e., to feed the parametric 
controller a "nominal" state which is corrected for disturbance. However, the key 
problem in anaesthesia is the scarsity of information, i.e., how to quantify this 
disturbance. The idea here is to assume that we know the correct value of the state xk,4. 
Based on this, we can collect the data which represents what the nominal Hill-curve 
would predict compared to the actual patient. This data is then used to (a) adjust the 
values of Ci and ei and (b) correct the value of xk,4 when it is fed to the controller so as to 
obtain a better control action. Mathematically, this can be understood as follows: 
 2
,
)(minarg pred
eC
yy   (Equation 4.8) 
 
where y is the actual output and 
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The values of C and e are adjusted over time and the “corrected” state is then calculated 
as: 
 )(~ 14,0 ii eyCx 

 (Equation 4.10) 
 
where i is based on y.  
Simulations have shown that the direct application of (Equation 4.8) does not yield 
satisfactory results, as the change in C can be substantial, altering the S-shaped nature of 
the Hill-curve. Hence, we have adopted a two-stage procedure where e is determined by 
finding the average difference between y and y
pred
 and C is only adjusted based on the 
difference corrected values.  
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4.3.2.4 Strategy 4 – Prediction Output Correction 
While the approach of adjusting C and e provides a theoretically more attractive 
approach, it also requires a new source of information. This last approach uses the state-
space prediction xk+1 in order to obtain data regarding the mismatch between y and ypred. 
The idea is the following: assume you have calculated xk,4 using (Equation 4.10), we get 
to stage k + 1 via the state-space model 
 
kkk BuAxx 1  (Equation 4.11) 
 
The new state xk+1 results in (a) a real output y, but (b) we can obtain the data according 
to (Equation 4.9) as we can predict how xk,4 would behave in the state-space model. This 
allows for the quantification of the mismatch between the linearization and the actual 
output without requiring any new parameters nor extra measurements. 
4.3.3 Hybrid Control Design 
In this section developed strategies are implemented with the hybrid mp-MPC for the 
control of intravenous anaesthesia. The proposed control design scheme for the 
simultaneous mp-MHE and mp-hMPC is presented in Figure 4.5 while in Figure 4.4 we 
have the design scheme for the mp-hMPC and the robust control strategies.  
 
Figure 4.4: Simultaneously hybrid mp-MPC and mp-MHE control scheme 
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Figure 4.5: Robust Hybrid mp-MPC control scheme 
 
The Patient in both design schemes, is simulated using the mathematical model of the 
patient composed of the pharmacokinetic part (linear) (Equation 4.1) and the 
pharamacodynamic part (Equation 4.2) and (Equation 4.3).  
For the design of the simultaneous mp-MHE mp-hMPC, the Estimator block is used to 
estimate the state of each individual patient. By estimating the states of every simulated 
patient, the controller instead of using the states computed using the nominal patient 
model will use the estimated values of states corresponding to each individual patient. 
Finally, the mp-hMPC block, using the individual patient states given by the Estimator 
block, calculates the error between the Measured BIS from the Patient and the Target BIS 
and provides the optimal Drug rate u to the Patient block. 
For the design of the robust mp-hMPC the developed robust strategies presented in 
Section 4.3.3 are implemented within the design of the mp-MPC. The Robust Hybrid mp-
MPC block, calculates the error between the Measured BIS from the Patient and the 
Target BIS and provides the optimal Drug rate u to the Patient block in order to drive it 
to the desired target value. 
 
4.4 Results 
 
In this section the results of a simulation study to evaluate the control strategies 
designed in this chapter, for the administration of Propofol are presented. The controllers 
are based on model based predictive control algorithm for automatic induction and 
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control of DOA. DOA is monitored using the Bispectral Index (BIS) during the induction 
and maintenance phase of general anaesthesia.  
The closed loop control tests are performed on a set of 12 patients (Ionescu et al., 2011c) 
plus an extra patient representing the nominal values of all 12 patients (PaN – patient 
nominal) presented in Table 2.1. For a particular patient E0 can be measured in awake 
state and Emax is considered to have the same value, Emax= E0. These parameters are 
considered known a priori in the simulations. 
All of the designed controllers are simulated first for the whole set of data presented in 
Table 2.1 in order to have a better understanding of their behaviour on the different types 
of patients, and also to be able to analyse the inter- and intra- patient variability. Next, the 
controllers showing the most relevant performances will be tested against each other and 
simulated for different patients so as to be able to compare their performances by means 
of the BIS index and the corresponding Propofol infusion rates. The performances of the 
five controllers are evaluated both in the induction and maintenance phase of DOA and 
the results are analysed comparatively. Note that the controllers are designed using the 
values of the nominal patient which means that for this patient we will have the best 
behaviour of the controllers.  
Ideally the induction phase of the patient in an operational DOA is performed as fast as 
possible, such that little time is lost before the surgeon can start operating. It is therefore 
desirable that the patient reaches the BIS=50 target and remains within the target value 
without much undershoot or overshoot, i.e., values below BIS=40 and above BIS=60 
should be avoided. In common practice the operation procedure does not start until the 
patient reaches an adequate DOA, usually taking up to 15 minutes. Thus, a rise time 
between 5 min and 7 min gives good performances 
During the maintenance phase, it is important that the controller rejects the 
disturbances occurred during surgery as fast as possible and bring the patient to the BIS 
target value. In this phase, typical disturbances can be applied additively to the output of 
the process to check the controller’s ability to reject them. A standard stimulus profile is 
defined and is presented in Figure 4.6. Each interval denotes a specific event in the 
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operation theatre. Stimulus A represents response to intubation; B a surgical incision that 
is followed by a period of no surgical stimulation i.e., waiting for pathology result; C 
mimics an abrupt stimulus after a period of low level stimulation; D the onset of a 
continuous normal surgical stimulation; E, F, and G simulate short-lasting, larger 
stimulation within the surgical period; and H represents the withdrawal of stimulation 
during the closing period (Yelneedi et al., 2009). 
 
Figure 4.6: The artificially generated disturbance signal 
 
4.4.1 No Offset Correction 
In Figure 4.7 and Figure 4.8 we have the simulations of all the patients and the nominal 
one in the induction phase for the mp-hMPC controller without any robust techniques or 
state estimation. Figure 4.7 represents the BIS response of the patients while Figure 4.8 
represents the corresponding control action. It can be observed that except the nominal 
patient (which was used for the design of the controller) all patients present an offset 
from the setpoint. Such behaviour is explained due to the high inter- and intra- variability. 
Figure 4.9 and Figure 4.10 present the simulations of all the patients and the nominal one 
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for the maintenance phase and it can be observed that, similar to the induction phase all 
patients (except the nominal one) present an offset from the setpoint. 
The average settling time for the whole set of patients is of 240 seconds and the 
undershoot for the most sensitive patient (patient 9), representing the worst case scenario 
is of 5.7%. 
 
Figure 4.7: BIS output for all 13 patients without offset correction – induction phase 
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Figure 4.8: drug infusion for all 13 patients without offset correction – induction 
phase 
 
Figure 4.9: BIS output for all 13 patients without offset correction – maintenance 
phase 
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Figure 4.10: drug infusion for all 13 patients without offset correction – 
maintenance phase 
 
The optimal control action of the multiparametric controller is presented in Table 4.2, 
along with the corresponding closed loop simulation control action for the nominal 
patient and patient 9 (Figure 4.11). Although both patients are in the induction phase, due 
to the inter- patient variability, different critical regions of the multiparametric controller 
i.e., control laws provide the optimal control action at each time step for the two patients. 
Table 4.2: mp-hMPC optimal control action for Patient 9 and the nominal Patient 
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Figure 4.11: Optimal control action for Patient 9 and the nominal patient 
 
In Figure 4.12 we show how the multiparametric hybrid model predictive controller 
operates for the nominal patient by presenting the correlation between the measured BIS 
output, the corresponding drug infusion rate, the active partition of the controller, the Ce, 
representing the fourth state of the process and the Hill function.  
1. At the first point (1), the second partition of the controller becomes active and the 
Hill function switches from the first linearization to the second. The control action 
gives the maximum infusion of Propofol to drive the patient to the desired BIS 
value. 
2. At the second point (2), the measured BIS reaches the target value of 50 and the 
controller stops providing the patient Propofol infusion rate. We can observe an 
undershoot on the BIS action since we have a more aggressive controller (which 
can be adapted by the tunning parameters of the controller). We are still in the 
second partition and the second linearization of the Hill function. 
3. At the third point (3), we reach the maximum value of the undershoot therefore 
the controller will still operate at zero infusion rate. We are still in the second 
partition and the second linearization of the Hill curve. We can observe that the Ce 
reaches its maximum. 
4. At the fourth point (4), the BIS settles at the value of 50, again providing the 
concentration Ce settles at the value of 42 [mg/min] and the controller starts 
giving Propfol infusion rate while it is also stabilising. Again the second partition 
remains active (second part of the linearization).  
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Note that in this case only the first and second linearization of the Hill curve become 
active i.e., only the first and second partition of the hybrid controller are activated. The 
third one will activate only when we have larger values of the concentration Ce therefore 
when the BIS value moves towards lower values. This will happen in the case of high 
disturbances in the maintenance phase. Also note that the concentration Ce is the inverse 
of the BIS output. 
 
Figure 4.12: Nominal mp-hMPC simulation for the nominal patient – induction 
phase 
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4.4.2 Strategy 1 – Moving Horizon Estimation (MHE) 
For the simultaneous mpMHE and mp-hMPC case we deal with the inter- and intra- 
patient variability by estimating the states of each simulated patient. The states are then 
used by the mp-hMPC to give the patient the optimal Propofol infusion rate. Therefore, 
the controller will be able to compensate for the offset from the setpoint. This can be 
observed in Figure 4.13 where we have the BIS response for all 13 patients and the 
nominal one and Figure 4.14 where we have the corresponding Propofol infusion rate. 
The average settling time is of 240 seconds and the undershoot of the most sensitive 
patient (patient 9) is of 3.5%. 
In Figure 4.15 and Figure 4.16 we have the simulations of all patients in the 
maintenance phase. 
 
Figure 4.13: BIS output for all 13 patients – strategy 1 (mp-MHE and mp-hMPC) – 
induction phase 
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Figure 4.14: drug infusion for all 13 patients – strategy 1 (mp-MHE and mp-hMPC) 
– induction phase 
 
Figure 4.15: BIS output for all 13 patients – strategy 1 (mp-MHE and mp-hMPC) – 
maintenance phase 
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Figure 4.16: drug infusion for all 13 patients – strategy 1 (mp-MHE and mp-hMPC) 
– maintenance phase 
 
4.4.3 Strategy 2 - Offset-Free 
Figure 4.17 and Figure 4.18 present the simulations of all the patients and the nominal 
one in the induction phase for the mp-hMPC using the offset correction. It can be 
observed from Figure 4.17 where we have the BIS response of the patients that the 
controller is able to compensate for the offset and brings all the patients to the setpoint 
value of 50. In Figure 4.18 we have the corresponding Propofol infusion rate. Simulations 
of some patients show very small oscillations around the steady state values. The average 
settling time is of 250 seconds. 
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Figure 4.17: BIS output for all 13 patients – strategy 2 – induction phase 
 
Figure 4.18: drug infusion for all 13 patients – strategy 2 – induction phase 
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The BIS response of all patients in the maintenance phase is depicted in Figure 4.19 
while Figure 4.20 depicts the corresponding drug infusion rate. The controller 
compensates for disturbances but due to pump limitation the simulations exhibit some 
offsets from the setpoint. 
 
Figure 4.19: BIS output for all 13 patients – strategy 2 – maintenance phase 
 
Figure 4.20: drug infusion for all 13 patients – strategy 2 – – maintenance phase 
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4.4.4 Strategy 3 - State-Output Correction 
The advantage of this approach is that it tackles the underlying problem of the varying 
coefficients of the Hill-curve, and hence is conceptually more advanced. Additionally, it 
does not require an additional parameter in the system. However, it does require the 
measurement of the fourth state (which is the concentration of the drug in the blood), 
which would require additional equipment or the use of the inverse of the Hill curve 
using the nominal patient data (introducing extra errors). Hence from a practical point of 
view this approach seems to be infeasible at the current state of the art. 
Figure 4.21 and Figure 4.22 we have the simulations of all patients and the nominal one 
for the induction phase where we have the BIS response and the corresponding Propofol 
infusion rate. Note that for this strategy the controller is only simulated in the induction 
phase since it can be observed that the performances of the offset free controller (Strategy 
2) exhibits better performances. 
 
Figure 4.21: BIS output for all 13 patients – strategy 3 – induction phase 
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Figure 4.22: drug infusion for all 13 patients – strategy 3 – induction phase 
 
4.4.5 Strategy 4 - Prediction-Output Correction 
Unlike the previous method, this method allows for the quantification of the mismatch 
between the linearization and the actual output without requiring any new parameters nor 
extra measurements. The only obstacle is that it needs be ensured that during the fitting 
process no other disturbances are present. However, in the setting of the surgery, such 
disturbances can be avoided as the real disturbances occur during the incisions/loss of 
blood etc. which can be controlled. 
In Figure 4.23 and Figure 4.24 we have the BIS response of all 13 patients and the 
nominal one in the induction phase and the corresponding Propofol infusion rate 
respectively. The average settling time is of 220 seconds and the maximum undershoot is 
5.8%. It can be observed from the simulations performed in the induction phase that the 
mp-hMPC using offset correction (Strategy 2) exhibits better performances, hence the 
controller using Strategy 4 will be tested only in the induction phase. 
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Figure 4.23: BIS output for all 13 patients – strategy 3 – induction phase 
 
 
Figure 4.24: drug infusion for all 13 patients – strategy 3 – induction phase 
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4.4.6 Comparison 
The nominal mp-hMPC controller (without any offset correction) is compared with the 
controller using estimation techniques and with one of the controllers using robust 
techniques, the simultaneous mp-MHE and mp-hMP, and the Offset Free mp-hMPC. The 
simulations are performed in the induction phase for two different patients: patient 2 and 
the most sensitive patient, patient 9.  
 
Figure 4.25: BIS response of the three controllers for patient 2 – induction phase 
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Figure 4.26: drug infusion of the three controllers for patient 2 –induction phase 
 
Figure 4.27: BIS response of the three controllers for patient 9 – induction phase 
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Figure 4.28: drug infusion of the three controllers for patient 9 – induction phase 
 
The simulations of the comparison of the three controllers for patient 2 is presented in 
Figure 4.25 where we have the BIS response and Figure 4.26 where we have the 
corresponding control action. It can be observed that for the nominal controller there is an 
offset from the setpoint due to the inter- and intra- patient variability. By using robust or 
estimation techniques the offset can be corrected and the controllers will take the patient 
closer to the desired BIS setpoint of 50.  
In Figure 4.27 we have the BIS response for patient 9 and Figure 4.28 presents the 
corresponding control action. As for patient 2, the controller that has no offset correction, 
presents an offset from the setpoint. The simultaneous mp-MHE and mp-hMPC gives the 
best performances: faster settling time, 240 seconds and an undershoot of 3.5%. The mp-
hMPC using offset correction has a settling time of 288 seconds and an undershoot of 
5.6%. 
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The comparison results show that the controller that uses the state estimates of each 
patient that is simulated is able to compensate better for the offset from the setpoint and 
also deal with the inter- and intra- patient variability. 
4.5 Discussion 
 
We have proposed a piece-wise affine formulation for a compartmental anaesthesia 
patient model, based on which a hybrid explicit/multiparametric MPC strategy is being 
developed. For the case when variability is not considered, it is shown that this requires 
the solution of a novel multiparametric mixed integer quadratic problem. In the presence 
of variability, a moving horizon estimation procedure and robust explicit MPC techniques 
were also incorporated within the overall hybrid explicit MPC strategy. These advanced 
control strategies are tested on a set of 12 patients and a nominal one for the automatic 
induction and control of DOA during induction and maintenance phase.  
The resulting mp-hMPC controller was tested for the set of patients in the induction. For 
the nominal case with no offset correction, we can observe from Figure 4.7 - Figure 4.10 
that, all patients present an offset from the desired target value with the exception of 
course of the nominal patient. This is due to the high inter- and intra- patient variability 
and can be compensated by making the control robust or using estimation techniques. 
Thus a number of robust techniques and an estimation strategy have been developed: (i) 
offset correction, (ii) state output correction, (iii) prediction output strategy, and (iv) 
moving horizon estimation. All the strategies have been tested for the set of patients in 
the induction phase. It can be observed that the applied strategies manage to correct the 
offset from the nominal case, therefore improving the performances of the controller. In 
the induction phase, the average settling time is of 250 seconds.  The operation procedure 
does not start until the patient reaches an adequate DOA, usually taking up to 15 minutes. 
Thus, a rise time between 4 and 5 min gives good performances. 
 Even though some patients show small oscillations around the steady state values, the 
highest undershoot or overshoot is of 5.8%. For DOA undershoots or overshoots of up to 
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10% are acceptable provided that the setpoint is reached as soon as possible. This further 
confirms the satisfactory performance of the derived hybrid controller. 
The nominal mp-hMPC as well as the simultaneous mp-MHE and mp-hMPC and the mp-
hMPC using offset correction (the second strategy) are tested in the maintenance phase in 
order to see how well they can deal with disturbance rejection. In Figure 4.19, and Figure 
4.15 the controllers response to a disturbance signal that mimics the events that occur in 
an operation theatre for all patients is shown. It can be observed that the robust 
controllers and the controller using mp-MHE are able to overcome the offset, especially 
around the value of 50, with the remaining offset due to limits imposed on the controller.  
The performance of the nominal controller are also compared with two strategies: (i) 
moving horizon estimation and (ii) offset free. The simulations are performed in the 
induction phase for two of the patients: patient 2 and patient 9 (the most sensitive patient) 
and presented in Figure 4.25 - Figure 4.28. As expected, the simultaneous mp-MHE and 
mp-hMPC and the hybrid offset free are able to deal with the inter- and intra- patient 
variability showing better overall performance. 
 
4.6 Conclusions 
 
In this chapter we have dealt with two of the main challenges in the control of the 
intravenous depth of anaesthesia: nonlinearity and inter-and intra- patient variability. To 
deal with the nonlinearity, a piece-wise linearization of the Hill curve was presented 
leading to a hybrid model-predictive control formulation which was solved explicitly 
offline via multiparametric quadratic programming algorithms. To account for the inter- 
and intra- patient variability, multiparametric moving horizon estimation as well as 
several robust algorithms were implemented simultaneous with multiparametric model 
predictive control. A simulation study was performed on a set of 12 patients for the 
induction and maintenance phase of intravenous anaesthesia for the designed strategies. 
Moreover, the performance of the most relevant strategies and the nominal controller 
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were compared with each other for two of the patients, including the most sensitive one. 
It is shown that the designed controllers are able to deal with the nonlinearities introduced 
by the Hill curve and exhibit good performances with no significant undershoot or 
overshoot and a fast settling time. The hybrid controllers using the simultaneous mp-
MPC and mp-hMHE as well as the offset correction show better performances and are 
able to deal with the offset problem. Furthermore, they are able to overcome the inter- 
and -intra patient variability proving a high-efficiency, optimal dosage and robustness of 
the model predictive control algorithm to induce and maintain the desired Bispectral 
Index reference while rejecting typical disturbances from surgery. 
Another important characteristic of using hybrid formulation and multiparametric model 
predictive control on the intravenous anaesthesia process is that it can be adapted to other 
drug delivery systems since the Hill curve is used to describe the nonlinearity in most of 
them.
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5. Chapter 5 
PAROC Framework for the Anaesthesia Process 
 
5.1 Introduction 
 
Model based optimization techniques have been proven to be essential for the control and 
operation of complex processes. In this context, model predictive control (MPC) - a 
model based control technique that calculates the optimal control action considering 
constraints on the input, output and state variables by solving an optimization problem at 
every sampling point (online) is perhaps the most widely accepted technology for 
advanced control applications.  
Explicit/multiparametric MPC where the solution of the online optimization problem can 
be obtained using off-line multiparametric programming has also received a lot of 
attention in the last fifteen years. A key feature of explicit/multiparametric MPC is that 
the governing control laws of the system at hand i.e., the control input as a function of the 
system states can be explicitly obtained, facilitating the implementation of MPC on 
embedded devices.(Bemporad et al., 2002g, Pistikopoulos et al., 2007a, Pistikopoulos, 
2009)  
The ability to derive in an explicit form the underlying control laws is particularly 
important for safety-critical applications, such as the control of drug delivery systems. 
Here we focus on the control of the depth of anaesthesia (DOA), which plays an 
important role in surgery and the intensive care unit. As the role of the anaesthetist has 
become more complex and indispensable to maintain the patients’ vital functions before, 
during and after surgery, the automation of the drug/anaesthetic administration may 
reduce workload while offering additional support during critical situations. Optimization 
of the drug infusion rates is also important for the safety of the patient and reduction of 
potential side-effects. While the control of DOA has been studied in the open 
literature,(Krieger et al., 2012, Krieger et al., 2014, Gentilini et al., 2001, Ionescu et al., 
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2011c, Nascu et al., 2011, Nascu et al., 2015c, Curatolo et al., 1996, Struys et al., 2003, 
Ionescu et al., 2008, Hodrea et al., 2012, Caiado Daniela et al., 2013, Dumont et al., 
2009, Haddad et al., 2003, Nascu et al., 2012, Sartori et al., 2005, Nascu et al., 2014e) it 
still remains a rather challenging task, mainly due to features such as inter-/intra- patient 
variability, variable time delays and nonlinearities.(Haddad et al., 2003, Absalom et al., 
2011). 
Complex systems such as the control of depth of anaesthesia presented in this chapter, 
control of drug delivery systems and in general biomedical processes often require 
advanced techniques for modelling, optimization and control. Complexity typically arises 
from the physical and operational characteristics of the processes such as periodicity, 
discontinuities, nonlinearity, time delays and large scale models. For advanced control 
applications, there is a clear need to address complexity issues in a systematic way in 
tandem with contemporary simulation software tools. Moreover, there is a need to 
address complex systems such as biomedical systems in a systematic way (Bogle, 2012). 
The development of PAROC (PARametric Optimization and Control),(Pistikopoulos et 
al., 2015) targets these issues in a step-by-step procedure including advanced modelling, 
approximation and state-of-the-art multi-parametric programming and explicit control 
techniques. A key feature of the framework is the closed-loop validation of the advanced 
controller against the high fidelity model. The PAROC framework is particularly suitable 
for safety-critical applications, and is applied to the process of intravenous and volatile 
anaesthesia process with the specific aim to overcome issues related to patient variability. 
This chapter is organized as follows: the PAROC framework is described step by step in 
Section 5.2. Section 5.3 presents the application of the presented framework on the 
process of intravenous anaesthesia while Section 5.4 presents the framework through the 
volatile anaesthesia process. Discussions are presented in Section 5.5 while the main 
outcome of this chapter is presented in Section 5.6. 
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5.2 The PAROC framework 
 
The PAROC framework presented in Figure 5.1,(Pistikopoulos et al., 2015) enables the 
solution of complex optimization control problems using a step-by-step-procedure to 
obtain explicit MPC control strategies. The framework starts from the development of a 
high-fidelity model of the system that could be approximated using discrete time models 
in state space form via model order reduction techniques or system identification 
techniques. The reduced model is then used to formulate an mp-MPC problem subject to 
the state space model and constraints. The resulting multiparametric programming 
problem is solved with state-of-the-art techniques and the map of the optimal control 
actions is acquired. Due to the fact that in many processes the measured output may be 
noisy and the system measurements do not produce this information directly, the state 
information needs to be inferred from the available output measurements. Therefore, a 
state estimator is implemented in the framework simultaneously with the mp-MPC. In the 
last step, the solution is validated against the original high fidelity model, thus closing the 
loop. 
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Figure 5.1: The PAROC framework 
 
One of the key advantage of the PAROC framework is that it follows a multiparametric 
approach for the controller design that transfers the computational burden 
offline(Pistikopoulos, 2000). Furthermore the framework is versatile and process-
independent with wide applicability;(Nascu et al., 2015a) implemented to systems 
including: (i) a combined heat and power (CHP) cogeneration system for residential use, 
(Diangelakis et al., 2014, Diangelakis et al., 2015) (ii) distillation column, (Nascu et al., 
2014e) (iii) a periodic chromatographic separation system of monoclonal antibodies, 
(Papathanasiou et al., 2015) (iv) pressure swing absorption, (Khajuria et al., 2011) (v) 
PEM fuel cell energy systems, (Panos et al., 2012, Ziogou et al., 2011) (vi) hydrogen 
storage tank, (Panos et al., 2010) (vii) batch polymerization system, (Asteasuain et al., 
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2006) (viii) wind turbines, (Kouramas et al., 2011a) and (ix) drug delivery systems 
including anaesthesia, (Nascu et al., 2015c) type-1 diabetes, (Zavitsanou et al., 2014, 
Zavitsanou et al., 2015) and leukemia (Fuentes-Garí et al., 2015, Velliou et al., 2014). 
PAROC addresses different classes of control problems such as: (i) nominal mp-MPC, 
(ii) hybrid mp-MPC, (iii) robust mp-MPC, (iv) simultaneous mp-MPC and moving 
horizon estimation, (v) integration of scheduling and control, (vi) development of mp-
MPC for periodic systems. The main features of PAROC are briefly discussed next. 
 
5.2.1 High – Fidelity Modelling 
The first step of the framework corresponds to the development of a high-fidelity model 
of the process, model analysis (for example through global sensitivity analysis), (Saltelli 
et al., 2006, Kiparissides et al., 2009) parameter estimation and dynamic optimization of 
the developed model. The validated high-fidelity model most commonly features 
nonlinear (partial) differential and algebraic equations ((P)DAEs) which can be 
developed in a high-level environment such as PSE's gPROMS® ModelBuilder (PSE, 
1997-2014). 
 
5.2.2 Model Reduction 
Sometimes it is necessary to reduce the original high fidelity model to a linear state space 
of lower dimensionality. In PAROC this can be done in two ways: either through (i) 
system identification or (ii) model reduction techniques. System identification is most 
commonly performed using the System Identification Toolbox in MATLAB®. Model 
order reduction techniques are also available (Narciso et al., 2008, Lambert et al., 2013) 
and presented in detail in Appendix B. 
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5.2.3 Multiparametric Optimization & Control Strategy 
Once an accurate state-space model is obtained the corresponding MPC problem is 
formulated explicitly by treating the states, output setpoints, measured disturbances and 
past inputs as parameters (Bemporad et al., 2002g). The solution of such an 
explicit/multiparametric model predictive control (mp-MPC) formulation requires the 
solution of a multiparametric programming problem. The main characteristic of mp-MPC 
is its ability to obtain: (i) the objective and optimization variable as a function of the 
varying parameters, and (ii) the regions in the space of the parameters where these 
functions are valid (critical regions) (Pistikopoulos et al., 2007a). This reduces the online 
implementation of the MPC to simple function evaluation, facilitating real time 
applications. To facilitate the solution of such problems the Parametric Optimization 
toolbox (POP), (ParOs, 2004) is used. POP is a solver for multiparametric linear and 
quadratic programming problems based on a variable step-size geometrical approach 
(Baotic, 2002). Key developments in multiparametric programming and 
multiparametric/explicit MPC are shown in Table 5.1 and Table 5.2. 
 
Table 5.1: Key developments in multiparametric programming 
Types  Theoretical development Authors 
mp-LP finding the optimal basis by evaluating a 
connected graph 
(Gal et al., 1972) 
explores the parameter space using the 
properties of the generated polytopes 
(Bemporad et al., 2002a) 
 
 
mp-QP 
a geometrical approach as presented for 
mp-LP problems 
(Dua et al., 2002i)  
(Bemporad et al., 2002g) 
(Baotic, 2002) 
163 
 
combinatorial (also called ’reverse 
transformation’) approach where the 
combination of all possible active sets of 
constraints are considered 
(Gupta et al., 2011a) 
(Seron et al., 2000) 
 
 
mp-MILP 
branch-and-bound approach in 
conjunction with suitable comparison and 
fathoming procedures 
(Acevedo et al., 1997a, 
Acevedo et al., 1999) 
(Oberdieck et al., 2014g) 
decomposition-type approach which 
alternates between a mixed-integer linear 
programming (MILP) and a mp-LP 
problem 
(Dua et al., 2000) 
(Wittmann-Hohlbein et al., 
2012, Wittmann-Hohlbein et 
al., 2013) 
mp-
MIQP 
a decomposition-type approach that relies 
on global optimization  
(Dua et al., 2002i) 
(Oberdieck and 
Pistikopoulos, 2015) 
 branch-and-bound approach (Oberdieck et al., 2014g) 
(Axehill et al., 2014a) 
 
 
Table 5.2: Key developments in multiparametric model predictive control 
Types  Theoretical development Authors 
nominal MPC Nominal mp-MPC problems (Bemporad et al., 2002g) 
(Pistikopoulos, 2009, 
Pistikopoulos et al., 
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2007) 
(Nikandrov et al., 2009) 
 
hybrid mp-MPC 
multiparametric model-based 
control of systems that are 
described by both linear as 
well as logical dynamics 
(Dua et al., 2002i) 
(Oberdieck and 
Pistikopoulos, 2015) 
(Axehill et al., 2014a) 
(Nascu et al., 2015e) 
(Trifkovic et al., 2014) 
robust mp-MPC 
(the immunity of a 
system against 
perturbations) 
Additive disturbances (Sakizlis et al., 2004c) 
(Alamo et al., 2005) 
(Olaru et al., 2006) 
(Raković et al., 2008) 
Model uncertainities (Pistikopoulos et al., 
2009) 
(Ricardez Sandoval et al., 
2008) 
Min-max robust mp-MPC (Alamo et al., 2005) 
(Bemporad et al., 2003) 
(Ricardez Sandoval et al., 
2008) 
(Muñoz De La Peña et 
al., 2006) 
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Linear input/output model (Olaru and Ayerbe, 2006) 
(Muñoz de la Peña et al., 
2005) 
 
5.2.4 Moving Horizon Estimation 
A main assumption in the implementation of the previous presented strategies is that 
accurate, noise-free information i.e., measurements is available for all system states. 
Since this is rarely the case, state estimators is used for the unavailable states as well as in 
order to overcome issues that arise from noisy outputs. In particular, moving horizon 
estimators (MHE), implemented in a multiparametric fashion are used (Darby and 
Nikolaou, 2007, Voelker et al., 2013). The resulting mp-MHE can be used 
simultaneously with mp-MPC within the PAROC framework. 
 
5.2.5 Validation 
The last step of the PAROC framework is the off-line closed loop validation, aiming to 
test the controller against the original high fidelity model developed in the first step. This 
(i) establishes the accuracy and robustness of the controller and (ii) the consistency of the 
approximate model; depending on the outcome of the validation step the explicit 
controller can be redesigned and revaluated. 
5.2.6 Software Platform 
Within the PAROC framework, the high-fidelity modelling and analysis step is 
performed in gPROMS® ModelBuilder or in MATLAB® for simpler models. The 
formulation and solution of the multiparametric programming problem is carried out in 
POP, (ParOs, 2004) within MATLAB®. The closed-loop validation of the developed 
controller can be performed in two ways. The first approach includes the simulation of 
the high-fidelity model as well as the controller through MATLAB® using PSE's 
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gO:MATLAB to simulate the high fidelity model as a single function call in the 
MATLAB® environment. This approach provides an effortless way of closing the loop 
but the user is unable to utilize the capabilities of the gPROMS® family to their full 
extent. As a result a tool that inserts the mp-MPC solution directly in gPROMS® has 
been developed. A dynamic link library (dll) is generated in C++ that contains the 
solution of the multiparametric programming control problem provided by POP. The dll 
is then called within the gPROMS® environment. A representation of the PAROC 
software platform is presented Figure 5.2. 
 
Figure 5.2: The PAROC platform software 
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5.3 The PAROC Framework for Intravenous 
Anaesthesia 
 
This section presents the application of the PAROC framework for the design and 
development of multiparametric model predictive controllers for the induction and 
maintenance phases of intravenous anaesthesia. As presented in the previous section, for 
the automatic depth of anaesthesia (DOA), the intravenous agent Propofol is the input 
with the Bispectral Index (BIS) as the output of the system. 
 
5.3.1 High – Fidelity Modelling 
The high fidelity model used for intravenous control of depth of anaesthesia is presented 
in detail in Chapter 2.1. 
 
5.3.2 Model Reduction 
The intravenous anaesthesia model presented in Chapter 2.1 and used for this study does 
not require model reduction. Hence it can be used directly for optimization and control 
via multiparametric programming. Model reduction has been applied for the case of 
volatile anaesthesia, (Nascu et al., Krieger et al., 2012) where the mathematical model is 
more complex. 
 
5.3.3 Multiparametric Optimization & Control Strategy 
The anaesthesia/patient mathematical model presented in the Chapter 2.1 together with 
the patient data provided in Table 2.1 provide the basis for the development of the 
explicit/multiparametric model predictive control strategy, which is described Chapter 2 
Chapter 3 and Chapter 4. 
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5.3.4 Moving Horizon Estimation 
The moving horizon estimation formulation is presented in Chapter 3 along with the 
simultaneous multiparametric model predictive control and multiparametric moving 
horizon estimation formulation. 
 
5.3.5 Validation 
 
In this step the simultaneous estimator and controller for automatic induction and control 
of DOA is tested against the original high fidelity model both for the induction and 
maintenance phases of general anaesthesia. The closed loop control tests are performed 
on the set of the 12 patients presented Table 2.1. In chapter 2 we have the results for the 
multiparametric model predictive control of DOA, in Chapter 3 the results for 
simultaneous multiparametric model predictive control and multiparametric moving 
horizon estimation and in Chapter 4 we present the simulations for the hybrid 
multiparametric model predictive control. 
 
5.4 The PAROC Framework for Volatile Anaesthesia 
 
This section presents the application of the PAROC framework for the design and 
development of multiparametric model predictive controllers for volatile anaesthesia. The 
PAROC framework applied on the process of anaesthesia is presented in Figure 5.3 
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Figure 5.3: PAROC framework for anaesthesia system 
 
5.4.1 High – Fidelity Modelling 
A suitable model for prediction should capture the dynamics of the patient in response to 
the applied anaesthetic signal. The relationship between the drug infusion rate and its 
effect can be described with pharmacokinetic (PK) and pharmacodynamic (PD) models 
used to represent the distribution of drugs in the body. The PK model follows the 
distribution of the drug in the body while the PD model describes the relationship 
between the drug blood concentration and its clinical effect. 
 
5.4.1.1 Pharmacokinetic Model 
The physiologically based four compartmental model was developed by Eger (Eger, 
1974) and is presented in Figure 5.4 (a). These compartments are the vessel rich group 
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(VRG), the muscle group (M), the adipose tissue (F) and the vessel poor group (VPG). 
Each compartment is further sub-divided into an ideally mixed blood and ideally mixed 
tissue part as presented in Figure 5.4 (b). All compartments are further sub-divided into 
blood and tissue parts. A detailed description of the model can be found in (Krieger et al., 
2014). 
The equations describing the uptake of the anaesthetic in the body compartments are 
presented below: 
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 (Equation 5.1) 
 
where Vb is the blood volume, Vt, the tidal volume, Q is the cardiac output, Cb, the 
concentration of the anaesthetic in the blood, Ct, is the concentration of the drug in the 
tissue, ut is the anaesthetic uptake by the tissue, rQ is the ratio of the cardiac output, rV the 
ratio of the total lung volume and λ is the blood gas partition coefficient and Ca is the 
concentration of the blood in the arterial blood. 
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Figure 5.4: Volatile anaesthesia - (a) Structure of the physiological based model (b) 
detailed fluxes of gas and blood in the lungs 
 
Two factors, the ventilation of air and the perfusion of blood through the lungs determine 
the uptake of the anaesthetic agent occurring in the lungs. The equations describing the 
anaesthetic uptake in the lungs are given as follows: 
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where V is the total minute ventilation, VA is the alveolar ventilation, VL, the lung volume, 
VD is the dead-space ventilation, VT, the tidal volume, Ca is the concentration of the drug 
in the arterial blood, CA the is the concentration of the drug in the alveoli just after 
inspiration, CE the end-tidal expired concentration, Cv is the mixed venous blood 
concentration and uL is the anaesthetic uptake by the lungs. 
To obtain an individualized patient model the parameters and variables in (Equation 5.1) 
and (Equation 5.2) described as a function of the patient’s weight, age, height and gender 
(male=1, female=0). 
Calculation of patient specific tissue mass: 
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(Equation 5.3) 
 
Calculation of the patient specific blood volume 
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 (Equation 5.4) 
 
Calculation of patient specific cardiac output 
 )1(62.003.008.084.5 genderageBMIQ   (Equation 5.5) 
 
Calculation of patient specific lung volume 
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 46.0)096.0exp(97.11  BMIVL  (Equation 5.6) 
 
C[vol%] is the concentration, QCO [mL/min] the cardiac output, Q [mL/min] the blood 
flow, V [mL] the volume, VT [mL] the tidal volume, VDS [mL] the dead space, fR [1/min] 
the respiratory frequency, ls the lung shunt. 
Assuming a constant tidal volume, VT, and a constant respiratory frequency, fR, the PK 
equations result in a linear state space system with the arterial blood concentration, Ca , as 
output and the inhaled concentration of the anaesthetic agent, CI , as input of the system. 
 
5.4.1.2 Pharmacodynamic Model 
The pharmacodynamics describe the link of concentration of the anaesthetic agent to the 
effect of the drug. 
An additional hypothetical effect compartment is added to represent the lag between 
plasma drug concentration and drug response. Its corresponding drug concentration is 
represented by the effect-site compartment concentration Ce, and ke0 denotes the delay of 
the drug action. The effect compartment receives drug from the central compartment by a 
first-order process and is considered as a virtual additional compartment. For volatile 
anaesthesia Ca denotes the concentration in the arterial blood calculated in (Equation 5.2) 
and the PD mathematical model is presented as follows: 
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5.4.2 Model Reduction 
For the design of a simultaneous control and estimation strategy, in the cases where the 
models are too complicated to be used directly for control studies, reduced models are 
first derived based on the model reduction scheme described in (Nascu et al., 2014e). 
This approach (i) reduces the computational complexity on both the controller and 
estimator since they no longer require full state information, and (ii) avoids any 
estimation errors due to poor/inadequate observability of some of the states (Singh et al., 
2005). For volatile anaesthesia, since the model in use is more complicated than for the 
intravenous anaesthesia, model order reduction is performed before proceeding to control 
studies. 
The state space matrices for the full volatile anaesthesia model are presented below: 
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(Equation 5.9) 
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Model order reduction techinques are applied on the full anaesthesia model as presented 
in Appendix B and the resulting reduced model is presented below: 
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(Equation 
5.10) 
   
5.4.3 Moving Horizon Estimation 
For the design of the estimation strategy in this case, the volatile anaesthesia model 
presented in Chapter 5.4.1 is reduced from 7 states to 4 (see chapter 5.4.3). This approach 
(i) reduces the computational complexity on the estimator since they no longer require 
full state information, and (ii) avoids any estimation errors due to poor/inadequate 
observability of some of the states (Singh and Hahn, 2005). The three types of estimators 
(the Kalman filter, online MHE and mp-MHE) are designed and implemented similar to 
the intravenous anaesthesia cases. 
For the mp-MHE, the vector of 9x1 parameters system consisting of: the 
measured/calculated state vector, the previous and current measured outputs and the 
previous control action is given to the multiparametric moving horizon estimator which 
computes the estimate for the reduced states of the system. These estimates are then used 
by the multiparametric controller to calculate the optimal control value that will be 
applied to the system. In the case of the mp-MPC, the vector of parameters is a 6x1 
system consisting of: the estimated states, the current time output and the output setpoint. 
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The measurement noise is included as noise for the moving horizon estimation. A 
Gaussian distribution with a 3% standard deviation is assumed. The state estimator is 
considered for a horizon of N=3. In this case the parameters vector therefore includes the 
N past measurements and values for the manipulated variable. 
Figure 5.5 presents the solution of the multiparametric programming problem in the form 
of 2-dimensional projection of the critical space. 
 
 
Figure 5.5: critical regions for Volatile Anaesthesia mp-MHE 
 
The results are presented in Figure 5.6 for one patient where it can be observed that 
better results are obtain with the use of MHE estimation. 
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Figure 5.6: Volatile anaesthesia - Comparison of actual and estimated reduced order 
state and MHE 
 
5.4.4 Multiparametric Optimization & Control Strategy 
The control design scheme of the simultaneous design strategies and mp-MPC is 
illustrated in Figure 5.7: 
 
Figure 5.7: Volatile anaesthesia - Schematic of simultaneous reduced order mp-
MHE and mp-MPC for volatile anaesthesia 
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The Patient block represents the high fidelity model of the patient composed of the PK 
and PD part as described in Section 5.4.1.1 and Section 5.4.1.2. The Estimator block uses 
the approximate model of the patient described in Section 5.4.2 and the drug infusion to 
estimate the state of each individual patient. Furthermore, the estimated states, the 
approximate model as well as the target of the concentration is used by the mp-MPC 
block to give the optimal control action. 
Using the explicit/multiparametric MPC formulation described in (Pistikopoulos et al., 
2007a), the control strategy is based on the nonlinearity compensation and the state space 
model of the PK-PD linear part for the nominal patient model. The following mp-QP 
optimization problem is solved to obtain the control laws using the POP toolbox 
(Pistikopoulos et al., 1999) and determine the controller. 
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(Equation 5.11) 
 
where N is the output horizon, Nu the control horizon, QR the weight matrix on reference 
tracking error, R1 the weight matrix on change in control input, A, B, C state space 
matrices, Ce effect site concentration (control output), Ce
R
 reference point on effect site 
concentration, CI inspired concentration (control input), ΔCI change in inlet concentration 
(change in control input). 
Although the first state of the original system of ODEs is also the measured variable, it 
is possible to reconstruct it from the estimated reduced states.The objective coefficients 
for states (x), Q=0 when we have no state estimation and Q=1 in the case with state 
estimation, the weight matrix for tracked outputs (y), QR=1000, weight matrix for 
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manipulated variables (u), R=1, the control horizon Nu=1 and the prediction horizon 
N=10.The initial system consists of 7 states. Using the model reduction techniques 
presented in the previous chapter the full model is reduced to 4 states. An mp-MHE is 
used to estimate the reduced states and a comparison between the estimated states and the 
reduced states are presented in Figure 5.6. The estimator is designed using the nominal 
patient.  
Figure 5.8 depicts the solution of the mp programming problem in the form of 2-
dimensional projections of the critical space. The projections are based on the states 
variables of the parameter vectors. The values of the rest of the parameters are set to 
fixed values within their feasible bounds in order to generate the graphs. 
 
Figure 5.8: Volatile Anaesthesia mp-MPC 
 
5.4.5 Validation 
Figure 5.9 and Figure 5.10 summarise the closed loop validation results. Once an 
accurate estimation of the states is obtained, this can be used to design the mp-MPC 
controller based on the nominal patient model. It is observed that (i) as shown in Figure 
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5.10, using the drug infusion as control action, the controller drives the anaesthesia 
process to the desired set point – Figure 5.9; (ii) from Figure 5.9 we can observe that the 
controller shows good performance with fast settling time and no significant overshoot or 
undershoot; (iii) also the mp-MHE based on the reduced model exhibits satisfactory 
performance with no significant mismatch between the states despite the presence of 
measurement noise; (iv) the estimator provides sufficiently accurate information to the 
parametric controller in order to drive the system to the desired set point based only on 
measurement information –Figure 5.9. 
 
Figure 5.9: Volatile anaesthesia - Close loop simulation of a set-point change 
operated through simultaneous mp-MHE and mp-MPC 
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Figure 5.10: Volatile anaesthesia - Evolution of the control input variable 
5.5 Discussion 
 
This chapter presents a framework for the development of simultaneous multi-parametric 
model predictive control and estimation for the anaesthesia process. Starting from the 
development of a high fidelity model of the anaesthesia process, suitable model reduction 
techniques provide, if necessary, an approximate model which is used in combination 
with state-of-the-art simultaneous explicit model predictive control and estimation 
algorithms to solve the underlying optimal control problem offline. The solution is 
validated against the original high fidelity model in a closed-loop in silico fashion. The 
PAROC framework is applied both to the intravenous as well as the volatile anaesthesia 
process for the induction phase. 
State estimation techniques are designed to estimate the states for the intravenous and 
volatile anaesthesia process. The estimation techniques are designed for different cases 
and they are tested comparatively. Furthermore the state estimators are implemented 
simultaneously with mp-MPC.  
For volatile anaesthesia model reduction techniques performed on the model before 
applying the control studies. The focus is on analysing different estimation techniques 
and their performances when used simultaneously with multiparametric model predictive 
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control, with or without noise influencing the output as well as testing the inter- and intra- 
patient variability like in the case of intravenous anaesthesia. The main aim for this case 
is to analyse the performances of the simultaneous multiparametric model predictive 
controller and state estimation using the reduced order model. This was tested against the 
high fidelity model 
In both intravenous and volatile process, the designed methodologies show good 
performances: fast settling time and no significant overshoot or undershoot. The moving 
horizon estimator exhibits better performance compared to the other estimation 
techniques especially under the influence of noise and constraints. Moreover since the 
BIS output is influenced by strong noise, the use of the mp-MHE brings improvements to 
the control strategies. The estimators provide sufficiently accurate information to the 
parametric controllers to induce and maintain the desired Bispectral Index reference 
based only on the measured information. The volatile anaesthesia process underlines the 
importance of using model order reduction for simultaneous multi-parametric moving 
horizon estimation and multi-parametric model predictive control.  
Furthermore the proposed strategies are able to deal with two of the main challenges in 
controlling the depth of anaesthesia: (i) nonlinearity by using the inverse of the Hill 
function and (ii) inter- and intra- patient variability by using estimation techniques to 
estimate the state of each individual patient. 
 
5.6 Conclusions 
 
In this chapter we have presented PAROC, a comprehensive framework and software 
platform for the development and validation of explicit MPC controllers. The presented 
framework targets complex issues in a step-by-step procedure including advanced 
modelling, approximation and state-of-the-art multiparametric programming and explicit 
control techniques. An important characteristic of the framework is the closed-loop 
validation of the advanced controller against the high fidelity model. Some of the key 
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features of the PAROC framework are: (i) it is easily implemented on fundamentally 
different classes of problems, (ii) it follows a multiparametric approach for the controller 
design that transfers the computational burden offline, (iii) the validation of the exact 
solution against the high fidelity model through the interconnectivity of the different 
software packages, (iv) due to its decomposed nature it allows for different advanced 
applications in the different steps. 
The capabilities and applicability of the framework are highlighted through the 
intravenous and volatile anaesthesia process during induction and maintenance phase. 
Overcoming challenges such as nonlinearity and inter- and intra- patient variability as 
well as the advantages of using the framework on such a system are presented in detail. 
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6. Chapter 6 
Conclusions and Future Directions 
 
6.1 Project Summary 
 
As the role of the anaesthetist has become more complex and indispensable to maintain 
the patients’ vital functions before, during and after surgery, the automation of the 
drug/anaesthetic administration may reduce workload while offering additional support 
during critical situations. Optimization and control of the depth of anaesthesia is also 
important for the safety of the patient and reduction of potential side-effects. 
The main objective of this thesis was to develop advanced explicit/multi-parametric 
model predictive (mp-MPC) control strategies for the anaesthesia process. 
Chapter 2 describes the mp-MPC framework based on a mathematical model for 
intravenous anaesthesia featuring a pharmacokinetic (PK) and pharmacodynamic (PD) 
compartment model structure. Different strategies were applied to overcome issues 
related to the nonlinear part of the model, the Hill curve of the PD model. Specialised 
linearization techniques were employed for this purpose. 
Chapter 3 describes the simultaneous mp-MPC and state estimation strategies for the 
intravenous anaesthesia. Different estimation techniques to estimate the state of each 
individual patient were implemented and tested. The estimators were applied 
simultaneous with the mp-MPC to overcome challenges related to the inter- and intra- 
patient variability and, unmeasurable and noisy outputs. 
Chapter 4 describes a piece-wise linearization of the Hill curve leading to a hybrid 
formulation of the patient model and thus the development of hybrid mp-MPC. An 
estimation technique and different robust algorithms are implemented with the hybrid 
mp-MPC to deal with the inter- and intra- patient variability issue. 
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Chapter 5 describes an integrated software platform for the development of advanced mp-
MPC, PAROC, that is applied to both intravenous and volatile anaesthesia. All the 
theoretical developments presented in this thesis were included as part of the framework. 
6.2 Key Contributions 
 
The contributions of the work presented in this thesis can be summarised as follows: 
 Novel advanced model predictive control strategies were developed for 
intravenous anaesthesia and implemented for the control of depth of anaesthesia 
(DOA) in the induction and maintenance phases 
 Inter- and intra- patient variability has been successfully addressed by employing 
different estimation techniques and implemented with the mp-MPC control 
strategy – for both intravenous and volatile anaesthesia process. 
 A nominal hybrid explicit/multiparametric MPC structure was developed based 
on a piece-wise affine approximation of the intravenous anaesthesia model, which 
efficiently addresses the nonlinearity of the Hill curve. 
 Robust hybrid mp-MPC strategies were developed and simultaneously 
implemented and tested. 
 Simultaneous hybrid mp-MPC and multiparametric moving horizon strategy was 
developed and implemented for the intravenous anaesthesia. 
 The strategies and methods developed were incorporated as part of the 
PARametric Optimization and Control (PAROC) framework and software 
platform, thereby paving the way for personalized healthcare systems. 
 
6.3 Future Directions 
 
Three main general future direction can be employed on modelling, control and 
automation, for anaesthesia and general biomedical systems. 
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Modelling 
Despite the advances made in the development of models for anaesthesia there is vast 
room for improvements. The compartmental model used in this work, while it addresses 
some of the issues pertaining to anaesthesia there are still important issues that still need 
to be addressed. General disturbances generated by external stimuli are still a long way 
for being well captured within a model. Developing a good model of these disturbances 
could bring significant improvements in controlling the maintenance phase of anaesthesia 
and moreover in helping the anaesthesiologist dealing with critical situations. 
General anaesthesia consists of three components acting simultaneously on the patient’s 
biological signals: hypnosis, analgesia and neuromuscular blockade. Hypnosis is 
relatively well characterized and sensors to measure it by means of electroencephalogram 
(EEG) data are currently employed in standard clinical practice. Neuromuscular blockade 
ensures that the patient remains paralyzed during surgical procedures and is also a 
relatively well-characterized process with standard sensors available. However, analgesia 
is not at all characterized and no sensor is available for measuring the pain level that the 
patient may experience during general anaesthesia. The challenge originates from the fact 
that perception of nociceptives in the neural dynamics and hence in the subsequent 
biological feedback is not understood properly since models to characterize this complex 
biological process are not available. In contrast to the well-understood dose-response 
relationship for the hypnotic component of sedation, the dose-response relationship for 
the analgesic component of sedation needs further study. The development of models for 
analgesia will significantly improve the derivation of more accurate control strategies for 
anaesthesia.  
Control 
As presented throughout the thesis, the control of anaesthesia poses a manifold of 
challenges: (i) inter- and intra-patient variability, (ii) multivariable characteristics, (iii) 
variable time delays, (iv) dynamics depending on the hypnotic agent, (v) model analysis 
variability and (vi) agent and stability issues (Haddad et al., 2003), (Absalom et al., 
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2011), (Morley et al., 2000). While in this thesis we have addressed issues related to the 
nonlinearity and inter- and intra- patient variability there are still more challenges that 
need to be overcome. Employing robust techniques and/or simultaneous hybrid 
estimators and mp-MPC can lead to a more systematic characterisation of the uncertainty, 
therefore paving the way to personalized health care systems. 
As mentioned previously, analgesia modelling will play a key role to the design of 
controllers for anaesthesia. Determining a second output that will originate from the 
effect of the analgesic agent will lead to the implementation of multivariable 
multiparametric model predictive control strategies that will significantly improve the 
control of anaesthesia. Therefore we will be able to tackle the synergic effects of several 
drugs induced in the patient during general anaesthesia, thus bringing us closer to a fully 
automated anaesthesia process. 
Automation 
Other applications of the developed strategies and of the PAROC framework for the 
anaesthesia process lie in the areas of: 
 patient simulators or mannequins for training of nurses, medical students or 
anaesthetists, 
 on-line computation of the current drug concentrations and effect on the patient 
during surgery 
One of the most advanced patient simulators on the market is the CAE Healthcare© 
HPS®, (Healthcare, 2013a). This patient simulator shows all vital functions and inhales 
and exhales oxygen and anaesthetic agents according to a mathematical model (Meurs, 
2011). Several software for training are available, the most well-known tool is Gas 
Man®, (MMSI, 2006) a computer tool for teaching, simulating and experimenting with 
anaesthesia uptake and distribution. The SmartPilot View by Drager, (Herbst, 2010) or 
the Navigator Applications Suite software by GE Healthcare, (Healthcare, 2013c) are 
software tools that enable a frequently updated state of the patient calculated based on 
drug infusions and boluses and the measured variables e.g. the exhaled and inhaled gases 
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and the vital functions. The aim of these tools is to provide the anaesthetist with a 
decision support. The anaesthetist can follow the moving state of the patient in a 2D 
graph and see the future states for the given infusions and inhalations.(Grunberg, 2009). 
A fully automated anaesthesia process will bring great advantages to both: (i) the patient 
by increasing their safety as well as reducing the side effects by optimizing the drug 
infusion rates, and (ii) the anaesthesiologist by acting as a teaching and testing platform 
and offering in depth understanding of the process. There is still a long way to go to a 
fully automated operation theatre since all three main components of anaesthesia 
(hypnosis, analgesia and muscle relaxation) have to be simultaneously controlled. 
Moreover there is still no established solution in measuring analgesia. Nevertheless, the 
intensive research in this field is undoubtedly paving the way to overcoming these 
challenges and achieving a fully operational automated anaesthesia process. 
Nowadays, embedded systems are used in many applications in the medical field for 
controlling various biomedical parameters. Several embedded systems can be found in 
anaesthesia monitoring systems but not yet in control of anaesthesia. By using mp-MPC 
the expensive online computation of the optimal control action is bypassed (online 
optimization via offline optimization) resulting in just the implementation of a simple 
look up table and simple function evaluation. This will facilitate the implementation of 
the control of DOA on embedded devices (MPC-on-a-chip).(Pistikopoulos, 2009). 
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The use of sensitivity analysis in the context of biomedical engineering is of critical 
importance. Sensitivity analysis has been increasingly used for the assessment of the 
robustness of complex biological and biomedical models and in uncertainty 
quantification (Kontoravdi et al., 2005, Kontoravdi et al., 2010, Yue et al., 2008, 
Kiparissides et al., 2009, Kucherenko et al., 2009). This is particularly relevant in the 
field of pharmacometrics when trying to estimate the relative influence of 
pharmacokinetic, pharmacodynamics and other uncertain parameters. Sensitivity analysis 
is also used in model simplification as an approach to decrease the parametric 
dimensionality of biological systems. It could also be used to remove some parts of a 
model that do not significantly affect its response. This is usually done by fixing non-
essential parameters to their mean value so that more attention can be dedicated to 
critically important factors to perform tasks like parameter estimation or optimal design 
of experiment. In recent years, global sensitivity analysis has gained considerable 
attention due to its advantages over local sensitivity analysis approaches (Homma et al., 
1996, Saltelli, 2004). Global sensitivity analysis (SA) can be used to quantify the 
variability in model predictions resulting from the uncertainty in multiple parameters and 
to shed light on the biological mechanisms driving system behaviour (Sumner et al., 
2012). It is model-independent by design and has the capability of detecting parametric 
interactions, unlike one factor at a time (OAT) local methods (Saltelli et al., 2010). An 
eminent class of global sensitivity analysis techniques is that of variance based method, 
which include the well-known Sobol’ method of sensitivity indices (Sobol, 1993, Sobol, 
2001). One of the disadvantages of such methods that are based on Monte-Carlo 
sampling is the necessity to repeatedly run potentially expensive simulations. This is 
exacerbated in the case of high dimensional input spaces for which exploration may 
become computationally intractable. One way to reduce the computational expense of 
performing sensitivity analysis has been the use of surrogate-models or meta-models. 
This approach consists of using relatively simpler models that emulate the dynamic 
behaviour of the original computationally intensive models. Various surrogate modelling 
approaches has been suggested such as Gaussian process modelling, polynomial chaos 
expansion (Sudret, 2008), radial basis function (Buhmann, 2003), and High Dimensional 
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model representation (Li et al., 2002)(actually a particular instance of PCE). The two 
main difficulties of these approaches are: The ability to handle higher dimension spaces 
and the sampling requirements to achieve convergence. For example regression based 
PCE approaches are better suited for systems with no more than 10 input variables 
(Blatman et al., 2010). Methods based on numerical integration like HDMR are able to 
perform in high dimensional spaces but may require a significant amount of sampling 
realization in order to achieve convergence. An efficient solution is the combined use of 
low computational screening methods to discards non-essential variables prior to the use 
of a variance-based method on the remaining parameters. One of the most commonly 
used screening methods is the Morris method (Morris, 1991). A very powerful set of 
data-driven approaches is the class of inductive modelling methods, in particular group 
method of data handling (Ivakhnenko et al., 1995). Group method of Data handling is 
based on the cybernetic principle of self-organization and has the ability to perform with 
limited data samples and in very high dimensional spaces, by selecting important 
parameters in an adaptive fashion. Another advantage of the approach is its immunity to 
noise. This is a very relevant aspect as in many cases, the sensitivity analysis practitioner 
does not necessarily have access to a model but only noisy field data.  
 
A1 The Sobol’s Sensitivity Analysis 
The Sobol’s sensitivity analysis method is a variance based approach based on the 
ANOVA decomposition(Sobol, 2001, Sobol et al., 2005). If 𝑓 is an integrable function 
defined on the unit hypercube 𝐼𝑛and 𝑥𝜖𝐼𝑛, 𝑥 = (𝑥1, … , 𝑥𝑛) the input variables, the output 
𝑓(𝑥) of the function may be expressed as: 
𝑓(𝑥) = 𝑓0 + ∑ ∑ 𝑓𝑖1…𝑖𝑠(𝑥𝑖1 , …
𝑛
𝑖1<⋯<𝑖𝑠
𝑛
𝑠=1
, 𝑥𝑖𝑠) 
(Equation A.1) 
 
  
𝑓0 is the mean response of 𝑓and the terms 𝑓𝑖(𝑥𝑖) and 𝑓𝑖𝑗(𝑥𝑖,𝑥𝑗) represent the first and 
second order terms and so on. The formula above is termed ANOVA decomposition. The 
component functions may then be expressed as integrals of𝑓: 
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∫ 𝑓(𝑥)𝑑𝑥 = 𝑓0 
∫ 𝑓(𝑥) ∏ 𝑑𝑥𝑘 = 𝑓0 + 𝑓𝑖(𝑥𝑖
𝑘≠𝑖
) 
∫ 𝑓(𝑥) ∏ 𝑑𝑥𝑘 = 𝑓0 + 𝑓𝑖(𝑥𝑖
𝑘≠𝑖,𝑗
) + 𝑓𝑖𝑗(𝑥𝑖 , 𝑥𝑗) 
 
(Equation A.2) 
 
One of the most known global sensitivity analysis methods was introduced by (Sobol, 
2001). If it is assumed that𝑓 is square integrable over 𝐼𝑛, we have: 
 
∫ 𝑓2(𝑥)𝑑𝑥 − 𝑓0 = ∑ ∑ ∫ 𝑓𝑖1…𝑖𝑠𝑑𝑥1 … 𝑑𝑥𝑠
𝑛
𝑖1<⋯<𝑖𝑠
𝑛
𝑠=1
 
 
(Equation A. 3) 
 
𝐷 = ∫ 𝑓2(𝑥)𝑑𝑥 − 𝑓0and𝐷𝑖1…𝑖𝑠 = ∫ 𝑓𝑖1…𝑖𝑠𝑑𝑥1 … 𝑑𝑥𝑠 
 
 
 
The terms represent the variance and partial variance respectively. The Sobol’s sensitivity 
indices (SI) can be given by: 
𝑆𝑖1…𝑖𝑠 =
𝐷𝑖1…𝑖𝑠
𝐷
 
 
(Equation A. 4) 
 
where: 
∑ ∑ 𝑆𝑖1…𝑖𝑠 = 1
𝑛
𝑖1<⋯<𝑖𝑠
𝑛
𝑠=1
 
 
(Equation A. 5) 
 
If a set of variables 𝑦 = (𝑥1, … , 𝑥𝑠)is considered and 𝑧 a set of the complementary 
variables, we note 𝑥 = (𝑦, 𝑧). Using the previous definition of the variance the total 
variance of the subset 𝑦 can be computed as: 
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𝐷𝑦
𝑡𝑜𝑡 = 𝐷 − 𝐷𝑧 (Equation A. 6) 
 
and: 
𝑆𝑦
𝑡𝑜𝑡 =
𝐷𝑦
𝑡𝑜𝑡
𝐷
 
(Equation A.7) 
 
The following inequality holds:  
0 ≤ 𝑆𝑦 ≤ 𝑆𝑦
𝑡𝑜𝑡 ≤ 1 
 
(Equation A. 8) 
 
If 𝑆𝑦 = 𝑆𝑦
𝑡𝑜𝑡 = 0 then 𝑓 does not depend on 𝑦. 
If 𝑆𝑦 = 𝑆𝑦
𝑡𝑜𝑡 = 1 then 𝑓only depends on 𝑦. 
 
The indices enable us to rank variables and discard unessential variables. Sensitivity 
analysis indices are usually computed through Monte-Carlo numerical integration (Sobol, 
2001). 
𝐷𝑦 = ∫ 𝑓(𝑥)𝑓(𝑦, 𝑧)𝑑𝑥𝑑𝑧 − 𝑓0
2 
(Equation A. 9) 
 
Using low discrepancy sequences have shown to increase the efficiency of the 
technique especially the Sobol’s sequence for uniform sampling. 
 
2.2.1.2 High Dimensional Model Representation (HDMR) 
In order to efficiently build the map of the input-output behavior of a model function 
involving high dimensional inputs, (typically 𝑛~102 − 103), the HDMR approach was 
introduced as a set of quantitative tools. In most engineering problems the expansion of 
functions can be truncated to the second order component function by Li et al.(Li et al., 
2006, Li et al., 2002) 
 
𝑓(𝑥) ≈ ℎ(𝑥) = 𝑓0 + ∑ 𝑓𝑖(𝑥𝑖)
𝑛
𝑖=1
+ ∑ 𝑓𝑖𝑗(𝑥𝑖
1≤𝑖<𝑗≤𝑛
, 𝑥𝑗) 
(Equation A. 10) 
 
A particular way of deriving an HDMR representation through monte-carlo sampling is 
the Random Sampling HDMR technique (RS-HDMR). Since the computation of 
multidimensional integrals may become prohibitive (Sobol, 1993), an alternative 
technique based on the use of interpolation of over families over low order component 
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functions has been introduced by Rabitz and co-workers(Li et al., 2002). If a set of 
piecewise continuous component functions {𝜑} is considered, we can derive: 
 
𝑓𝑖(𝑥𝑖) = ∑ 𝛼𝑟
𝑖 𝜑𝑟(
𝑘
𝑟=1
𝑥𝑖) 
𝑓𝑖𝑗(𝑥𝑖 , 𝑥𝑗) = ∑ ∑ 𝛽𝑝𝑞
𝑖𝑗 𝜑𝑝(𝑥𝑖)𝜑𝑞(𝑥𝑗)
𝑚
𝑞=1
𝑙
𝑝=1
 
(Equation A. 11) 
 
Once a family of component functions has been selected the coefficients  
 
∀𝑟𝜖[1, 𝑘], 𝛼𝑟
𝑖 = ∫ 𝑓𝑖(𝑥𝑖)𝜑𝑟(
1
0
𝑥𝑖)𝑑𝑥𝑖 
∀𝑝𝜖[1, 𝑙], ∀𝑞𝜖[1, 𝑚], 𝛽𝑝𝑞
𝑖𝑗
= ∫ ∫ 𝑓𝑖𝑗(𝑥𝑖 , 𝑥𝑗)𝜑𝑝(
1
0
𝑥𝑖)
1
0
𝜑𝑞(𝑥𝑗)𝑑𝑥𝑖𝑑𝑥𝑗 
 
 
(Equation A. 12) 
 
In practice these calculations are done through Monte-Carlo Integration. There is a 
direct relationship between the HDMR expansion coefficients and the Sobol’s sensitivity 
analysis technique:  
 
𝐷𝑖 = ∑(𝛼𝑟
𝑖 )
2
𝑘𝑖
𝑟=1
 
(Equation A. 13) 
 
And 
𝐷𝑖𝑗 = ∑ ∑(𝛽𝑝𝑞
𝑖𝑗 )
2
𝑙𝑗
𝑞=1
𝑙𝑖
𝑝=1
 
 
(Equation A. 14) 
 
The sensitivity indices are obtained by dividing with the total variance. Even though, 
the total effect coefficients and the total variance, involving interaction order greater than 
three will still require the use of the Sobol original approach.  
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Although, HDMR has been very successful in a number of sensitivity analysis studies, it 
can be problematic in the case of a large number of parameters. The calculation of its 
component often require large sampling sets  even though the method is able of 
presenting high dimensional input-output relationships. In the case of computationally 
intensive simulation models this may become very impractical. 
2.2.1.3 Group Method of Data Handling (GMDH) 
Group Method of Data Handling (GMDH) is based on the principle of self-organization 
and is sometimes referred to as Polynomial Neural Networks. This technique is based on 
representing complex functions through networks of elementary expressions, like other 
advanced surrogate-modelling approaches such as neural networks or the HDMR 
approach.(Lorentz, 1966) and (Kolmogorov, 1957) have shown that any continuous 
function 𝑓(𝑥1, . . . , 𝑥𝑑) of dimension d on  [0, 1]
𝑑 can be exactly represented as a 
composition of sums and continuous one-dimensional functions. The GMDH approach is 
very efficient in data-driven modelling of complex systems with several advantages over 
conventional neural networks. We can refer to(Ivakhnenko and Muller, 1995, Lemke, 
1997)for more ample theoretical description of the method.  An advantage over the 
classical neural networks is that GMDH is inductive, adaptively creating models from 
data under the form of networks of optimized active neurons in an evolutionary manner. 
The aim is to estimate an optimal structure of a network that self-organizes itself during 
training making this a combined structure and parameter estimation procedure that starts 
from a basic structure the mean value of the time series output data. 
A first layer is built by considering all possible variables pair and inductively self-
constructing and validating neurons made of simple expressions, usually within linear or 
second order polynomials.  
This will result in a set of transfer functions for the first network layer. A number of 
fittest and best generalizing models consisting of neurons are then selected via an 
external criterion. After each single induction step model validation is performed as 
integrated critical part of model self-organization. In the classical approach, in order to 
create a new layer the selected neurons are subsequently used as inputs, while other 
neurons are discarded. More complex organizations can be generated by using the 
selection criterion and using the cybernetics inheritance principle. The final optimal 
complex structure consists of a single network. There is no need to predefine the number 
of neurons or layers to be used since they are adaptively determined through the learning 
process.  
The model self-organization stops itself when an optimal complex model has been found, 
i.e., further increasing model complexity would result in over-fitting the design data by 
starting adapting to noise. This is an important advantage over the RS-HDMR approach 
or regression based PCE that require the computation of a full set of predefined 
parameters. HDMR requires the computation of a large number of 𝛼𝑟
𝑖  coefficients 
through numerical integration 𝛽𝑝𝑞
𝑖𝑗
, for many combinations of parameters (𝑥𝑖,𝑥𝑗) and 
polynomial orders and unessential parameters can only be weeded-out a posteriori upon 
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calculation of these coefficients. 
2.2.1.4 GMDH-HDMR 
As shown previously, GMDH holds a number of advantages that are essential to global 
sensitivity analysis. The method is able to handle high dimensionalities, this being 
important in the context of biomedical engineering. Moreover, GMDH is, by design, a 
very efficient screening procedure in itself by adaptively weeding out unessential 
parameters in a computationally tractable manner. Also, it has good performance for 
small data samples. The presented method is based on the direct construction of the 
HDMR expansion by using GMDH inductive modelling. If a set of parameters (𝑥𝑖)𝑖∈⟦1,𝑛⟧ 
is considered, additional ‘synthetic’ variables are built.  
These correspond to Legendre orthogonal polynomials of up to a predefined order 𝑛 and 
evaluated on the original variables: 𝑋𝑟,𝑖 = 𝜑𝑟(𝑥𝑖), 𝑟 = 1. . 𝑛.  
The GMDH algorithm is performed only on these variables, imposing a multi-linear 
relationship between the variables. For the calculation of the Sobol’s sensitivity indices 
the coefficient of the GMDH expression are used. 
The main advantage of this method is its inductive ability to eliminate unessential 
parameters during the modelling process leading to the elimination of the calculation of 
coefficients for parameters that do not contribute to the variance of the output. The 
method, indeed incorporates the screening step and calculation of sensitivity indices in a 
single procedure. 
219 
 
 
 
 
 
 
Appendix B 
Model Reduction 
 
 
 
 
 
 
 
 
 
 
 
220 
 
Model order reduction (MOR) describes a methodology intended to reduce the 
dimensionality of a dynamical system while preserving its input-output behaviour (Figure 
B.1). The main purpose of model order reduction originally stemmed from a need to 
derive approximations of large-scale dynamical systems for simulation purposes. One 
major area of application has concerned the reduction of finite element models 
originating from the discretization of large-scale systems of ordinary differential 
equations (ODEs), differential algebraic equations (DAE), partial differential equations 
(PDEs) and partial differential algebraic equations (PDAEs). In effect, sophisticated 
discretization techniques yield computationally prohibitive high dimensional systems. 
These discretized systems tend to be extremely complex and sometimes intractable for 
the purpose of prediction and simulation, and even more so, in the case of the resolution 
of inverse problems characterizing optimization, parameter estimation and model 
predictive control. In the context of multiparametric/explicit model predictive control, 
this complexity takes a very specific meaning. Indeed, complexity directly materializes in 
steep increase in the number of critical regions, which results from the compounded 
effect of a high number of state variables (parameters) and constraints (dependent on the 
length of the prediction horizon) 
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Figure B. 1:  Schematic representation of the MOR approximation procedure 
Linear Model Order Reduction 
An important class of model reduction techniques concern linear systems. A major area 
of application of this class of problem has been the reduction of large-scale 
microelectromechanical systems(Antoulas, 2005). Most MOR techniques are projection 
based i.e., consist of projecting the dynamics of the original system on a lower 
dimensional subspace. One major class of methods is that of singular value 
decomposition methods (SVD) and is based on the more general concept of principal 
component analysis (PCA). PCA is a procedure concerned with inferring the covariance 
structure of a system by converting a set of observations of possibly correlated variables 
into a set of values of linearly uncorrelated variables called the principal components. 
The transformation results in a hierarchized set of principal components ordered by 
decreasing variance. In particular, it allows the identification of the principal directions 
(e.g. state variables) in which the data varies. The two main classes of MOR techniques 
are SVD methods and moment matching approaches.  In balanced truncation, a 
transformation is operated that project the system dynamics in a space where the most 
observable systems correspond to the most controllable ones. Following the procedure 
described in (Antoulas, 2005), we formulate a dynamical system in an equivalent 
balanced form: 
 
 (Equation B. 1) 
The linear gramians controllability and observability gramians and are defined as 
the unique positive definite solution to the Lyapunov equations: 
tt
ttt
Cxy
BuAxx

1
CW OW
222 
 
 
  
 
(Equation B. 2) 
 
 
Finding a balanced form for these gramians consists of finding a diagonal matrix  such 
that: 
 
  (Equation B. 3) 
 
Where 
  
 
(Equation B. 4) 
 
is a transformation matrix and the are the Hankel singular values. The 
transformation matrix is then used to reformulate the dynamical system in an equivalent 
balanced form: 
 
 
 (Equation B. 5) 
 
It is possible to truncate the system by retaining the states accounting for most of its 
dynamical behaviour by partitioning the balanced system: Noting and 
a reduced order LTI is obtained: 
 
 (Equation B. 6) 
 
where: 
 
 (Equation B. 7) 
 
Those synthetic i.e., physically meaningless states form an ordered set of decreasing 
controllability and observability. Another very important class of linear MOR techniques 
is that of moment-matching approaches. This class of method consists of the interpolation 
of the transfer function of a system, usually via the Pade approximation(Gallivan et al., 
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1994). It also belongs to the wider class of projection techniques known under the name 
of Krylov subspace methods(Krylov, 1931). Two widely used moment matching methods 
are the method of (Arnoldi, 1951) and (Lanczos, 1950). Current research concerns the 
combination of the two paradigms(Antoulas et al., 2001). These techniques are 
commonly referred to as  ‘SVD-Krylov’ methods.  For a thorough overview of linear 
MOR techniques, the reader will refer to (Antoulas, 2005). In some cases, a linear system 
is not sufficient to accurately capture the dynamics of a dynamical system. As 
linearization potentially leads to a significant loss of information, nonlinear model 
reductions approaches were introduced. 
Nonlinear Model Reduction 
The second approach employed is nonlinear balanced truncation, which is a snapshots 
based technique and an empirical extension of the linear balanced truncation technique. 
Consider a nonlinear system of ODEs of the following form: 
 
))(),(()(
))(),(()(
tutxhty
tutxftx


 (Equation B. 8) 
As in linear balanced truncation, the method consists of finding a transformation matrix 
T in order to project the state vector on a lower order subspace x =Tx . In order to 
compute these matrices, empirical gramians or covariance matrices are derived from 
simulation data from the system. 
Defining the following sets: 
  riITTTTTT iTinnirn ,...,1,,;,...,1    
 siIccccM iis ,...,1,0,;,...,1   
 n
n eeE ,...,1 standard unit vectors in
n  
(Equation B. 9) 
 
where r is the number of matrices for perturbation directions; s  the number of different 
perturbation sizes for each direction and n  the number of inputs of the system. Using the 
sets above it is possible to derive empirical controllabity and observability gramians as 
follows: 
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10) 
Where nnilm t  )(  
is given by   Tilmilmilmilmilm xtxxtxt 00 )()()(  and )(txilm is the state of the nonlinear 
system corresponding to the impulse input: 
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0)()( uteTctu ilm   and
ilm
x0 corresponds to the steady state of the system. Similarly an 
empirical observability gramian is defined by: 
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nnlm t  )(  
Is defined as 
  jlmjlmilmilmijlm ytyytyt 00 )()()(  and )(ty ilm  is the output of the system 
corresponding  to the initial condition 00 xeTcx ilm   
The ilmy0  corresponds to the output measurement when the system is at steady state.  A 
balanced system is then obtained from the previously defined empirical gramians as:  
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(Equation B. 
12) 
Using a Garlekin projection  0,IP   matrix with the same rank as the reduced system, 
the unimportant states may be set a nominal steady state value and the nonlinear reduced 
order model: 
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13) 
 
Note that in the case of the presence of parametric uncertainty, the system may be 
reduced by treating the parameters as exogenous inputs in a similar way as the method 
described above:  
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Simply by posing 
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A classification of linear and nonlinear model reduction techniques can be found in Table 
B. 1 and Table B. 2 presents a Summary of the literature on model order reduction for 
mp-MPC applications. 
Table B. 1: Classification of the main order reduction techniques (Antoulas, 2000) 
Moment Matching Methods SVD Methods 
Linear Systems Nonlinear Systems 
Arnoldi(Arnoldi, 1951) 
Lanczos(Lanczos, 1950) 
 
Balanced Truncation 
(Moore, 1982) 
Hankel Approximation 
(Adamjan et al., 1971), 
(Antoulas and 
Sorensen, 2001))  
POD  (Wong, 1971); Astrid, 
2004) 
Empirical Balanced 
Truncation (Lall et al., 1999, 
Hahn et al., 2002) 
 
TPWL (Rewieński et al., 
2001) 
 
Table B. 2: Summary of the literature on model order reduction for mp-MPC 
applications 
Authors Methodologies Key Features 
(Narciso and Pistikopoulos, 
2008) 
Balanced 
Truncation, mp-
MPC 
Combines linear balanced truncation 
and explicit MPC incorporating the 
error bound into the control 
formulation. 
(Singh and Hahn, 2005) Empirical 
Balanced 
Truncation, 
Luenberg type 
observers 
State estimation on nonlinear reduced 
order models obtain through empirical 
balanced truncation 
(Hovland et al., 2008) POD, mp-MPC, 
Kalman filters  
Implementation of a ‘goal-oriented’ 
model constrained optimization 
framework to determine the optimal 
POD reduction projection basis. 
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Simultaneous use of Kalman state 
estimation on the reduced order 
systems. 
(Bonis et al., 2012) Successive 
linearization, 
Krylov Methods 
‘Equation-free’ successive 
linearization of nonlinear systems of 
ODEs to which an Arnoldi order 
reduction scheme is applied. 
   
(Agarwal et al., 2013) POD Implementation of a trust-region 
framework to guarantee optimality 
conditions with respect to the original 
system in optimization problems 
defined on reduced order POD 
models. 
(Hedengren et al., 2005) Empirical 
balanced 
truncation, ISAT 
Order reduction through empirical 
balanced truncation coupled to 
complexity reduction and linearization 
via ISAT 
(Xie et al., 2012) ANNs, POD A hybrid, data-driven approach, 
constructing POD approximate 
models with 𝑎𝑖(𝑡) time varying 
coefficient determined via ANN 
black-box models and the basis 
function in POD from data plant 
‘snapshots’. 
   
(Lambert et al., 2013) Empirical 
balanced 
truncation 
Empirical balanced balance truncation 
combined to linearization and 
balanced truncation for application of 
mp-MHE 
(Rivotti et al., 2012) Empirical 
balanced 
Empirical balanced truncation 
combined to nonlinear mp-NMPC  
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truncation 
(Lambert et al., 2013) Variance-based 
model reduction 
Use numerical integration for a 
variance based approximation 
technique using global sensitivity 
analysis principles 
(Xie et al., 2011) POD,TPWL, mp-
MPC 
POD model order reduction of the 
dimensionality with respect to the 
spatial coordinate and use of TPWL to 
linearize the time dependent 
coefficients in the POD expansion. 
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C1. Multiparametric programming 
Multiparametric programming is a technique for solving any optimization 
problem, where the objective is to minimize or maximize a performance criterion subject 
to a given set of constraints and where some of the parameters vary between specified 
lower and upper bounds. The main characteristic of multiparametric programming is its 
ability to obtain: (i) the objective and optimization variable as a function of the varying 
parameters, and (ii) the regions in the space of the parameters where these functions are 
valid [critical regions (CR)] (Kouramas et al., 2011b). 
The advantage of using multiparametric programming to address these problems is that 
for problems pertaining to plant operations, such as for process planning, scheduling, and 
control one can obtain a complete map of all the optimal solutions. Hence, as the 
operating conditions vary, one does not have to reoptimize for the new set of 
conditions(Pistikopoulos et al., 2007a). 
A general multiparametric programming problem may be formulated as follows. 
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Where f, g and h are twice continuously differentiable in x and θ.  
If (Equation C.1) has a quadratic objective function, linear constraints, and the 
parameters appear on the right-hand side of the constraints the equation will have the 
following form 
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(Equation C.2) 
 
where c is a constant vector of dimension n, Q is an (n x n) symmetric positive definite 
constant matrix, A is a (p x n) constant matrix, F is a (p x m) constant matrix, b is a 
constant vector of dimension p, and X and Θ are compact polyhedral convex sets of 
dimensions n and m, respectively. Note that a term of the form θTPx in the objection 
function can also be addressed in the following formulation, as it can be transformed into 
the form given in (Equation C.2) by substituting x = s – Q-1PTθ, where s is a vector of 
arbitrary variables of dimensions n and P is a constant matrix of dimension (m x n). 
 If we apply the basic sensitivity theorem to (Equation C.2) at [x(θQ),θQ] we will 
obtain the following result: 
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Where 
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(Equation C.4) 
 
and Y is a null matrix of dimension (n x m). Thus, in the linear-quadratic optimization 
problem, the Jacobian reduce to a mere algebraic manipulation of the matrices declared in 
(Equation C.2) 
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The space of θ where this solution remains optimal is defined as the critical 
region, CR
Q
, and can be obtained by using feasibility and optimality conditions. The 
notation CR will be used to denote the set of points in the space of θ that lie in CR as well 
as to denote the set of inequalities which define CR. Feasibility is ensured by substituting 
xQ(θ) into the inactive inequalities given in (Equation C.2), whereas the optimality 
condition is given by λ̃Q(θ)≥0, where λ̃Q(θ) corresponds to the vector of active 
inequalities, resulting in a set of parametric constraints. This is represented by 
  ,,0)(~,)( IGQQR CRFbxACR  

 (Equation C.6) 
 
where ?̌?, ?̌?, and ?̌? correspond to the inactive inequalities and CRIG represents a set of 
linear inequalities defining an initial given region. A compact representation of CR
Q
 is 
obtained from the parametric inequalities by removing the redundant inequalities:  
232 
 
  ,RQ CRCR   (Equation C.7) 
 
where Δ is an operator which removes redundant constraints(Pistikopoulos et al., 2007a). 
Once CR
Q
, which is a polyhedral region, has been defined for a solution, [x(θQ), θQ], the 
next step is to define the rest of the region, CR
rest
, as proposed in(Pistikopoulos et al., 
2007b)]: 
 QIGrest CRCRCR   (Equation C.8) 
 
We then obtain another set of solutions in each of these regions and their 
corresponding CRs. The algorithm terminates when there are no more regions to be 
explored, namely when the solution of the differential equation (Equation C.3) has been 
fully approximated by first-order expansions. 
Table C. 1: mp-QP algorithm 
Step 1 In a given region solve (Equation C.2) by treating θ as a free variable 
to obtain a feasible point [θQ] 
Step 2 Fix θ = θQ and solve (Equation C.2) to obtain [x(θQ), λ(θQ)] 
Step 3 Compute [-(MQ)
-1
NQ] from (Equation C.3) 
Step 4 Obtain [xQ(θ),λQ(θ)] from (Equation C.5) 
Step 5 Form a set of inequalities, CR
R
, as described in (Equation C.6) 
Step 6 Remove redundant inequalities from this set of inequalities and define 
the corresponding CR
Q
 as given in (Equation C.7) 
Step 7 Define the rest of the region, CR
rest
as given in (Equation C.8) 
Step 8 If no more regions to explore, go to the next step, otherwise go to Step 
1 
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Step 9 Collect all the solutions and unify the regions having the same solution 
to obtain a compact representation 
 
The main steps of the algorithm are presented in Table C. 1. While defining the 
rest of the regions, some of the regions are split and hence the same optimal solutions 
may be obtained in more than one region. Therefore, the regions with the same optimal 
solutions are united and a compact representation of the final solution is obtained. 
 
C.2 Multiparametric mixed-integer programming 
The solution of mp-MIP problems is very challenging. The additional complications 
introduced by the presence of integer variables are (i) combinatorial complexity and (ii) 
nonconvexity. In the following, the problem and solution characteristics of mp-MIP 
problems are described, before approaches are reviewed which have been proposed to 
solve certain mp-MIP problems. Based upon these, a general framework for the solution 
of a certain class of mp-MIP problems is presented, as well as a novel strategy on how to 
handle the presence of nonconvexity in the description of the critical regions. 
Remark C.1 The most common mp-MIP problems, and thus the ones considered here, 
are multiparametric mixed-integer linear and quadratic programming (mp-MILP and 
mp-MIQP, respectively) problems, whereas mp-MILP problems are a subclass of the mp-
MIQP problems with a linear objective function. 
C 2.1 Problem and Solution Characterization 
In the following, the following mp-MIQP problem is considered 
 
𝑧(𝜃) = min
𝑥,𝑦
(𝑄𝜔 + 𝐻𝜃 + 𝑐)𝑇𝜔 
𝑠. 𝑡.        𝐴𝑥 + 𝐸𝑦 ≤ 𝑏 + 𝐹𝜃 
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               𝑥 ∈ 𝑅𝑛, 𝑦 ∈ {0,1}𝑝, 𝜔 ∈ [𝑥𝑇 , 𝑦𝑇]𝑇 
               𝜃 ∈ Θ ≔ {𝜃 ∈ 𝑅𝑞|𝜃𝑙
𝑚𝑖𝑛 ≤ 𝜃𝑙 ≤ 𝜃𝑙
𝑚𝑎𝑥, 𝑙 = 1, … , 𝑞} 
 
(Equation C.9) 
 
 
where Θ is a polyhedral subset of the parameter space, and the matrices have appropriate 
dimensions. Note that this formulation only includes binary variables. Furthermore, only 
𝑄 > 0 is considered. 
When the integer combination 𝑦 = ?̅? is fixed in problem (Equation C.9), the following 
mp-QP problem results 
 
𝑧(𝜃) = min
𝑥
(𝑄𝑥𝑥 + 𝐻𝑥𝜃 + ?̃?𝑥)
𝑇𝑥 + 𝑓(𝜃) 
𝑠. 𝑡.        𝐴𝑥 ≤ (𝑏 − 𝐸?̅?) + 𝐹𝜃 
               𝑥 ∈ 𝑅𝑛, 
               𝜃 ∈ Θ ≔ {𝜃 ∈ 𝑅𝑞|𝜃𝑙
𝑚𝑖𝑛 ≤ 𝜃𝑙 ≤ 𝜃𝑙
𝑚𝑎𝑥, 𝑙 = 1, … , 𝑞}, 
 
(Equation C.10) 
 
 
where the index 𝑥 denotes the part of the matrix or variable associated with the 
continuous variable 𝑥, and ?̃?𝑥 = 𝑐𝑥 + 𝑄𝑥𝑦?̅?, where 𝑄𝑥𝑦 is the part of 𝑄 associated with 
the combination of continuous and binary variables. Note that 𝑓(𝜃) does not influence 
the solution 𝑥(𝜃), as it is a scaling factor of the objective function value. 
The solution of problems of type (Equation C.10) has been studied extensively, and its 
solution characteristics are reported in the following definition and theorem. 
Definition C.1 (Piecewise affinity and critical regions (Bemporad et al., 2002c)) A 
function 𝑥(𝜃): 𝛩 ↦ 𝑅𝑛, where 𝛩 ⊆ 𝑅𝑞 is a polyhedral set, is piecewise affine if it is 
possible to partition 𝛩 into convex polyhedral regions, called critical regions, 𝐶𝑅𝑖, and 
𝑥(𝜃) = 𝐾𝑖𝜃 + 𝑟𝑖, ∀𝜃 ∈ 𝐶𝑅𝑖 . 
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Remark C.3 The definition of a piecewise quadratic function is analogous. 
Definition C.2 (Parametric profile) The solution of a mp-P problem is referred to as a 
parametric profile, and it consists of the closure of the critical regions and the solutions 
associated with them. 
Theorem C.1 (Properties of mp-QP solution (Bemporad et al., 2002c, Dua et al., 
2002a)) Consider the optimal solution mp-QP problem (3.7) and let 𝑄𝑥 be positive 
definite, 𝛩 convex. Then the set of feasible parameters 𝛩𝑓 ⊆ 𝛩 is convex, the solution 
𝑥(𝜃) is piecewise affine and the optimizer solution 𝑧(𝜃): 𝛩𝑓 ↦ 𝑅 is continuous, convex 
and piecewise quadratic. 
In the case of mp-MIQP problems of type (Equation C.9), the solution properties are 
given by the following theorem and lemma. 
Theorem C.2 (Properties of mp-MIQP solution (Borrelli et al., 2005)) Consider the 
optimal solution of problem (Equation C.9) and let 𝑄 be positive definite. Then, the 
solution 𝑥(𝜃) is piecewise affine, and the set 𝐶𝑅𝑖 has the following form 
𝐶𝑅𝑖 = {𝜃: 𝜃
𝑇𝐺𝑖,𝑗𝜃 + ℎ𝑖,𝑗
𝑇 𝜃 ≤ 𝑤𝑖,𝑗 , 𝑗 = 1, … , 𝑡𝑖} (Equation C.11) 
 
 where 𝑡𝑖 is the number of constraints that describe 𝐶𝑅𝑖. 
Lemma C.1 (Quadratic boundaries (Borrelli et al., 2005)) Consider the solution of 
problem (Equation C.9) as a combination of solutions of the mp-QP problems associated 
with all possible combinations of binary variables. Then, quadratic boundaries arise 
from the comparison of quadratic objective functions associated with feasible 
combinations of binary variables. 
C.2.3 A general framework for the solution of mp-MIQP problems 
Based on the similarities highlighted in the comments, it is possible to formulate a unified 
framework for the solution of mp-MIQP problems of type (Equation C.9). This 
framework incorporates all approaches presented so far and shows their underlying 
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similarities. This does not only lead to a good theoretical understanding, but also is the 
basis for a unified software implementation of all the approaches. 
This framework is based on the following 5 key components: 
Initialization: The algorithm is initialized. 
Integer Handling: A candidate integer solution is found, which is fixed in the original 
 problem thus transforming it into a mp-QP problem. The three options to find a 
 suitable candidate are (i) global optimization (Dua et al., 2002a), (ii) branch-and-
bound (Acevedo et al., 1997b, Axehill et al., 2011, Axehill et al., 2014c, Oberdieck et al., 
2014a) and  (iii) exhaustive enumeration (Borrelli, 2003). 
mp-QP solution: The mp-QP problem is solved using available solvers (e.g. (Bemporad 
et al., 2002c, Dua et al., 2002a, Spjøtvold et al., 2006, Tøndel et al., 2003)). 
Comparison procedure: The objective function values of the mp-QP problem and the 
upper bound in the critical region considered are compared against each other to form a 
new, tighter upper bound. The four comparison procedures are (i) no comparison of the 
objective function (Dua et al., 2002a, Borrelli, 2003), (ii) comparison of the objective 
function over the entire  critical region considered (Axehill et al., 2011, Axehill et 
al., 2014c), (iii) linearization of the nonlinearities in the objective function using 
McCormick relaxations (Oberdieck et al., 2014a) and (iv) calculation of the exact 
 solution via piecewise outer approximation of quadratically constrained critical 
 regions, a procedure which will be explained in detail in section 3.2.5. Note that 
the approaches (i)-(iii) might result in envelopes of solutions. 
Termination: The algorithm terminates if a termination criterion is reached. 
A schematic representation of the framework is shown in Figure C.1: The general 
framework for the solution of mp-MIQP problems.. 
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Figure C.1: The general framework for the solution of mp-MIQP problems. 
 
The framework presented presents several options for the way integer variables are 
handled and the comparison procedures are done. Since the integer handling has a greater 
influence on the structure of the algorithm, as it changes how the problem is approached, 
this will be used to distinguish the way the unit operations are approached by the integer 
handling method chosen. 
In the following, each aspect of the framework is discussed and suggestions for their 
implementation are presented. 
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C.2.4 Detailed analysis of the general framework 
Initialization 
The aim of the initialization procedure is to convert the input data efficiently into a 
suitable form such that the main algorithm can solve the problem. The initialization 
procedures for mp-MIQP problems presented so far involve initializing the binary search 
tree (in the case of a branch-and-bound procedure) (Acevedo and Pistikopoulos, 1997b, 
Axehill et al., 2011, Axehill et al., 2014c, Oberdieck et al., 2014a), creating a list of all 
possible integer variable combinations (in the case of an exhaustive enumeration 
procedure) (Borrelli, 2003) and setting the upper bound to ∞ (Acevedo and 
Pistikopoulos, 1997b, Dua et al., 2002a, Oberdieck et al., 2014a). 
Remark C.9 Notably this part could also be used for other tasks such as upper bound 
creation of initialization of parallelization strategies. These topics are subject to ongoing 
research and provide possibilities of lowering the computational burden. 
 Integer Handling 
The aim of this unit operation is to (i) find a candidate integer variable combination and 
(ii) fix it in the original mp-MIQP resulting in a mp-QP. As previously mentioned, three 
different approaches have been presented: 
 Global Optimization (Dua et al., 2002a): A candidate binary variable solution is 
found by solving the global optimization problem. 
 Branch-And-Bound (Acevedo and Pistikopoulos, 1997b, Axehill et al., 2011, 
Axehill et al., 2014c, Oberdieck et al., 2014a): The branch-and-bound procure 
relies on relaxing the binary variables 𝑦 ∈ {0,1}𝑝 to continuous variables ?̅? ∈
[0,1]𝑝, which results in a mp-QP problem. Based on this relaxation a binary 
search tree , and at each node one binary variable is fixed to either 0 or 1. 
Additionally, each node inherits a parameter space from its parent node, where the 
mp-QP is solved. This parameter space is based on the original parameter space 
Θ, after the following fathoming criteria have been applied 
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o The problem is infeasible 
o An integer solution is found 
o The optimal objective function value of the parent node is greater than the 
current best upper bound in the entire parameter space considered. 
 Exhaustive Enumeration (Borrelli, 2003): All possible combinations of binary 
variables, a total of 2𝑝, are considered exhaustively. Note that this approach is 
identical to considering the final depth of a binary search tree. 
Solution of the mp-QP problem 
The solution of mp-QP problem has been discussed extensively in the open literature. 
The two main approaches are thereby: 
 Geometrical approach (Bemporad et al., 2002c, Dua et al., 2002a, Spjøtvold et al., 
2006, Tøndel et al., 2003, Patrinos et al., 2010, Patrinos et al., 2011): A 
geometrical interpretation of the polyhedral regions as half spaces is used to 
successively explore the initial parameter space. Different techniques discussing 
different exploration and redundancy checks have thereby been discussed. 
 Combinatorial approach (Gupta et al., 2011c, Feller et al., 2013a, Feller et al., 
2013b): The solution of the mp-QP problem is viewed at via the Karush-Kuhn-
Tucker conditions, where a certain combination of the inequality constraints is 
active and inactive, thus leading to a system of linear equations. The consideration 
of all combinations of all constraints thereby exhaustively solves the problem. 
The different approaches presented aim at limiting this combinatorial complexity. 
Comparison procedure 
After the solution to the mp-QP problem has been obtained, it has to be compared against 
the current upper bound. The need for such a comparison procedure arises from the fact 
that it is not possible to explore the parameter space like performed for the solution of the 
mp-QP problem due to the presence of the integer variables. 
Mathematically, this comparison procedure can be described as 
240 
 
 
𝑃𝑃𝑠𝑜𝑙 = min
𝜃∈Θ
𝑃𝑃1 ∪ 𝑃𝑃2 (Equation C.12) 
 
Where 𝑃𝑃𝑖 refers to the 𝑖-th parametric profile (see Definition C.2) and 𝑃𝑃1 ∪ 𝑃𝑃2 
represents the union of the two parametric profiles. The main challenges to solve 
(Equation C.12) are thereby: 
 Combinatorial complexity: In order to obtain 𝑃𝑃𝑆𝑜𝑙, each critical region of 𝑃𝑃1 
has to be compared to each critical region of 𝑃𝑃2, thus leading to combinatorial 
complexity. 
 Nonconvexity: the possibly quadratic nature of the objective functions might lead 
to nonconvexities. As the handling of nonconvex critical regions is a challenging 
problems, other ways have to be found to deal with this issue. 
Remark C.10 All comparison procedures presented to date focus on how to deal with the 
nonconvexity, while little attention has been given to the combinatorial complexity of the 
problem. At the end of this section we will present a first analysis of the problem. 
Additionally, in the next section a new comparison procedure resulting in the exact 
partitioning of the parameter space is presented.  
In the open literature, three different comparison procedures have been presented: 
 No objective function comparison (Dua et al., 2002a): This approach, first 
presented in (Dua et al., 1999), does not compare the objective functions of the 
two parametric profiles, but directly creates an envelope of solutions (see 
Definition C.3). 
 Objective function comparison over entire CR (Axehill et al., 2011, Axehill et 
al., 2014c): This approach was first presented in the realms of multiparametric 
dynamic programming (mp-DP) problems (Borrelli et al., 2005), and later on 
applied to mp-MIQP problems. It consists of classifying the situation in the 
currently considered intersect of critical regions  and eq. (3.14). If case (c) is 
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realized, then an envelope of solutions (Definition C.3) is created over the entire 
critical region. 
 Direct objective function comparison via McCormick relaxations (Oberdieck 
et al., 2014a): In this procedure, the difference Δ𝑧(𝜃) between the objective 
functions in the considered intersect of critical regions is directly considered. If 
quadratic terms are present in Δ𝑧(𝜃), then affine under- and overestimators using 
McCormick relaxations (McCormick, 1976) are calculated. These estimators 
generate polyhedral regions, in which either the objective function of one of the 
parametric profiles is optimal or an envelope of solutions is created. 
In order to lessen the combinatorial complexity of the system, it is necessary to 
incorporate additional information into the solution of problem. In particular, it is 
necessary to classify each critical region 𝐶𝑅𝑘 of parametric profile 𝑖 according to the 
following criteria: 
Case (a): 𝐶𝑅𝑘 does not overlap with any critical region from the other parametric 
profile, 𝑃𝑃𝑗 . 
Case (b): 𝐶𝑅𝑘 partially overlaps with one or multiple critical regions from the other 
parametric profile, 𝑃𝑃𝑗 . 
Case (c): 𝐶𝑅𝑘 completely overlaps with one or multiple critical regions from the 
other parametric profile, 𝑃𝑃𝑗 . 
 
Figure C.2: The three classifications of overlap between 𝑪𝑹𝒌 and 𝑷𝑷𝒋 
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Any part of 𝐶𝑅𝑘 that does not overlap with 𝑃𝑃𝑗  does not have to be considered in the 
comparison procedure, as it cannot be compared to anything. Thus, the number, or 
volume, of critical regions considered can be reduced, thus lessening the impact of the 
combinatorial complexity. However, in order perform the classification, the union of all 
critical regions in 𝑃𝑃𝑗  has to be calculated, a procedure which also is subject to 
combinatorial complexity. However, this complexity is lower than the previous one, as it 
only requires the comparison of all critical regions associated with one parametric profile, 
and not with two.  
Termination 
In order to conclude the framework description, a suitable way of defining the 
termination criterion has to be outlined. The structure of this termination criterion 
depends on the integer handling approach chosen: 
 Global optimization: If the problem is infeasible in every critical region. 
 Branch-and-bound: If the list of nodes 𝑁 is empty. 
 Exhaustive Enumeration: If all combinations of binary variables have been 
explored. 
As previously mentioned, the exhaustive enumeration approach is thereby the only 
approach which allows for an a priori determination of the number of problems that will 
be solved in the course of the algorithm. 
Comments 
Based on the proposed framework, the following comments are made. 
 Any of the comparison procedures presented can be combined with any of the 
integer handling strategies to create an algorithm which is most suitable to ones 
needs. Among these combinations are also the mp-MIQP algorithms that have 
been presented so far. Thus, the presented framework sheds a light on the 
development of these algorithms and gives great theoretical insight. 
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 It is possible to include relative and absolute suboptimality into this framework 
(the first description of which was presented in (Axehill et al., 2011, Axehill et 
al., 2014c)). However, it does not significantly add to the scientific content 
presented and is thus omitted. 
 If any advances are made in any of the components of the framework, e.g. 
initialization, integer handling or comparison procedure, then these advances can 
be readily incorporated into the existing framework. Thus it is a flexible account 
not of a specific algorithm, but rather of a general solution approach for this class 
of problems. 
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Appendix D 
Advanced Model Based Control Strategies 
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Model Predictive Control (MPC) is a control methodology based on two main 
principles: explicit on-line use of a process model to predict the process output at future 
time instants and the computation of an optimal control action by minimizing one or 
more cost functions, possibly including constraints on the process variables. 
For a better understanding of the MBPC principle, the concept is presented in Figure D.1 
 
Figure D.1: Strategy of MBC principle 
 
The process output y(t+k) is predicted over a time horizon k=1..N2 at each 
‘current’ moment t. The predicted values are indicated by y(t+k/t) and the value N2 is 
called the prediction horizon. Assuming that the model is available, the prediction will be 
done by means of a model of the process. The forecast depends on the past inputs and 
outputs, but also on the future control scenario {u(t+k/t),k=0…N2-1}. Starting at 
r(t/t)=y(t) we define a reference trajectory {r(t+k/t),k=0…N2-1} over the prediction 
horizon, describing how we want to guide the process output from its current value y(t) to 
its setpoint w(t). The control vector{u(t+k/t),k=0…N2-1} is calculated in order to 
minimize a specified cost function. This cost function depends on the predicted control 
errors {r(t+k/t)-y(t+k/t) k=1…N2-1}. All other elements of the calculated control vector, 
except the first one, u(t/t), that is actually applied to the real process can be forgotten, 
because at the next sampling instant all time-sequences are shifted, a new output 
measurement y(t+1) is obtained and the whole procedure is repeated. This leads to a new 
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control input u(t+1/t+1), which is generally different from the previously calculated 
u(t+1/t); this principle is called the ‘receding horizon’ strategy. The MBPC strategy can 
be visualized in the following block-scheme: 
 
 
Figure D.2: MBC block-scheme. 
 
EPSAC Strategy – Theoretical Background 
The EPSAC - MPC strategy, as described in detail in (De Keyser, 2003), for linear 
models is based on a generic process model: 
 ( ) ( ) ( )y t x t n t   (Equation D.1) 
 
The disturbance n(t) includes the effects in the measured output y(t) which do not come 
from the model input u(t) via the available model. These non-measurable disturbances 
have a stochastic character with non-zero average value, which can be modelled by a 
coloured noise process: 
 1 1( ) ( ) / ( ) ( )n t C q D q e t      (Equation D.2) 
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-
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with: e(t) - uncorrelated (white) noise with zero mean value;  C(q
-1
) and D(q
-1
) - monic 
polynomials in the backward shift operator q
-1
 of orders nc and nd. This design filter can 
be used to improve the quality of the control performance, by supplying information to 
the controller about the type of disturbances. In this application, the disturbance filter
1 1( ) / ( )C q D q  is defined as a pure integrator, used to remove the steady-state error, 
similarly to the effect of the integrator in case of PID controller. 
The relationship between u(t) and x(t) is given by the generic dynamic system model: 
  ( ) ( 1), ( 2), , ( 1), ( 2),x t f x t x t u t u t      
 
(Equation D.3) 
In our case the input applied to the patient, u(t), is a scalar containing the Propofol 
delivery rate. The process output is predicted at time instant t over the prediction horizon, 
N2 based on the measurements available at that moment and the future outputs of the 
control signal. The predicted values of the output are:  
 )|()|()|( tktntktxtkty   (Equation D.4) 
 
Prediction of x(t+k|t) and of n(t+k|t) can be done respectively by recursion of the 
process model and by using filtering techniques on the noise model (Equation D.2) (De 
Keyser, 2003). 
In EPSAC for linear models, the future response is then considered as being the 
cumulative result of two effects: 
 
base optimize
( | ) ( | ) ( | )y t k t y t k t y t k t      (Equation D.5) 
The component 
base ( | )y t k t  is a sum of the effects of: 
 past control {u(t-1), u(t-2), ...},  
 a base future control scenario, defined a priori (a simple choice being 
 base ( | ) 0, 0u t k t k   ) 
 future (predicted) disturbances n(t+k|t).  
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The vector 
base ( | )y t k t can be easily obtained using (Equation D.2) - (Equation D.4) 
taking ( | )baseu t k t  as the model input for (Equation D.3).  
The vector optimize ( | )y t k t represents the effect of the optimizing future control actions 
  ( | ), ( 1| ), ( 1| )uu t t u t t u t N t      (Equation D.6) 
 
With 
 
base( | ) ( | ) ( | )u t k t u t k t u t k t       (Equation D.7) 
 
The vector 
optimize ( | )y t k t  is given by: 
 optimize 1
1
( | ) ( | ) ( 1| )
                       ... ( 1| )
u
k k
k N u
y t k t h u t t h u t t
g u t N t
 


 
    
   
 (Equation D.8) 
 
The parameters 
21 2
, ,... ,...k Ng g g g are the coefficients of the unit step response of the system, 
i.e., the response of the PK-PD system for a stepwise change of the input (with amplitude 
1). The parameters 
21 2
, ,... ,...k Nh h h h  are the coefficients of the unit impulse response of the 
system and can be easily calculated from the step response coefficients and vice versa: 
1k k kh g g     
 (and 
0 -1 0 -1... ... 0h h g g      ). 
The key EPSAC-MPC equation:  
  Y Y GU  (Equation D.9) 
 
is obtained, where:  
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Y
Y
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G
 
(Equation D.10) 
 
with the horizons N1, N2 being design parameters, N1 being equal to the time-delay, in 
samples.  
The controller output is obtained by minimizing a cost function: 
 2
1
2( ) [ ( | ) ( | )]
N
k N
J r t k t y t k t

   U  
 
(Equation D.11) 
 
where r(t+k|t) is the desired reference trajectory. 
The cost function (Equation D.11) is a quadratic form in U, having the following 
structure using the matrix notation from (Equation D.10) and with R defined similarly to 
Y:  
 1( ) [ ] [ ]J     U R Y GU R Y GU  (Equation D.12) 
 
which leads after minimization w.r.t. U to the optimal solution: 
 * 1[ ] ( )T T U G G G R Y  (Equation D.13) 
 
Only the first element )/( ttu in U
*
 is required in order to compute the actual control and 
this represents the control signal which will be applied to the patient: 
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 base base( ) ( | ) ( | ) ( | ) (1)u t u t t u t t u t t
   U  (Equation D.14) 
 
At the next sampling instant t+1, the whole procedure is repeated taking into account the 
new measurement information y(t+1). 
The cost function can be extended in order to penalize excessive control actions: 
 UUYRYRU
TT=)J(  )()(  
UGYY   
(Equation D.15) 
 
 
and the control input is calculated by 
 )()( 1 YRGIGGU   TT   (Equation D.16) 
 
It is worthwhile to notice that optimization with input constraints (on the manipulated 
variable) are accepted only if the control horizon Nu >1. Since in this paper the control 
horizon is unitary, the input is constrained using clipping. 
 
D.2 mp-MPC Strategy – Theoretical Background 
We consider the mp-MPC problem of a linear discrete-time system with state and input 
constraints: 
 
 
𝑥𝑘 ∈ 𝑋 ⊆ ℝ
𝑝, 𝑢𝑘 ∈ 𝑈 ⊆ ℝ
𝑠 
(Equation D.17) 
 
 
where  are the states, outputs and inputs of the system, respectively. are the 
sets defining the state and input constraints and that contain the origin in their interior. 
are positive semi definite matrices and is a symmetric 
positive matrix, is the horizon length of the MPC. 
min
uk
xNMPC PMPC
2
+ xk
k=1
NMPC
å
QMPC
2
+ uk
k=0
NMPC-1
å
RMPC
2
xk+1 = Axk +Buk, y =Cxk
uyx ,, UX ,
0,0  MPCMPC PQ 0MPCR
MPCN
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 The reformulation as a multiarametric quadratic problem is given by: 
 
 
k
kk
TT
U
Cxy
NkBuAxx
Gts
YxxxFUHUUU





k
1k
          
..1  ,           
ExWU ..      
2
1
2
1
minarg)(
 (Equation D.18) 
 
where 𝑈 is the vector contain the control moves sequence. The quadratic optimization 
problem in (Equation D.18) can be converted to a multi-parametric programming 
problem by performing the linear transformation: 
 𝑧 = 𝑢 + 𝐻−1𝐹𝑇𝑥 (Equation D.19) 
 
The resulting mp-QP has the following form: 
  
 
 
𝑥𝑘 ∈ 𝑋 ⊆ ℝ
𝑝, 𝑧 ∈ 𝑈
⊆ ℝ𝑠 
 
(Equation D.20) 
 
where 𝑧 represents the new decision variable while 𝑆 is defined as: 
 
𝑆 = 𝐸 + 𝐺𝐻−1𝐹𝑇 
(Equation D.21) 
 
 
In this new formulation, 𝑥 is now acting as a parameter of the optimization problem and 
only appears in the constraints. Next, local sensitivity analysis is performed on the 
Karush-Kuhn-Tucker (KKT) conditions of the mp-QP: 
 𝐻𝑧 + 𝐺𝑇𝜆 = 0 (Equation D.22) 
 
 
min
z
1
2
zTHz
Gz £W + Sx
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 𝜆𝑖(𝐺𝑖𝑧 − 𝑊𝑖 − 𝑆𝑖𝑥) = 0, 𝑖 = 1. . 𝑞 
𝜆 ≥ 0 
 
(Equation D. 23) 
 
 
[
𝑧(𝑥)
𝜆(𝑥)
] = −(𝑀0)
−1𝑀0(𝑥 − 𝑥0) + [
𝑧(𝑥0)
𝜆(𝑥0)
] 
(Equation D.24) 
 
   
 
 
 (Equation D.25) 
 
 
 
 (Equation D.26) 
 
 
The parameter space i.e., the set of 𝑥 values for which the explicit relationship between 
[𝑧(𝑥), 𝜆(𝑥)] and the parameter around the point [𝑧(𝑥0), 𝜆(𝑥0)] remains optimal is termed 
a critical region, which is of the following form: 
 
𝐶ℛ𝑖 = {𝑥 ∈ ℝ
𝑛|𝐻𝑖𝑥 ≤ 𝑏0} 
(Equation D.27) 
 
 
 Each of these critical regions contains an affine expression describing the optimal 
control value of the states: 
 
 (Equation D.28) 
 
where is the number of critical regions.  
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T
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As explained before, this reduces the online implementation of MPC to simple function 
evaluation, facilitating real time applications. One of the main difficulties when 
attempting to design a multi-parametric/explicit controller is the increase in the number 
of critical regions with the number of states and constraints, the latter being function of 
the control prediction horizon. Here we give the worst-case computational complexity for 
an mp-QP controller: 
 
𝑁𝑟 = ∑ 𝑘! 𝑙
𝑘
𝜂
𝑘=0
 
𝜂 = ∑
𝑙!
(𝑙 − 𝑖)! 𝑖!
ℎ
𝑖=0
 
(Equation D. 29) 
 
 
where ℎ is the number of optimization variables and 𝑙 is the number of inequalities. 
Another issue is the transposition of mp-MPC techniques to nonlinear systems. This is 
the topic of the next paragraph. 
One of the advantages of model predictive control is the ability to handle generic 
constraints. Additional constraints, specific to the application being considered, may be 
easily added without loss of generality.  
The reformulation presented in this section may be adapted in a straightforward way to 
different model predictive control strategies, such as reference output tracking, constraint 
softening, or to include penalties to the rate of change in the input vector 
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E.1 Kalman Filter 
The Kalman filter is a standard method for unconstrained state estimations and it 
follows a two-step procedure to calculate the maximum a-posteriori Bayesian estimate 
(Rawlings et al., 2009, Rao, 2000, Welch and Bishop, 2001). The first step is the time 
update which uses the system model to predict the current state of the system based on 
the last estimate. The second step is the measurement update. The prediction from the 
previous step is updated by using the sensor information. Therefore, we can say that the 
Kalman filter is predictor-corrector type estimator that is optimal in the sense that it 
minimizes the estimated error covariance . 
Time update (prediction step) 
Prediction of the state: 
 11/11/ ˆˆ   kkkkk BuxAx  (Equation E.1) 
 
 Projection of the error covariance: 
 
kal
T
kkk QAAPP   11/  (Equation E.2) 
 
Measurement update (correction step) 
 
Computation of the Kalman gain: 
 1
1/1/ )(

  kal
T
kk
T
kkk RCCPCPK  (Equation E.3) 
 
 Update of the estimate with measurement: 
 )(ˆˆ 1/1//   kkkkkkkk CxyKxx  (Equation E.4) 
 
 Update of the error covariance 
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 1/)(  kkkk PCKIP  (Equation E.5) 
Where Qkal and Rkal represent the measure of confidence in the model and the 
measurement.  
The solution of the discrete algebraic Riccati equation (Söderström, 2002). 
 
kal
T
kal
TTT QPABRPBBPBAPAAP  1)(  (Equation E.6) 
  
Can be used for the calculation of the steady-state gain which makes Pk+1=Pk=P constant. 
 
E.2 Moving Horizon Estimation 
The idea of moving horizon estimation is to estimate the state using a moving and fixed-
size window of data. Once a new measurement becomes available, the oldest 
measurement is discarded and the new measurement is added. The concept is to penalize 
deviations between measurement data and predicted outputs. In addition – for theoretical 
reasons - a regularization term on the initial state estimate is added to the objective 
function. There are two main characteristics that distinguish MHE from other estimation 
strategies, such as Kalman filter: (i) prior information in the form of constraints on the 
states, disturbances and parameters can be included; (ii) since MHE is optimization based 
it is able to handle explicitly nonlinear system dynamics through the use of 
approximative nonlinear optimization algorithms. In (Haseltine and Rawlings (2005)) 
MHE was shown to possess superior estimation properties compared to the Extended 
Kalman Filter . 
 
The Kalman filter considers only one set of measurements at a time. In (Rawlings and 
Mayne, 2009) is shown that the Kalman filter is the algebraic solution to the following 
unconstrained least-square optimization problem: 
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k
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k
kP
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Where 
 
kkk
kkkk
vCxy
GwBuAxx

1
 (Equation E. 8) 
 
And Qk>0, Rk>0, P0 >0 are positive definite matrices. This optimization problem now 
opens the possibility to add system knowledge in the form of constraints. The constraints 
might for example capture the fact that a leak is always an outflowing stream or account 
for non-zero non-Gaussian noise (Robertson et al., 2002). 
The optimization problem (Equation E.7) is then not equivalent to the Kalman filter any 
more. If all the available past measurements are used for the estimation as in (Equation 
E.7), the estimation problem grows unbounded with time. This is referred to as the full 
information estimator (Rao, 2000). The derivation is based on the maximization of the a-
posteriori Baysian estimate. In order to keep the estimation problem computationally 
tractable it is necessary to limit the processed data, for example by discarding the oldest 
measurement once a new one becomes available. This essentially slides a window over 
the data, leading to the moving horizon estimator (MHE). The data that is not considered 
any more can be accounted for by the so called arrival cost so that the information is not 
lost. The MHE then considers only a limited amount of data so that the constrained 
optimization problem becomes: 
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ˆˆ
ˆˆˆ
1
 
(Equation E.9) 
 
whereT is the current time, ,0,0  kk RQ 01/  TNTP are the covariances of kw kv NTx 
assumed to be symmetric, N is the horizon length of the MHE,  TTTT NTT NT yyY ,...,1   is a 
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vector containing the past 1N  measurements and  TTTT NTT NT uuU 11 ,...,   is a vector 
containing the past N inputs.  wvx ,, denotes the variables of the system and wvx ˆ,ˆ,ˆ
denote the estimated variable of the system and NTTx /ˆ and  
1
/
1 ˆˆ



 
T
NTT
T
NTT wWW TTNT Wx
ˆ,ˆ
/  
denote the decision variable of the optimization problem, respectively the estimated state 
variable and the noise sequence. 
 2
1
2
/
1
2
//
ˆxˆ
1/




 

P
T
NTTNT
T
NT
P
TNTTNT bUcxOYx
TNT
 
(Equation E.10) 
 
is described as the smoothed arrival cost. For steady-state MHE Qk = Q, Rk = R, and 
PT−N|T−1 = P are time invariant.  
The current state of the system can be calculated from the initial state xT|T−N by 
forward programming using the discrete time linear system if the deterministic input U
T−1 
T−N and the noise sequence 
1

T
NTW are known. It is thus sufficient to estimate the initial 
state ˆx*T|T−N and the noise ˆW
*
T .The concept of MHE is illustrated in Figure E. 1 where 
(·)T−k|T denotes the sample at time T − k obtained at time T 
 
Figure E. 1: Concept of MHE 
 
The MHE is applied with the following steps: 
1. The optimization problem (Equation E.9) is solved to obtain 
*
/
ˆ
NTTx  and
*ˆ
TW . 
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2. The current state estimate 
*
/
ˆ
TTx is obtained by substituting 
*
/
ˆ
NTTx  and 
*ˆ
TW into the 
system dynamics 
kkkk wGBuxAx ˆˆˆ 1  and projecting the state values forward from time 
T − N to the current time T by 



 
1
1*
/
*
/
ˆˆˆ
T
NTj
k
jT
TNT
N
TT wGAxAx  
3. When the next measurement becomes available (at the next sampling instance), steps 1 
and 2 are repeated. 
Remark E.1In the case T ≤ N, the full information estimator is solved using the arrival 
cost
2
// 1
0
ˆ   PTNTTNT xx
. The horizon ‘fills up’ and no data is discarded (Rao, 2000). 
Remark E.2 (Rao, 2000) points out that wrongly posed constraints might lead to an 
infeasible optimization problem and that constraints on 
kvˆ could be problematic due to 
the possibility of outliers in the measurement. Any constraints posed in (Equation E.9) 
should hence be chosen such that the real system does not violate them (Rao, 2000). 
This observation leads to the following assumption for the work in this thesis: 
Assumption E.1The real system does not violate the constraints posed to the MHE: 
WwVvx ˆ,ˆ,ˆ  which contain the origin in their interior. 
 
Multiparametric Moving Horizon Estimation 
The formulation of the MHE with the smoothed arrival cost is still an open issue which 
will be addressed here. In order to formulate and solve the constrained moving horizon 
estimator with multi-parametric programming, the optimization problem needs to be 
reformulated into the standard multi-parametric quadratic form. 
Darby and Nikolaou(Darby and Nikolaou, 2007) have re-formulated the MHE with the 
filtered arrival cost.  
The multiparametric formulation of the constrained MHE is obtained by substituting the 
state space formulation of the estimated system ?̂?𝑡+1 = 𝐴?̂?𝑡 + 𝐵𝑢𝑘 + 𝐺?̂?𝑡, 𝑣𝑡 = 𝑦𝑡 −
𝐶?̂?𝑡 into: 
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/11
1
/11
1
1
1
1
}{,
1
11
11
NTNTNTSS
T
NTNTNT
T
NTk
k
T
k
NT
NTk
k
T
k
wx
T
NTNT
xxPxxvRv
wwQwwwx
NT
NTNT













  (Equation E.11) 
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subject to 
arrive cost to  theof update        ˆ
 vnoise on the sconstraintpath                                                              
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Where N is the length of the horizon, T is the current point in time, Q and R are positive 
definite diagonal weighting matrices on the noises, PSS is the steady state solution for the 
Kalman filter. 
NT
NTw

 1}ˆ{  and 
T
NTv 1}{   are sequences of independent, normally distributed 
random numbers with mean values w  for {w} and zero-mean for {v}. NTNTx  /1  is the 
arrival costwhich captures the previous measurements that are not considered any more. 
1
ˆ
NTx  is the solution of the MHE at the previous time step. 
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(Equation E.12) 
where  
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(Equation E.13) 
 
where diag(·) denotes a matrix denotes a matrix of appropriate size with (·) on its main 
diagonal and zero everywhere else. Further details can be found in (Darby and Nikolaou, 
2007) and (Voelker et al., 2013). 
The optimal solution to the MHE optimization (Equation E.12) 
[?̂?𝑇−𝑁+1
∗ (𝜃), {?̂?}𝑇−𝑁+1
𝑇−1 ∗(𝜃)]
𝑇
  ( * denotes the the optimizer of problem (Equation E.12)) 
is a piecewise affine function of the measurements, inputs, and the arrival cost.  
 
 
[
?̂?𝑇−𝑁+1
∗ (𝜃)
{?̂?}𝑇−𝑁+1
𝑇−1 ∗(𝜃)
] = 𝐹(𝜃) = {
𝐾1𝜃 + 𝑐1 𝑖𝑓 𝜃 𝜖 𝐶𝑅
1
⋮ ⋮
𝐾𝑙𝜃 + 𝑐𝑙 𝑖𝑓 𝜃 𝜖 𝐶𝑅
𝑙
 
(Equation E.14) 
 
 
where l is the number of critical regions (CR). 
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Remark E.3 Often only the state estimate TTx /ˆ is of interest and hence it might be 
sufficient if only TTx /ˆ has to fulfil the constraints rather then all Tkx /ˆ for all k = T − N, . . . 
, T. It might therefore suffice to pose constraints only on TTx /ˆ rather than the whole 
horizon by replacing the matrix col )ˆ( xd with dx and the matrix diag )
ˆ( xD with  xDˆ...0
. This reduces the number of parameters in the optimization problem . 
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Appendix F 
Distillation Column 
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F.1 Distillation Column model 
This example considers the design of a controller for a simplified model of a distillation 
column (Benallou et al., 1986). The motivation for this example is to demonstrate how 
nonlinear model reduction techniques may be used to overcome the limitations of 
multiparametric programming algorithms for systems with high dimensionality. The 
assumptions in this example do not intend to describe an industrial situation and, at the 
current state of the art, explicit multiparametric controllers are not suitable for large scale 
applications such as industrial distillation columns (Pistikopoulos, 2009). The system is 
schematically depicted in Figure F. 1 and the underlying equations presented in Table F. 
1 and  
 
Table F. 2. It may be noted that the system is mostly linear, with nonlinearities arising 
only from the equilibrium relations. The control problem consists of regulating the 
product purity to a fixed set-point of y(t-1) = 0.935, using the reflux ratio as the 
manipulated variable. The system states, 𝑥𝑖, 𝑖 = 1. .3 are assumed to be measured and no 
external disturbances are considered. A constraint is imposed on the manipulated 
variable, which is allowed to vary in the interval RR ∈ [0 ; 5]. Due to the high 
dimensionality of the model, the mp-NMPC algorithm cannot be directly applied and a 
model order reduction step should be included beforehand. For the purposes of this 
example, reduced order models with 1 and 2 states were derived, using the technique 
presented in Appendix B. The discrete-time representation of the reduced system of 
ODEs was obtained using an implicit Runge–Kutta method. For the discretization, 3 
collocation points were used, and the number of finite elements was set to 9 and 6 for the 
reduced order controllers with 1 state and 2 states, respectively. The number of 
collocation points and finite elements may be determined performing off-line 
simulations. Even though a larger number of finite elements would lead to a finer 
approximation, and have impact on the control performance, it is limited by the 
corresponding increase in computational burden. The resulting control law consists of an 
expression for the manipulated variable, u, as an explicit function of the reduced states of 
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the system.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table F. 1: Schematic of the distillation column example model 
 
 
Condenser 
 
𝑑𝑥𝐴,1
𝑑𝑡
=
1
𝐴𝑐𝑜𝑛𝑑
𝑉(𝑦𝐴,2 − 𝑥𝐴,1) 
Trays in the rectification 
section 𝑖 = 2. .16 
 
𝑑𝑥𝐴,𝑖
𝑑𝑡
=
1
𝐴𝑇𝑟𝑎𝑦
[𝐿1(𝑥𝐴,𝑖−1
− 𝑥𝐴,𝑖)
− 𝑉(𝑦𝐴,𝑖
− 𝑦𝐴,𝑖+1)] 
Feed Tray: 
 
𝑑𝑥𝐴,17
𝑑𝑡
=
1
𝐴𝑇𝑟𝑎𝑦
[𝐹𝑥𝐴,𝐹𝑒𝑒𝑑
+ 𝐿1𝑥𝐴,16 − 𝐿2𝑥𝐴,17
− 𝑉(𝑦𝐴,17 − 𝑦𝐴,18)] 
 
Trays in the stripping section 
𝑖 = 2. .16: 
 
𝑑𝑥𝐴,𝑖
𝑑𝑡
=
1
𝐴𝑇𝑟𝑎𝑦
[𝐿2(𝑥𝐴,𝑖−1 − 𝑥𝐴,𝑖)
− 𝑉(𝑦𝐴,𝑖 − 𝑦𝐴,𝑖+1)] 
 
Reboiler: 
 
𝑑𝑥𝐴,32
𝑑𝑡
=
1
𝐴𝑅𝑒𝑏𝑜𝑖𝑙𝑒𝑟
[𝐿2𝑥𝐴,31
− (𝐹 − 𝐷)𝑥𝐴,32
− 𝑉𝑦𝐴,32] 
 
Mass balances  𝑉 = 𝐿1 + 𝐷     𝐿2 = 𝐿1 + 𝐹 
𝑅𝑅 =
𝐿1
𝐷
 
Volatilility 
     𝛼𝐴,𝐵 =
𝑦𝐴(1 − 𝑥𝐴)
𝑥𝐴(1 − 𝑦𝐴)
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Table F. 2: variables description Distillation column 
 
 
 
 
 
𝐴𝑐𝑜𝑛𝑑 total molar holdup in the 
condenser 
𝐴𝑇𝑟𝑎𝑦  total molar holdup in each tray 
 
𝐴𝑅𝑒𝑏𝑜𝑖𝑙𝑒𝑟 total molar holdup in each tray 
𝐹 Feed flowrate 
𝐷 Distillate flowrate 
 
𝐿1 Flowrate of the liquid in the  
rectification section 
𝐿2 Flowrate of the liquid in the 
stripping section 
𝑉 Vapour flowrate in the column 
 
𝑅𝑅 reflux ratio 
𝑥𝐴,𝑖 liquid composition of 
component 𝐴 on the 𝑖𝑡ℎ stage 
𝑥𝐴,𝐹𝑒𝑒𝑑 Feed composition of component 
𝐴  
𝑦𝐴,𝑖 vapour composition of 
component 𝐴 on the 𝑖𝑡ℎ stage 
𝛼𝐴,𝐵 relative volatility (assumed 
constant) 
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Multiparametric moving horizon estimators were built for the following approximated 
models: 
Case 1: The original distillation column model was first linearized, thus yielding a 32 
states linear time invariant system. This latter was subsequently reduced to two states via 
balanced truncation.  
Case 2: The original distillation column model was reduced to two states by using 
empirical nonlinear balanced truncation. The resulting two states system of ODEs was 
then linearized. 
Relative performance of both reduced order model is shown in Figure F.2. It is evident 
that the transient response of in case 1 gives a better fidelity to the original model. 
Figure F. 1: Schematic of the distillation column example 
model 
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Figure F.2: Dynamic simulations of the original system compared to reduced order 
models 
 
In this work we do not intend to have the original state information for the physical 
system. Note that the 32-states model cannot be directly used to derive multiparametric 
controllers/estimators. Also note that the remaining states are also those required to 
compute optimal control laws when deriving a mp-MPC controller. Although the first 
state of the original system of ODEs is measured, it is also possible to reconstruct it from 
the estimated reduced states. This is shown inFigure F.3 . One can notice that case 2 
offers a significantly better estimation than case 1 although both systems are linear. The 
comparison is also performed on the reduced states. The two lower dimensional 
subspaces onto which the original states are projected are not the same since the 
linearization in case 1 is performed around the steady states values of the original states 
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while the linearization in case 2 is carried out on the steady state values for the nonlinear 
reduced order model. In Figure F.4 we show the critical regions for the moving horizon 
estimator based on case 2,  which will be used for simultaneous mp-MPC/MHE. 
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Figure F.3: Comparison of reconstructed states for both reduced order models. 
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Figure F.4: actual and estimated reduced order state information for case 1 
Figure F. 5: actual and estimated reduced order state information for case 2 
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Figure F. and Figure F.  show the performance of both reduced order estimators in their 
respective subspace. One observation that can be made, having used similar reduction 
techniques both based on singular value decomposition and balancing of the system, is 
that the order in which the linearization and reduction steps are performed does matter 
and nonlinear model order reduction seems to perform better if employed prior to 
linearization 
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Figure F.4: Multiparametric critical region maps for the estimator built based on case 
2: Projection on the first two parameters, which are the two past measurements in the 
estimation problem. 
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mp-MHE and mp-MPC were combined  and a close-loop simulation, shown in Figure 
F.5, was performed to evaluate the performance of the methodology. It can be seen that 
the estimator provides sufficiently accurate information to the parametric controller to 
drive the system to the desired set point based only on measurement information. The 
combination of two reduced order parametric maps is then sufficient to operate a control 
policy for high order chemical process. A slight offset is observed around the set-point 
and is mainly due to the noise or uncertainty of the inlet concentration of the column. In 
the case of high measurement noise (Figure F.6 and Figure F.7), the control profiles are 
more erratic but the simultaneous implementation of mp-MPC and mp-MHE still achieve 
the desirable set-point change. 
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Figure F.5: Close loop simulation of  a set-point change operated through 
simultaneous mp-MHE and mp-MPC. 
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Figure F.6: Evolution of the control input variable in the case of high 
measurement noise 
 
Figure F.7: Evolution of the output variable input variable in the case of high 
measurement noise 
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Figure F.8: Critical regions for the mp-MPC controller implemented 
simultaneously to mp-MHE 
 
 
 
 
 
 
 
 
 
 
 
 
Case 1 Case 2 


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

 

92291.003223.0
051464.097902.0
A  









039587.0
06874.0
B  
 10013.0096179.0 C  
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09309532.0
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Table F. 3: LTI system for case 1 and case 2 
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